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engineering of Saccharomyces cerevisiae, and the application of these tools to investigate 
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Abstract 
 
The brewers’ yeast Saccharomyces cerevisiae has long been a close friend of humanity. 
Yeast has been used in food and beverage production for thousands of years, and our close 
relationship with yeast has led to it becoming a model organism in research. Yeast was the 
first eukaryote to have its genome sequenced, and has helped in the study of human 
diseases, such as cancer. This extensive characterisation, along with its routine use in 
bioprocesses makes it an attractive target for metabolic engineering efforts.  
 
The work presented in this thesis encompasses some of the work that has been undertaken 
as part of the Ph.D. programme. Herein, I present work towards the development of tools 
to improve the process of engineering S. cerevisiae, as well as to apply those and other 
existing metabolic engineering tools to gain insights into the metabolism of engineered 
yeast strains. This research focuses on the production of hydroxy acids, a class of 
carboxylic acid. 
 
In the first research study, we developed a new set of integrative yeast expression vectors 
based on the previously developed EasyClone system. We adapted this system for use with 
CRISPR-Cas9 to insert expression cassettes into the yeast genome without the need for 
also integrating markers. This increases the speed of the engineering cycle as no marker 
loop-out is required between transformations. It also negates the need for markers, both 
auxotrophic and dominant, which can alter native host physiology and potentially affect 
experimental results. We have made this vector toolkit available through the Addgene 
platform, and hope many will use it to facilitate their research in S. cerevisiae. Using our 
vector toolkit, we investigated different acetyl-CoA supply strategies and their impact on 
the production of 3-hydroxypropionic acid (3HP), a bulk chemical that is a common target 
for metabolic engineering. We discovered that expression of a bacterial pyruvate 
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dehydrogenase complex was the most successful strategy, which increased 3HP titres by 
almost 100% when grown in a simulated fed-batch medium. 
 
In the second study, focus is shifted away from tool development and towards metabolic 
engineering. Here we engineered a Crabtree-negative strain of S. cerevisiae to produce 
three different hydroxy acids; lactate, malate, and 3HP. We characterised these strains, and 
sought to gain an understanding of how these heterologous pathways influence the 
metabolism and physiology of the host strain. We performed 13C-based metabolic flux 
analysis to quantify the carbon flux distributions through the central carbon metabolism. 
Between the strains, we identified large differences in flux distribution, but each strain 
showed surprisingly high levels of flux through the pentose phosphate pathway, and only 
low levels of flux through the tricarboxylic acid (TCA) cycle.  
 
The third study attempts to use metabolic flux and transcriptomic analysis to identify key 
gene deletion strategies that can boost the production of 3HP in a host strain (ST938) 
capable of producing high levels of this hydroxy acid. Transcriptomic analysis revealed 
that much of central carbon metabolism was upregulated in ST938 compared to the WT 
strain, but metabolic flux analysis revealed lower proportional carbon flux through the 
TCA cycle. Metabolic flux analysis also revealed that only a small proportion of the 
available carbon flux was diverted into 3HP production. Computational approaches and 
insights from the transcriptomic analysis identified several gene deletion strategies that 
were then implemented in vivo. Of these strategies, the deletion of PRY1 was able to 
increase final 3HP titres by 27%. 
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Dansk Resumé 
 
Bryggergæren Saccharomyces cerevisiae har længe været en nær ven af menneskeheden. 
Gær har været brugt i mad og drikkevareproduktion i tusindvis af år, og vores tætte forhold 
til gær har ført til brugen af denne som modelorganisme i forskning. Gær var den første 
eukaryot der fik sit genom sekventeret og har været vigtig for forskning af menneskebårne 
sygdomme, såsom kræft. Den omfattende karakterisering i kombination med den 
rutinemæssige anvendelse i bioprocesser gør det til et attraktivt mål for metabolisk 
genmodificering. 
 
Denne afhandling omfatter noget af det arbejde, der er udført som led i mine Ph.D studier. 
Heri præsenterer jeg arbejde i forbindelse med udvikling af værktøjer til forbedring af 
processen omkring genmodificering af S. cerevisiae, samt at anvende disse nyudviklede 
værktøjer sammen med allerede eksisterende værktøjer til at få indblik i metabolismen hos 
de nyudviklede gærstammer. Denne forskning fokuserer på produktion af hydroxysyrer, 
en klasse af carboxylsyre. 
 
I det første studie udviklede vi et nyt sæt integrerede gærekspressionsvektorer baseret på 
det tidligere udviklede EasyClone-system. Vi tilpassede dette system til brug med CRISPR-
Cas9 til at indsætte ekspressionskassetter i gærgenomet uden behov for også at integrere 
markører. Dette øger hastigheden, da der ikke kræves en markørsløjfe mellem 
transformationer. Det negerer også behovet for markører, både auxotrofe og 
dominerende, hvilket kan ændre indfødt værtsfysiologi og potentielt påvirke 
eksperimentelle resultater. Vi har gjort denne vektor værktøjskasse tilgængelig via Addgene 
platformen, og håber mange vil bruge den til at gøre deres forskning i S. cerevisiae 
nemmere. Ved hjælp af vores vektor værktøjssæt undersøgte vi forskellige acetyl-CoA 
forsyningsstrategier og deres indvirkning på produktionen af 3-hydroxypropionsyre (3HP), 
et kemikalie, der ofte bliver brugt som mål for metabolisk genmodificering . Vi fandt, at 
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ekspression af et bakterielt pyruvat-dehydrogenasekompleks var den mest vellykkede 
strategi, der forøgede 3HP-titrer med næsten 100%, når de blev dyrket i et simuleret fodret 
batch medie. 
 
I det andet studie er fokus rykket væk fra værktøjsudvikling, og fokus er i stedet på 
metabolisk genmodificering. I dette studie konstruerede vi en Crabtree-negativ stamme af 
S. cerevisiae til fremstilling af tre forskellige hydroxysyrer; lactat, malat og 3HP. Vi 
karakteriserede disse stammer og søgte at få en forståelse for, hvordan disse heterologe 
veje påvirker værtsstammens metabolisme og fysiologi. Vi udførte 13C-baseret metabolisk 
fluxanalyse til at kvantificere carbonfluxfordelingen gennem den centrale 
carbonmetabolisme. Vi identificerede store forskelle i fluxfordelingen mellem stammerne, 
men alle stammer viste overraskende høje niveauer af flux gennem pentosefosfatvejen og 
kun lave niveauer af flux gennem tricarboxylsyre (TCA) -cyklussen. 
 
I det tredje studie forsøger vi at anvende metabolisk flux og transkriptomisk analyse til at 
identificere nøglestrategier for målrettet genfjernelse, der kan øge produktionen af 3HP i 
en værtsstamme (ST938), der allerede er kendt for at producere høje niveauer af denne 
hydroxysyre. Transcriptomisk analyse viste, at meget af den centrale carbonmetabolisme 
er opreguleret i ST938 sammenlignet med WT-stammen, mens metabolisk fluxanalyse 
afslørede at en lavere proportion af kulstoffet føres gennem TCA-cyklusen. Metabolisk 
fluxanalyse afslørede dog også, at kun en lille del af den tilgængelige carbonflux blev omledt 
til 3HP-produktion. Computerberegninger og indsigt fra den transkriptomiske analyse 
identificerede adskillige genfjernelsesstrategier, som derefter blev implementeret in vivo. 
Af disse strategier var sletningen af PRY1 i stand til at øge de endelige 3HP titre med 27%. 
  
	vi 
Acknowledgements 
 
I have learnt many new things during my time at CfB, both in and outwith science. Having 
not been exposed to a lab setting before starting the Ph.D., there was a steep hill to climb. 
All of my thanks and gratitude go to those who have helped me gain the skills that I need 
to undertake the work I have done. There are too many to thank individually, but all past 
and present members of both Yeast Metabolic Engineering and Synthetic Biology Tools 
for Yeast have not only helped me to learn, but also have provided a kind and supportive 
atmosphere to work in. My office mates too, for providing some very interesting 
discussions. Also important to mention are my new colleagues in the (formerly known as) 
iLoop unit who have been very supportive, with particular thanks to Niko Sonnenschein, 
and my office mates; Ali Kaafarani, Svetlana Kutuzova, Alba Lopez, Emre Özdemir, 
Moritz Beber, Pannipa Ponpitakpong, Alex Hoffmeyer, and Ibrahim El-Semman. There 
are also many people and friends that I have met during my PhD at CfB and DTU, 
unfortunately too many to mention all by name. But I wish to extend thanks to them all.  
 
I could not have completed my studies without the supportive and patient hand of my 
supervisor, Dr. Irina Borodina without whom I would not have had this opportunity. 
Regards must also be paid to Dr. Itay Budin, with whom I worked in the Keasling Lab in 
the University of California, Berkeley.  
 
Particular, individual, thanks need to be extended to the following; Jonathan, who provided 
me with many favours towards the end of my studies. Gheorghe, for his invaluable 
practical tutelage in the commencement of my PhD, and for many enjoyable discussions. 
Christian, for offering a rare and much appreciated kind of friendship, spurring a different 
kind of creativity than that found during my studies. Sarah, for always being so much fun, 
and for having the most interesting life of anyone that I know and managing to do all the 
  vii 
things I would never be able to. And lastly as always, Mikkel, who provides a much needed 
distraction from academic thought.   
 
My final and most important thanks must be given to my family for all their support and 
to my girlfriend, Kathrine, for always being there for me. I cannot express my gratitude 
enough, but I hope to keep trying. 
	viii 
Contents 
 
PREFACE........................................................................................................................................ i 
ABSTRACT .................................................................................................................................... ii 
DANSK RESUME ....................................................................................................................... iv 
ACKNOWLEDGEMENTS ...................................................................................................... vi 
CONTENTS ............................................................................................................................... viii 
LIST OF PUBLICATIONS ........................................................................................................ x 
LIST OF ABBREVIATIONS .................................................................................................... xi 
LIST OF FIGURES AND TABLES ....................................................................................... xv 
THESIS OVERVIEW ............................................................................................................. xviii 
CHAPTER 1: Introduction .......................................................................................................... 1 
    1.1 Introduction to metabolic engineering of Saccharomyces cerevisiae ......................... 1 
        1.1.1 Overview of S. cerevisiae ........................................................................................... 2 
        1.1.2 Crabtree-negative S. cerevisiae .................................................................................. 5 
        1.1.3 Yeast as a cell factory .................................................................................................. 8 
        1.1.4 Hydroxy acid production in yeast ........................................................................... 10 
            1.1.4.1 Lactate ................................................................................................................. 11 
            1.1.4.2 Malate .................................................................................................................. 13 
            1.1.4.3 3-Hydroxypropionic acid .................................................................................. 15 
    1.2 Tools for the metabolic engineering of yeast ............................................................... 20 
        1.2.1 Design ......................................................................................................................... 21 
            1.2.1.1 Metabolic modelling .......................................................................................... 21 
            1.2.1.2 Biological “Parts” .............................................................................................. 24 
        1.2.2 Build ............................................................................................................................ 26 
            1.2.2.1 Genetic manipulation of yeast ......................................................................... 26 
        1.2.3 Test/Learn – Omic technologies ............................................................................ 31 
            1.2.3.1 Transcriptomics ................................................................................................. 32 
	 ix 
            1.2.3.2 13C-based metabolic flux analysis (Fluxomics) .............................................. 34 
    1.3 References .......................................................................................................................... 37 
     
CHAPTER 2: EasyClone-MarkerFree: A vector toolkit for marker-less integration of 
genes into Saccharomyces cerevisiae via CRISPR-Cas9 ........................................................ 57 
	
CHAPTER 3: A comparative study into the effects of pyruvate derived product 
production pathways on the physiology and metabolism of a Crabtree-negative 
Saccharomyces cerevisiae strain ................................................................................................. 91 
 
CHAPTER 4: Omic data based improvement of a high performance 3-hydroxypropionic 
acid producing strain of Saccharomyces cerevisiae .............................................................. 133 
 
CHAPTER 5: Conclusions and future perspectives ............................................................ 169 
	
 
 
 
 
 
  
	x 
 
List of Publications 
 
Paper I. 
 
Mathew M Jessop-Fabre*, Tadas Jakočiūnas*, Vratislav Stovicek, Zongjie Dai, Michael K 
Jensen, Jay D Keasling, Irina Borodina. (2016) EasyClone-MarkerFree: A vector toolkit 
for marker-less integration of genes into Saccharomyces cerevisiae via CRISPR-Cas9. 
Biotechnology Journal. 11(8): 1110-1117. 
 
Paper II. 
 
Mathew M Jessop-Fabre, Jonathan Dahlin, Vratislav Stovicek, Itay Budin, Jay D Keasling, 
Irina Borodina. (2018) A comparative study into the effects of different pyruvate 
derived product production pathways on the physiology and metabolism of a 
Crabtree-negative Saccharomyces cerevisiae strain. Manuscript in preparation. 
 
Paper III. 
 
Mathew M Jessop-Fabre, Kanchana R Kildegaard, Birgitta E Ebert, Emre Özdemir, Lars 
M Blank, Irina Borodina (2018) Omic data based improvement of a high performance 
3-hydroxypropionic acid producing strain of Saccharomyces cerevisiae. Manuscript in 
preparation. 
  
	 xi 
List of Abbreviations 
 
0-9 
3HP    3-hydroxypropionic acid 
3HPA   3-hydroxypropionaldehyde 
 
A 
ACL    ATP-dependent citrate lyase 
ACS   Acetyl-CoA synthase 
ADH   Alcohol dehydrogenase 
AHA   α-hydroxy acid 
ATP    Adenosine triphosphate 
 
B 
BAPAT   β-alanine-pyruvate amino transferase 
BHA   β-hydroxy acid 
 
C 
CAD   Computer aided design 
Cameo   Computer aided metabolic engineering and optimisation 
Cas    CRISPR-associated system 
cDNA   Complementary DNA 
CDW   Cell dry weight 
CoA    Co-Enzyme A 
CRISPR    Clustered Regularly Interspaced Short Palindromic Repeats 
crRNA   CRISPR RNA 
CSM    Complete supplement mixture 
CTR   Carbon transfer rate 
C2   Compound containing two carbon atoms 
 
D 
DHAP   Dihydroxy-acetone-phosphate 
DNA   Deoxyribonucleic acid 
DSB   Double-strand break 
	xii 
dsDNA    Double-stranded DNA 
 
 
F 
FBA   Flux balance analysis 
FIT    Feed-in-time 
 
G 
GC-MS   Gas chromatography - mass spectrometry 
GEM   Genome scale metabolic model 
GFP    Green fluorescent protein 
GO   Gene ontology 
GRAS   Generally regarded as safe 
gRNA    Guide RNA 
 
H 
HIBADH   3-hydroxyisobutyrate dehydrogenase  
HPDH   3-hydroxypropionate dehydrogenase 
HPLC    High-performance liquid chromatography 
HR    Homologous recombination 
 
I 
INCA   Isotopomer network compartment analysis 
 
L 
LB   Lysogeny broth 
LDH   Lactate dehydrogenase 
 
M 
MATLAB   Matrix laboratory 
MFA    Metabolic flux analysis 
MM    Minimal media 
mRNA    Messenger RNA 
 
N 
	 xiii 
NAD+    Nicotinamide adenine dinucleotide  
NADH    Reduced nicotinamide adenine dinucleotide  
NADP+    Nicotinamide adenine dinucleotide phosphate 
NADPH    Reduced nicotinamide adenine dinucleotide phosphate 
NGS    Next generation sequencing 
NHEJ    Non-homologous end joining 
NMR   Nuclear magnetic resonance 
 
O 
OD    Optical density 
OHA   Ω-hydroxy acid 
OTR   Oxygen transfer rate 
 
P 
PAM    Protospacer adjacent motif 
PCR    Polymerase chain reaction 
PDC    Pyruvate decarboxylase 
PDH    Pyruvate dehydrogenase 
pFBA   Parsimonious flux balance analysis 
pH   Potential of hydrogen 
PP   Pentose phosphate  
 
Q 
qPCR    Quantitative PCR 
 
R 
RNA   Ribonucleic acid 
RPM   Revolutions per minute 
RQ   Respiratory quotient 
rRNA    Ribosomal RNA 
 
S 
SBOL   Synthetic biology open language 
SC   Synthetic complete 
SD    Standard deviation 
	xiv 
SDM   Site directed mutagenesis 
sgRNA    Single guide RNA 
SNP   Single nucleotide polymorphism 
 
T 
TALEN    Transcription activator-like effector nuclease 
TCA    Tricarboxylic acid 
tracrRNA   Transactivating CRISPR RNA 
tRNA    Transfer RNA 
 
U 
USER    Uracil-specific excision reagent 
UV    Ultra-violet 
 
W 
WT   Wild-type 
 
Y 
YPD    Yeast extract peptone dextrose 
 
Z 
ZFN   Zinc finger nuclease 
 
 
 
  
	 xv 
List of Figures and Tables 
 
Chapter 1 
 
Figure 1: Central carbon metabolism of S. cerevisiae .............................................................. 3 
Figure 2: Ethanol production from glucose in S. cerevisiae .................................................... 7 
Figure 3: Yeast as a production organism .................................................................................. 9 
Figure 4: Chemical structures for three commonly produced hydroxyacids ...................... 10 
Figure 5: Two routes to 3HP production in yeast .................................................................. 17 
Figure 6: The “Design-Build-Test-Learn” cycle adopted in metabolic engineering ......... 20 
Figure 7: The stoichiometric matrix The popularity of CRISPR based DNA editing ...... 21 
Figure 8: Constraining the solution space ................................................................................ 23 
Figure 9: An example of a common “gene circuit” ................................................................ 25 
Figure 10: Mechanism of CRISPR-Cas9 .................................................................................. 29 
Figure 11: The popularity of CRISPR based DNA editing ................................................... 31 
 
Chapter 2 
 
Graphical abstract: EasyClone-MarkerFree Vector Set ......................................................... 59 
Figure 1: An overview of the EasyClone-MarkerFree method ............................................ 69 
Figure 2: Validation of the EasyClone-MarkerFree vector toolkit ....................................... 71 
Figure 3: Effect of acetyl-CoA supply strategies on the production of 3-
hydroxypropionic acid ................................................................................................................. 73 
Table S1: List of primers used in this study ............................................................................. 75 
Table S2: List of BioBricks used in this study ......................................................................... 78 
Table S3: List of plasmids used in this study ........................................................................... 79 
Table S4: Chromosomal coordinates of the EasyClone-MarkerFree integration sites ..... 82 
Table S5: Sequences of E. faecalis PDH complex genes ....................................................... 83 
	xvi 
	
	
Figure S1: Growth profile of the 3HP producing laboratory strains ................................... 84 
Figure S2: Final titres of 3HP in the engineered industrial Ethanol Red strains ............... 85 
 
Chapter 3 
 
Figure 1: Metabolic routes for the production of three different hydroxy acids in S. 
cerevisiae ........................................................................................................................................ 97 
Table 1: Fermentation parameters of the hydroxy acid production strains ...................... 105 
Figure 2: Fermentation profiles of the hydroxy acid production strains .......................... 108 
Figure 3: Respiration characteristics of the hydroxy acid production strains ................... 111 
Figure 4: 13C-based metabolic flux analysis of the hydroxy acid production strains ....... 112 
Figure S1: Respiration profiles of each hydroxy acid producing strain ............................. 116 
Figure S2: Optical density profiles of the respiration experiments .................................... 117 
Figure S3: Total gas exchanges after 37.5 hours ................................................................... 117 
Figure S4: 3HP pathway fluxes from pyruvate, shown for both 3HP strains .................. 118 
Table S1: List of primers used in this study ........................................................................... 118 
Table S2: List of plasmids used in this study ......................................................................... 120 
Table S3: List of strains used in this study ............................................................................. 121 
Table S4: Sequences of heterologous genes used in this study ........................................... 122 
Table S5: Flux calculation from INCA used to constrain a genome scale model of S. 
cerevisiae ...................................................................................................................................... 123 
 
Chapter 4 
 
Figure 1: Map of metabolic fluxes and transcriptomic profile of the central carbon 
metabolism of CfB938 compared to the WT strain (CEN.PK) ......................................... 143 
	 xvii 
Figure 2: Gene set enrichment analysis of CfB938 ............................................................... 146 
Table 1: Fermentation characteristics of strains used in this study .................................... 149 
Figure 3: Shakeflask fermentations of engineered CfB938 strains carrying predicted 
beneficial gene deletions ........................................................................................................... 151 
Figure S1: Correlation analysis of the WT vs. CfB938 transcriptomes ............................. 155 
Figure S2: Volcano plot of the RNAseq data for CfB938 and the WT strain ................. 156 
Figure S3: Impact of computationally predicted gene knock-out strategies on the in vivo 
production of 3HP ..................................................................................................................... 156 
Figure S4: Stress tolerance of a PRY1 deletion in CfB938 .................................................. 157 
Table S1: Primers used in this study ....................................................................................... 158 
Table S2: Strains used in this study ......................................................................................... 159 
Table S3: Calculated central carbon fluxes ............................................................................. 159 
Table S4: Results from RNAseq .............................................................................................. 161 
	
	
	
	
	
	
 
 
  
	xviii 
Thesis Overview 
 
The yeast, Saccharomyces cerevisiae, is an important organism in research and in its use in 
many bio-industrial processes. Much work has been, and will continue to be, applied to 
the construction of yeast as a cell factory. The disciplines of Metabolic Engineering, 
Systems Biology, and Synthetic Biology are all integral parts in furthering the development 
of yeast and in helping to realise its potential as a source of biological and sustainable 
products.  
 
This thesis offers a small addition to the field of yeast metabolic engineering, by 
contributing tools to engineer, and basic research into, yeast metabolism. The research 
contained herein focuses on the production of hydroxy acids in the model yeast organism 
Saccharomyces cerevisiae. Often talked about in metabolic engineering is the “Design-
Build-Test-Learn” cycle, and its indispensability for progress within the field. Here, I 
present work that touches on all four of these segments, but with much of the focus on 
the testing side. 
 
Chapter 1 introduces the themes that have surrounded the PhD studies and are 
foundational to the work undertaken therein. This chapter is not meant to serve as an 
exhaustive introduction to metabolic engineering in S. cerevisiae, as such an effort would 
fill an entire book. Instead, the topics related to the research work presented in the thesis 
are selected, in the aim of introducing the reader to the key topics of the thesis.  
 
Chapter 2 is the first research article presented in the thesis, and focuses on the 
development of a CRISPR-Cas9 based toolkit for gene addition in the chromosomes of S. 
cerevisiae without the need to simultaneously insert marker cassettes. This system, named 
EasyClone-MarkerFree, builds upon the previous EasyClone vector sets and offers a 
method to increase the standardisation and reproducibility within the field through the use 
	 xix 
of defined integration sites. We test this system in a diploid strain of S. cerevisiae, showing 
that it is possible to successfully use these vectors to insert genes into industrial strains, 
inserting gene copies into both chromosomes. We hope that people will use these vectors, 
along with the other EasyClone vectors, to facilitate their yeast genome engineering 
projects and reduce some of the complexity inherent in strain design. We demonstrate the 
practicality of this vector set by using it to test the impact of different cytosolic acetyl-CoA 
supply strategies on the production of the hydroxy acid, 3-hydroxypropionic acid (3HP). 
We discover that the functional expression of the pyruvate dehydrogenase complex from 
Enterococcus faecalis is a promising method for increasing acetyl-CoA pools in the 
cytosol. 
 
Chapter 3 keeps with hydroxy acids, this time presenting a study on lactate and malate 
production as well as 3HP. In this study, we investigate the impact that these hydroxy acid 
production pathways have on the metabolism of a pyruvate over-producing Crabtree-
negative yeast strain. This Crabtree-negative strain does not produce ethanol, making it an 
attractive host for the production of a wide range of chemicals that can be produced from 
pyruvate. In this study we use a mixture of different techniques, including 13C-based flux 
analysis to probe the metabolic responses to high levels of lactate, malate, and 3-
hydroxypropionic acid production. We show that all strains assimilate glucose primarily 
through the pentose phosphate pathway and have low fluxes through the TCA cycle. The 
strains show variation in lower glycolysis, with the 3HP strains showing high activity in 
glycerol-3-phosphate biosynthesis pathways, whereas the lactate and malate producers 
show reduced activity in these pathways.  
 
The final article, presented in Chapter 4, utilises -omic scale technologies, this time with 
the aim of characterising a yeast strain capable of high levels of 3-hydroxypropionic acid 
production. Here we show that this high producer upregulates glycolysis, and components 
of the pentose phosphate pathway. 13C-based flux analysis determined that the engineered 
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strain had much lower flux through the tricarboxylic acid cycle than the WT, due to 
pyruvate being drawn from this pathway into the synthesis of 3HP. However, we also 
show that not all of the available pyruvate is successfully converted to 3HP, revealing that 
there are still opportunities for further engineering of this biosynthetic pathway. We used 
a flux constrained genome scale metabolic model and the OptKnock algorithm to 
computationally predict gene knock-out strategies. In this study we confirm that the 
monocarboxylic acid transporter Jen1p is not active in 3HP. We also show that a deletion 
of PRY1 increases 3HP titres by ~27% compared to the parental strain. 
 
Chapter 5 offers conclusions made over the span of the entire thesis, highlighting the areas 
where more research is needed and the outlook for the future opportunities within the 
field.  
 
1 Introduction 
 
 
 1 
1 Introduction 
 
The introduction to this thesis is split into two sections. The first, Section 1.1, covers an 
introduction to the field of metabolic engineering, and to the studied organism of this 
thesis. Section 1.2 proceeds to introduce the tools and methods that have been developed 
within metabolic engineering and synthetic biology, and are used throughout the research 
section of the thesis. 
 
1.1 Introduction to the metabolic engineering of Saccharomyces cerevisiae 
 
At present, the majority of chemical production stems from petroleum, with a market size 
of USD ~5 trillion in 2016 (https://www.statista.com/statistics/302081/revenue-of-
global-chemical-industry/). The petrochemical industry contributes 18% of the global CO2 
emissions, and is reliant on a dwindling supply of finite fossil fuel reserves (Benchaita, 
2013). CO2 is the main greenhouse gas contributing to anthropogenic climate change, and 
as such global efforts must be made to curb such emissions (Benchaita, 2013; Solomon et 
al., 2009). One route that can be taken to reduce greenhouse gas emissions is through 
metabolic engineering. Metabolic engineering is the field of biology concerned with the 
alteration of the native metabolism in cells and organisms. Often within this field, single 
celled organisms are engineered to produce chemicals of commercial interest from carbon 
feedstocks such as glucose. A wide array of different chemicals can be produced through 
biological means, and can begin to replace chemicals that are currently produced via 
unsustainable practices. As well as the ecological benefits to bio-based production of 
chemicals, there is also a clear financial incentive to develop sustainable chemicals. The 
renewable chemicals market is predicted to show strong growth (a compound annual 
growth rate of 11.29%) and to be worth USD 103 billion by 2022 
(https://www.zionmarketresearch.com/report/renewable-chemicals-market). The first 
1.1.1 Overview of Saccharomyces cerevisiae 
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section of this introduction focuses on the use of the common brewer’s yeast 
Saccharomyces cerevisiae as a cell factory for the renewable production of chemicals. 
 
1.1.1 Overview of Saccharomyces cerevisiae  
 
Alcoholic beverages have a long history in human societies, with evidence for fermented 
beverage production dating back at least 9,000 years (McGovern et al., 2004). The 
producers of these beverages discovered that by inoculating bread dough with small 
amounts of the beverage, it would cause the dough to rise. These are early examples of 
using microbes to produce chemicals (ethanol and carbon dioxide) that had some value to 
society. Yeast was later recognised as the living organism that is the source of alcoholic 
fermentation in beer in 1857 (Pasteur, 1995). Since then, the brewers yeast Saccharomyces 
cerevisiae (often referred to simply as “yeast”) has been extensively studied (Botstein et al., 
1997). It has helped shed light on many human diseases, and is routinely used in basic 
genetics and cancer research (Botstein and Fink, 2011; Guaragnella et al., 2014).  
 
 
 
 
Figure 1 (See next page). Central carbon metabolism of S. cerevisiae. Under high 
concentrations, even when oxygen supply is also high, S. cerevisiae channels most of the flux 
from glucose into ethanol production (the Crabtree effect). Glucose catabolite repression causes 
the shut-down of aerobic respiration pathways and can present a problem for the implementation 
of pathways dependent on ATP, as not enough can be generated through the ethanol production 
route to provide energy for heterologous pathways. Abbreviations; GLC glucose, G6P glucose-
6-phosphate, 6PGL D-6-phospho-glucono-δ-lactone, 6PGC 6-phospho-D-gluconate, RU5P 
ribulose-5-phosphate, XU5P xylulose-5-phosphate, R5P ribose-5-phosphate, S7P 
sedoheptulose-7-phosphate, G3P glyceraldehyde-3-phosphate, E4P erythrose-4-phosphate, F6P 
fructose-6-phosphate, FDP fructose-1,6-diphosphate, DHAP dihydroxy-acetone-phosphate, 
GLYC3P glycerol-3-phosphate, GLYC glycerol, 13DPG 1,3-diphosphateglycerate, 3PG 3-
phosphoglycerate, 2PG 2-phosphoglycerate, PEP phosphoenolpyruvate, PYRcyt pyruvate 
(cytosolic), ACALD acetaldehyde, EtOH ethanol, AC acetate, PYRmit pyruvate (mitochondrial), 
ACoAmit acetyl-CoA (mitochondrial), CIT citrate, ICIT isocitrate, AKG α-ketoglutarate, 
SUCCoA succinyl-CoA, SUC succinate, FUM fumarate, MAL malate, OAA oxaloacetate. 
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S. cerevisiae is an important industrial organism due to many features that make it suitable 
for an array of industrial applications. Yeast holds GRAS status (Generally Regarded as 
Safe), allowing it to be easily and safely used in research as well as in industrial processes. 
In addition, yeast has been well characterised, being the first eukaryotic organism to have 
its genome sequenced (Goffeau et al., 1996; Nevoigt, 2008). Common laboratory strains 
are easy to genetically manipulate, with established techniques for inserting and deleting 
DNA into/from the yeast chromosome (described further in section 1.2.2). As well as 
chromosomal gene integration, yeast can also express genes maintained in plasmids, which 
makes them flexible host organisms. S. cerevisiae also played an important role in the 
creation of the first synthetic genome, as it is able to maintain and recombine large sections 
of heterologous DNA (Gibson et al., 2008; Kouprina and Larionov, 2016). Yeast is 
relatively fast growing for a eukaryotic organism, with a generation time of ~90 minutes 
when grown on glucose (Sherman, 2002), and several different carbon sources are able to 
be metabolised by yeast, such as; glucose, galactose, sucrose, fructose, maltose, ethanol, 
and glycerol (Gancedo, 1998; Zaman et al., 2008). 
 
Glucose is the preferred carbon source for yeast (see Figure 1 for an overview of central 
carbon metabolism in yeast), and in the presence of glucose there is tight regulation of 
many genes and pathways involved in non-glucose metabolism (Gancedo, 1998; Trumbly, 
1992). Such control usually occurs at the transcriptional level, effected largely through the 
Snf3p/Rgt2p glucose sensing cascade (Kaniak et al., 2004). Under high concentrations of 
glucose, yeast preferentially switches to fermentative metabolism even when oxygen is 
abundant (as discussed further in Section 1.1.2).  
 
As a eukaryote, yeast is able to perform some functions that can not be performed by 
prokaryotes, such as certain post-translational modifications – which can be especially 
important in the production of recombinant therapeutic proteins (Mattanovich et al., 
2012). Yeast fermentations can be performed under low pH conditions, which can be 
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advantageous in limiting microbial contamination during fermentation, and can also be 
beneficial in the production of organic acids where a low pH can reduce the costs 
associated with product separation (Baek et al., 2017; Chen et al., 2018; Curran et al., 2013). 
In addition, yeast is not susceptible to phage contaminations during fermentation, unlike 
bacterial hosts such as Escherichia coli (Hong and Nielsen, 2012; Runguphan and 
Keasling, 2014). Metabolic engineering of S. cerevisiae for the production of acids (in 
particular – hydroxy acids) is a central theme to this thesis and is covered more extensively 
in Section 1.1.4. 
 
1.1.2 Crabtree-negative S. cerevisiae 
 
The Crabtree effect was discovered by Herbert Grace Crabtree and is based on the 
observation that S. cerevisiae will opt to ferment glucose when it is in high concentrations 
and will do so even under aerobic conditions (De Deken, 1966; Pronk et al., 1996). The 
reasons behind this behaviour are not yet fully understood, but one explanation is that 
although the yield of ATP through fermentation is greatly reduced compared to 
respiration, the rate of ATP formation is actually higher, and so yeast may use this strategy 
to out-compete rivals (Pfeiffer and Morley, 2014). Another theory is that this behaviour is 
in fact a result of limitations in protein production and allocation, which causes metabolism 
to shift to pathways that are less efficient but capable of higher rates of flux that are thereby 
allowing the metabolism to maintain a higher growth rate (Molenaar et al., 2009; Sánchez 
et al., 2017). Whatever the precise reason behind this phenomenon, the practical 
implication is that a great amount of the carbon flux from the substrate gets converted 
into ethanol when fermentation is performed with a fermentable sugar such as glucose. 
Three strategies can be adopted to reduce or eliminate flux into ethanol;  
 
1. Feeding with a non-fermentable carbon source such as ethanol or glycerol 
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2. Slow feeding of a fermentable carbon source in aerobic conditions to stay 
below the threshold where yeast begins to ferment 
3. Engineering the yeast strain to be incapable of producing ethanol 
 
Although the first two strategies can be of benefit to creating economical bioprocesses, 
they are not always suitable solutions, and therefore engineering a strain that is incapable 
of ethanol production has been the focus of much interest within the field. Perhaps the 
most obvious way to construct a Crabtree-negative S. cerevisiae strain is through the 
deletion or down-regulation of the alcohol dehydrogeneases (ADH). Drewke, Thielen and 
Ciriacy, (1990) successfully created a strain lacking detectable ADH activity, but high levels 
of ethanol were still formed, along with an accumulation of toxic acetaldehyde due to 
acetaldehyde being produced but unable to be converted to ethanol making this strain 
unsuitable as a production organism. 
 
Another strategy, as shown in Figure 2, is to delete the three major pyruvate decarboxylase 
(PDC) isozymes encoded by the genes PDC1, PDC5, and PDC6, stopping the conversion 
of pyruvate to acetaldehyde (Flikweert et al., 1996, Flikweert et al., 1997). Deleting these 
genes leaves the strain incapable of growing on high glucose concentrations due to the 
effects of glucose repression, and the addition of a C2 compound such as acetate or ethanol 
is required to rescue growth (Flikweert et al., 1999). A Pdc- strain is incapable of meeting 
its requirements for cytosolic acetyl-CoA biosynthesis, even though the mitochondrial 
pyruvate dehydrogenase pathway is still functional, suggesting a lack of export mechanisms 
of acetyl-CoA from the mitochondria (Flikweert et al., 1999). To relieve the dependency 
on C2 compounds, and to enable growth on high concentrations of glucose, directed 
evolution was performed on a Pdc- strain (van Maris et al., 2004a). The strain was first 
gradually fed less acetate, until it could grow completely in the absence of it. It was then 
grown under steadily increasing concentrations of glucose, until a mutant was able to 
tolerate glucose concentrations of 100 g L-1 (van Maris et al., 2004a). Perhaps the single 
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largest contributing factor to the ability of the evolved strain (termed the TAM strain) to 
grow on high concentrations of glucose is a large deletion found in the glucose sensing 
transcriptional regulator MTH1 (Oud et al., 2012). This deletion is hypothesised to result 
in a decreased degradation rate of Mth1p, which in turn restricts the import of glucose into 
the cell to rates at which the cell can manage which prevents the build-up of toxic levels 
of intracellular pyruvate (Oud et al., 2012). The restriction of glycolysis in this way is also 
thought to allow time for the mitochondrial respiratory chain to reoxidise NADH, 
resulting in a NADH/NAD+ ratio high enough to sustain growth (Oud et al., 2012). 
Overexpression of MTH1 in the non-evolved Pdc- strain partially restored the ability of 
the strain to grow on glucose as the sole carbon source, confirming the importance of this 
gene to the observed phenotype of the TAM strain (Oud et al., 2012). 
Figure 2. Ethanol production from glucose in S. cerevisiae. a) the native pathway, generating 
2 mol ATP per mol of glucose and maintaining a closed redox loop by the regeneration of 
NAD+. b) The pathway of a S. cerevisiae strain lacking pyruvate decarboxylase activity. 
Ethanol is no longer produced, but neither is NAD+, leading to a redox imbalance in the 
cytosol. 
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Cytosolic acetyl-CoA supply is also reliant on pyruvate decarboxylase activity, and a Pdc- 
strain is therefore unlikely to be able to produce the acetyl-CoA that is required for lipid 
biosynthesis – unless mitochondrial acetyl-CoA can be transported into the cytosol. The 
CoA transferase gene ACH1 is thought to facilitate the indirect production of acetyl-CoA 
in Pdc- yeast strains. Ach1p is thought to convert acetyl-CoA to acetate, which can then 
be transported across the mitochondrial membrane, and then converted back to acetyl-
CoA in the cytosol (Chen et al., 2015).  
 
However, even with these compensatory pathways the TAM strain has much less robust 
growth characteristics than the WT strain (0.20 h-1 vs. 0.33 h-1) when grown on glucose 
but does not produce any ethanol (van Maris et al., 2004a). Due to the lack of ethanol 
formation, pyruvate accumulation is observed, making it an attractive host for producing 
compounds derived from the central carbon metabolism such as the organic acids (van 
Maris et al., 2004a). Research paper 2 in this thesis explores this strain’s capacity to produce 
various hydroxy acids derived from pyruvate, and how these modifications affect the 
physiology and metabolic flux distribution of the host strain. 
 
1.1.3 Yeast as a cell factory 
 
Aside from its role in the food and beverage industries, yeast serves as an integral part of 
the biotechnology industry. Routinely used in bioethanol production, it is also used in the 
production of other biofuels as well as; therapeutic proteins, pharmaceuticals, flavourings, 
fragrances, and biodegradable polymers – see Figure 3 (Jensen and Keasling, 2015; 
Krivoruchko et al., 2011; Li and Borodina, 2015; Nielsen, 2015). Chemical production 
from yeast, as with other organisms, can offer a sustainable path to replace many chemicals 
that are currently produced from petroleum (Borodina and Nielsen, 2014; Van Dien, 2013; 
Morales et al., 2016). While the environmental benefits of bio-based production are 
promising, the processes must still be able to compete economically with existing 
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technologies before they can be widely adopted. Commercial production of bulk chemicals 
from biorefineries is currently limited to a handful of cases, although projected to grow 
significantly in the coming years (Nielsen and Keasling, 2017; Nielsen et al., 2013). 
Common challenges must be addressed when producing bulk chemicals from biological 
hosts, such as how to divert flux from the native catabolic pathways into those that 
produce the target compounds.  
 
The following section will focus on production of hydroxy acids in yeast. Hydroxy acids 
are bulk chemicals that need to be produced to high titres and efficiencies if they are able 
to compete with traditional manufacturing processes. Yeast fulfils many of the 
requirements to be a valuable production organism, but much research is still needed to 
fully utilise the potential of yeast for the efficient production of bulk chemicals (Dai et al., 
2015; Fletcher et al., 2015; Nielsen et al., 2013).  
 
  
Figure 3. Yeast as a production organism. S. cerevisiae is capable of producing an array of 
different fine chemicals, bulk chemicals, and biofuels. Organic acids, alcohols, and isoprenoids 
are common classes of chemicals that are the targets of metabolic engineering efforts in S. 
cerevisiae. 
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1.1.4 Hydroxy acid production in yeast  
 
Hydroxy acids are a sub-class of carboxylic acids that have a hydroxyl group located along 
the carbon backbone (Karlheinz, 2000). They can be further subdivided into three 
categories; α-hydroxy acids (AHAs) have a hydroxyl group located on the carbon atom 
that is one away from the carboxyl group (denoted as the α-position), β-hydroxy acids 
(BHAs) have a hydroxyl group on the second carbon atom away from the carboxyl group, 
and Ω-hydroxy acids (OHAs) have a hydroxyl group on the carbon atom that is most 
distant from the carboxyl group (Karlheinz, 2000; Kornhauser et al., 2010). AHAs have 
become well known for their use in cosmetic products, with a range of different AHAs 
used to chemically peel outer layers of skin (Fiume, 2017). The smallest of the AHAs is 
glycolic acid, one of the main AHAs used in cosmetics and healthcare, but also in many 
Figure 4. Chemical structures for three 
commonly produced hydroxyacids. Lactate 
(a), and malate (b) are both examples of α-
hydroxy acids, with the hydroxyl group 
adjacent to the carboxyl group. 3-
hydroxypropionic acid (c) is a β-hydroxy 
acid as its hydroxy group is located on the 
second carbon atom from the carboxyl 
group. 
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industrial processes such as in food and pharmaceutical production (Fredenberg et al., 
2011; He et al., 2010; Murad et al., 1995; Reed and Gilding, 1981). Glycolic acid can be 
polymerised to create biodegradable plastics, either as a homo-polymer, or as a co-polymer 
with lactate and is therefore of interest to researchers working towards the sustainable 
production of plastics (Ayyoob et al., 2017; Gentile et al., 2014; Sarazin et al., 2004).  
 
1.1.4.1 Lactate 
 
Lactate (Figure 4a) is the next largest AHA after glycolic acid, with three carbon atoms. 
Like glycolic acid, lactate is widely used in the cosmetic and pharmaceutical industries. It 
is also used to produce polylactic acid, a biodegradable plastic used in a variety of 
applications from industry and healthcare, to packaging and consumer products (Chiulan 
et al., 2018; Jamshidian et al., 2010; Juturu and Wu, 2016; Rathin and Michael, 2006). The 
global market for lactate was valued at USD 1.275 billion in 2014, with a strong growth 
forecast (https://www.credenceresearch.com/report/lactic-acid-market). Lactate is a 
common metabolite found in many species as a carbon sink, and much work has been 
done towards optimising lactate production in a range of species (Fumi et al., 2009; 
Hofvendahl and Hahn–Hägerdal, 2000; Ilmén et al.; Mazumdar et al.; Meussen et al., 2012; 
Sauer et al., 2010). Lactate can be synthesised chemically, but in this process both of 
lactate’s optical isomers (D and L) are produced, which is undesirable for certain 
applications where optically pure lactate is required (Sauer et al., 2010). Microbial 
fermentation can produce highly optically pure L-lactate, making it an ideal method of 
production (Abdel-Rahman et al., 2011; Saitoh et al., 2005; Tan et al., 2018; Yun et al., 
2003). Common hosts for lactate production are the lactic acid bacteria that naturally 
produce high titres (>100 g L-1) under fermentative conditions (Abdel-Rahman et al., 2011; 
Papagianni, 2012; Tan et al., 2018; Upadhyaya et al., 2014). Although capable of high titres, 
lactic acid bacteria based fermentations need to be performed at near to neutral pH, 
resulting in high separation costs, which lowers the economical efficiency of the process 
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(Gao et al., 2011; Sauer et al., 2010). A host able to tolerate low pH is therefore desirable 
for industrial lactate production, and considerable effort has been made to produce lactate 
in yeast (Branduardi et al., 2006; Colombié et al., 2003; Ishida et al., 2005; Sauer et al., 
2010).  
 
Lactate can be produced in a single enzymatic step from pyruvate, requiring only the 
reduction of the ketone functional group by a lactate dehydrogenase (LDH). Flux through 
pyruvate is high in yeast, as pyruvate is an intermediate in the production of ethanol (Pronk 
et al., 1996). Lactate production is theoretically able to replace ethanol production in yeast 
and act as a carbon sink, as one mole of glucose is converted into two moles of lactate and 
two moles of ATP, the same ratio as for ethanol production. The process also forms a 
closed redox loop, with the NADH formed in glycolysis being oxidised through the 
reduction of pyruvate, as is also the case for ethanol production. Efficient lactate 
fermentations have been achieved in S. cerevisiae strains lacking the ability to produce 
ethanol - see section 1.1.2 for more information on Crabtree-negative S. cerevisiae (van 
Maris et al., 2004b). A pyruvate decarboxylase-negative strain of S. cerevisiae engineered 
with the addition of an LDH gene from Lactobacillus plantarum has been shown to be 
capable of producing ~50 g L-1 lactate in buffered media containing 70 g L-1 glucose (a 
yield of 1.44 mol mol-1 glucose), highlighting the promise for the use of yeast as a host 
organism (Lui and Lievense, 2005). More recently, Lee et al., (2015) demonstrated a strain 
that was capable of producing 117 g L-1 lactate in a fed-batch bioreactor. This high titre 
was achieved through the deletion of PDC1, CYB2, GPD1, NDE1, and NDE2 from the 
genome of S. cerevisiae with the addition of several copies of a heterologous LDH from 
Pelodiscus sinensis. Deletion of CYB2 prevents lactate utilisation, while a GPD1 deletion 
prevents glycerol synthesis. The redox state of the cell was engineered through deletion of 
the NADH dehydrogenases NDE1 and 2. The majority of NAD+ regeneration was now 
a result of lactate production, enabling this strain to produce high lactate titres (Lee et al., 
2015). The positive effects of NDE1 and 2 deletions on the improvement of lactate 
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production in this strain are not clear, but this strategy did increase cytosolic NADH levels 
and so could present a target for future engineering attempts for other pathways that 
require redox balancing. However, this strain was unable to reach higher yields than 
previously achieved by Lui and Lievense, (2005), producing a yield of 0.945 mol mol-1 
glucose in shakeflasks and 1.17 mol mol-1 glucose in fed-batch fermentation (Lee et al., 
2015). Importantly though, these were carried out in un-buffered media which is an 
important step to be able to make the process economically viable as the efficient 
extraction of lactate from the media occurs only at low pH (Sauer et al., 2010).  
 
To make the process more cost efficient, anaerobic fermentation is also desirable. But 
although homofermentative lactate production is similar in many ways to ethanol 
fermentation, lactate production is unable to support the anaerobic growth of yeast in the 
Crabtree-negative TAM strain, most likely due to ATP-dependent export of lactate (Maris 
et al., 2004).  
 
1.1.4.2 Malate 
 
Malate (Figure 4b) is a four carbon AHA, containing two carboxyl groups. It is present as 
an intermediate in the tricarboxylic acid (TCA) cycle, and therefore widespread across all 
aerobic species (Fernie et al., 2004). Malate occurs naturally in a variety of food and drinks, 
and is often used as an additive (Kunkee, 1968; Tsao et al., 1999). Like the previously 
mentioned AHAs, it is routinely used in cosmetics, pharmaceuticals, and in industrial 
processes, as well as in food and beverage production (Fiume, 2001; Liu et al., 2017a; 
Werpy and Petersen, 2004). Valued at USD 159 million in 2016, the market size is smaller 
than for lactate, but still represents a large economic opportunity, with growth forecast to 
remain strong into the next decade (https://www.grandviewresearch.com/industry-
analysis/malic-acid-market). 
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Malate can be produced efficiently via a redox-neutral two-step pathway converting 
pyruvate first to oxaloacetate with the incorporation of CO2 (Liu et al., 2017b; Yin et al., 
2015). This reductive TCA cycle also has a maximum product yield of 2 mol mol-1 glucose, 
identical to that of the lactate pathway (Yin et al., 2015). Unlike lactate however, there is 
no net production of ATP, as the conversion of pyruvate to oxaloacetate requires the 
expenditure of one mole of ATP (Zelle et al., 2008). Therefore, even with energy neutral 
export processes, anaerobic production would not be possible via this pathway.  
 
Aspergillus flavus is capable of naturally producing high amounts of malate, and has 
achieved yields of 1.26 mol mol-1 glucose (Battat et al., 1991). While promising as a 
production organism, A. flavus produces aflatoxins which makes  it unsuitable for 
industrial production of malate (Do and Choi, 2007). The non-aflatoxin producing 
Aspergillus oryzae has also shown promise as a cell factory for the production of malate, 
with yields of up to 1.38 mol mol-1 glucose, and titres of 154 g L-1 (Brown et al., 2013). 
Bacterial production methods are also showing promise, with research into using E. coli 
producing high titres and yields (Guo et al., 2018; Li et al., 2018; Zhang et al., 2015). 
Through the rerouting of carbon metabolism to phosphoenolpyruvate via several gene 
deletions, and the use of a two stage fermentation process, malate yields of 1.42 mol mol-
1 glucose were achieved in E. coli (Zhang et al., 2015). However, the titre and productivity 
remained low, excluding it from use in an industrial setting. 
  
Effort has also been invested in engineering S. cerevisiae to produce high malate titres. 
Natively, S. cerevisiae only produces low levels of secreted malate, but through the 
engineering of the Crabtree-negative TAM strain (see Section 1.1.2), a yield of 0.42 mol 
mol-1 glucose and titre of 59 g L-1 were possible (Zelle et al., 2008). The implemented 
strategy involved overexpression of the pyruvate carboxylase gene PYC2, introduction of 
a variant of the malate dehydrogenase gene MDH3 lacking the peroxisomal targeting 
sequence (McAlister-Henn et al., 1995), and expression of a heterologous malate 
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transporter from Schizosaccharomyces pombe (Zelle et al., 2008). To achieve these titres, 
CaCO3 was used as a buffering agent to neutralise the excreted malate (as is also commonly 
used in lactate production studies). The use of a buffering agent may not be practical in 
industrial fermentations, and such factors should be borne in mind when comparing 
different production strategies. After the optimisation of the fermentation media and 
conditions, a malate yield of 0.48 mol mol-1 glucose was obtained (Zelle et al., 2010). While 
these titres and yields fall behind those obtained from Aspergillus species, it demonstrates 
the potential for S. cerevisiae to become a platform strain in malate production. 
 
 
1.1.4.3 3-Hydroxypropionic acid 
 
3-Hydroxypropionic acid (3HP) is a three carbon BHA (Figure 4c) that can be used to 
produce other chemicals such as acrylic acid, which alone in 2011 had a market value of 
USD 11.5 billion (Borodina et al., 2015). 3HP can be polymerised to form biodegradable 
polymers, and can be converted into acrylic acid and other compounds of industrial 
interest; including plastics and superabsorbent polymers (Andreessen et al., 2010; Borodina 
et al., 2015; Jiang et al., 2009; Li et al., 2016).  
 
Unlike lactate and malate, 3HP has not been identified as a native highly produced 
compound in any organism to date, but has been shown to be a metabolic end product in 
glycerol fermentation by organisms such as Lactobacillus 208A, and Lactobacillus reuteri 
(Sobolov and Smiley, 1960; Talarico and Dobrogosz, 1990) – for a comprehensive review 
see: Kumar et al., (2013). It is also found in the CO2 fixation pathway of at least one 
organism – Chloroflexus aurantiacus  (Holo, 1989).  
 
Several pathways have been evaluated as possible routes of 3HP production, and so far 
two main pathways have been found to be thermodynamically feasible from glucose as a 
substrate (Borodina et al., 2015; Kildegaard et al., 2016; Kumar et al., 2013). Of these, the 
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pathway with the most promising characteristics is one that goes through a β-alanine 
intermediate, which can have a net production of 1 mol ATP per mol of 3HP formed. 
Another pathway that was predicted to be thermodynamically feasible, goes through 
acetyl-CoA and malonyl-CoA as precursors (Figure 5). Unlike the β-alanine route, this 
pathway has no net production of ATP, but does have a balanced co-factor cycle. Both of 
these pathways (shown in Figure 5) have been successfully engineered in S. cerevisiae, with 
the β-alanine pathway proving to be capable of producing higher titres of 3HP than the 
malonyl-CoA pathway (Borodina et al., 2015; Kildegaard et al., 2016). 
  
The production of 3HP via β-alanine (shown in Figure 5), requires the introduction of a 
heterologous enzyme for the conversion of aspartate to β-alanine, as the native β-alanine 
biosynthesis pathway is unlikely to be able to carry high levels of flux (Borodina et al., 
2015). The aspartate-1-dehydrogenase gene from Tribolium castaneum (panD) was shown 
to produce β-alanine from aspartate, with a β-alanine pyruvate aminotransferase (BAPAT) 
from Bacillus cereus capable of the inter-conversion of β-alanine and pyruvate to L-alanine 
and malonic semialdehyde. The final step from malonic semialdehyde to 3HP is catalysed 
by a NADPH dependent 3HP dehydrogenase (HPDH) from E. coli (ydfG). Construction 
of this pathway in yeast resulted in a strain that produced ~14 g L-1 3HP in a fed-batch 
fermentation, representing a product yield of 0.27 mol mol-1 glucose (Borodina et al., 
2015). 
 
Through the recent construction of a kinetic model of the β-alanine route of 3HP 
biosynthesis, it is predicted that 3HP titres can be increased through the overexpression 
of the final two enzymes in the pathway (BAPAT and HPDH) (Dalwadi et al., 2017). 
Overexpression of just one of these would not likely lead to an increase in 3HP titres, and 
if only BAPAT was overexpressed there would be an accumulation of malonic 
semialdehyde, a toxic intermediate. 
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The production of 3HP through malonyl-CoA, while capable of lower theoretical 
maximum yields than the β-alanine route, can still present a viable pathway for high titre 
3HP synthesis (Kildegaard et al., 2016). C. aurantiacus synthesises 3HP from malonyl-
CoA, requiring 2 moles of NADPH per mole of malonyl-CoA via malonyl-CoA reductase 
(MCR), and this enzyme can be functionally expressed in yeast (Kildegaard et al., 2016; 
Tabita, 2009). Due to the net zero ATP production of this pathway, high 3HP yields are 
more heavily dependent on the TCA cycle and efficient aeration than in the β-alanine 
Figure 5. Two routes to 3HP production in yeast. The red pathway summarises the route via 
malonyl-CoA, and the green pathway is the route via β-alanine. The β-alanine route has been 
shown to be more efficient for 3HP production in yeast, but optimisation is still necessary to 
achieve commercial titres, rates, and yields. For each step the enzyme responsible for the 
catalysis of the reaction is shown. Metabolite abbreviations; 3HP – 3-hydroxypropionic acid. 
Enzyme abbreviations; PDC – pyruvate decarboxylase, ALD – acetaldehyde dehydrogenase, 
ACS – acetyl-CoA synthase, ACC – acetyl-CoA carboxylase, MCR – malonyl-CoA reductase, 
PYC – pyruvate carboxylase, AAT – aspartate aminotransferase, PAND – aspartate 
decarboxylase, BAPAT - β-alanine pyruvate aminotransferase, HIBADH – 3-hydroxyisobutarate 
dehydrogenase, HPDH – 3-hydroxypropionate dehydrogenase.  
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pathway, which could limit 3HP titres when scaling up fermentations (Borodina et al., 
2015). This pathway is dependent on a plentiful supply of cytosolic acetyl-CoA, and 
optimisation of acetyl-CoA supply strategies has been shown to have a strong impact on 
3HP titres (Jessop-Fabre et al., 2016 - Research article 1 in this thesis). Acetyl-CoA is also 
important in the production of a range of other chemicals, and so it is necessary to engineer 
robust supply pathways that serve a broad range of production pathways (Nielsen, 2014).  
 
Engineering of the the pyruvate dehydrogenase (PDH) bypass can be a successful strategy 
to increase pools of acetyl-CoA (Shiba et al., 2007). Overexpression of the native pyruvate 
decarboxylase gene PDC1, and aldehyde dehydrogenase gene ALD6, along with 
expression of a heterologous acetyl-CoA synthase (ACS) proved a robust strategy in the 
production of isoprenoids dependent on acetyl-CoA (Shiba et al., 2007). Native acetyl-
CoA synthase (Acs1p) is negatively repressed by glucose, keeping cytosolic acetyl-CoA 
pools low (Nielsen, 2014). The use of a Salmonella enterica ACS that is not sensitive to 
the feedback inhibition mechanisms of yeast can increase flux into acetyl-CoA production 
(Shiba et al., 2007). Conversion of acetyl-CoA to malonyl-CoA is natively catalysed by the 
acetyl-CoA carboxylase Acc1p (Lynen, 1959; Wakil et al., 1983). This step is also subject 
to glucose repression, with Acc1p being controlled at both the transcriptional and post-
translational levels (Shi et al., 2014; Shirra et al., 2001; Tehlivets et al., 2007). Post-
translational control of Acc1p is effected through the glucose repressor Snf1p. However, 
deletion of SNF1 is not a viable approach to lift glucose repression of Acc1p, as Snf1p 
plays a role in various processes that are controlled by glucose responsive pathways 
(Hedbacker and Carlson, 2008; Thompson-Jaeger et al., 1991; Wilson et al., 1996). Instead, 
site directed mutagenesis (SDM) has been used to produce mutant versions of Acc1p that 
are no longer subject to Snf1p repression (Shi et al., 2014). A double mutant created by 
SDM , ACC1S659A, S1157A is particularly beneficial to the production of fatty acid ethyl esters 
and 3HP, and has been used successfully in further metabolic engineering studies (Jessop-
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Fabre et al., 2016 - Research article 1 in this thesis; Kildegaard et al., 2016; Li et al., 2015; 
Shi et al., 2014). 
  
Introduction of a cytosolically localised PDH complex can circumvent the increased 
production of acetaldehyde (a toxic intermediate) associated with the PDH bypass by 
producing acetyl-CoA directly from pyruvate. In yeast the PDH complex is capable of 
performing this enzymatic step, but is located only in the mitochondria. However, the 
successful expression of a PDH complex from Enterococcus faecalis into the cytosol of 
S. cerevisiae has been previously demonstrated (Kozak et al., 2014). This complex is large, 
with an estimated mass of 14 MDa (Snoep et al., 1992). Unlike production through ACS, 
this enzyme does not require ATP to convert pyruvate into acetyl-CoA and is also 
insensitive to high NADH/NAD+ ratios (Kozak et al., 2014). However, the correct 
functionality of this enzyme is dependent on lipoic acid supplementation. This enzyme 
effectively boosted final 3HP titres by nearly 100% in a S. cerevisiae strain expressing the 
malonyl-CoA pathway (Jessop-Fabre et al., 2016 - Research article 1 in this thesis).  
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1.2 Tools for the metabolic engineering of yeast 
 
Progress towards the goals of a metabolic engineering project is dependent on the tools 
available for designing, building, testing, and learning from new strategies. This “Design-
Build-Test-Learn” cycle (as illustrated in Figure 6) is central to all engineering practices. 
The second half of the introduction chapter will focus on the tools and methods used 
throughout the research sections of this thesis. 
 
Figure 6. The “Design-Build-Test-Learn” cycle adopted in metabolic engineering. The cycle is 
fundamental to metabolic engineering practices. Strain design is becoming more and more 
automated by the development of software capable of predicting successful production strategies. 
The build part is becoming increasingly high-throughput, with technologies being developed to 
create entire libraries of strains rather than producing them one by one. Strain testing is largely 
reliant on the use of chromatographic and mass spectrometry methods, which are incapable of 
dealing with the large number of strains that can be developed.  
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1.2.1 Design 
 
1.2.1.1 Metabolic modelling  
 
Computer aided design (CAD) is commonly used in many fields of engineering, and so 
too is it used in metabolic engineering (Cardoso et al., 2018; Delepine et al., 2016; Fehér 
et al., 2014; Machado and Herrgård, 2015). For CAD to be a useful tool to the biological 
engineer, there need to be sophisticated models of the chosen organisms and techniques 
for analysing these models and to generate predictions for successful strain design 
strategies. One way in which it is possible to create a model of an organism is by viewing 
cellular metabolism as a set of equations. In the most basic form, each enzymatic reaction 
can be expressed in terms of a mass balance e.g. for the reaction A + B → C, there will be 
a net consumption of one mole of A, and one mole of B, with a net production of one 
mole of C in each cycle. In the reaction; 2D → B + E, there will be a net consumption of 
two moles of D with a net production of one mole of B and one mole of E. Each reaction 
in a cell can be formalised in this manner, and can be built up into a stoichiometric matrix 
Figure 7. The stoichiometric matrix. The stoichiometry of each reaction in a system. A cellular 
network can be captured in a stoichiometric matrix (S-matrix). The r columns, represent each 
reaction in the system, whereas the m rows represent each metabolite in the system. Each 
reactions rate of flux under steady-state conditions is captured in the v variables. 
1.2.1.1 Metabolic modelling 
 
 
 22 
that captures this information. An example of a stoichiometric matrix is shown in Figure 
7, where r represents a reaction, m represents a metabolite, and v represents the flux 
through a given reaction under steady-state conditions. Stoichiometric matrices can be 
used to calculate rates for each reaction in the matrix. However, several constraints have 
to be first set in order for the system to return feasible solutions. Thermodynamic 
constrains, as well as experimentally derived insights into metabolic pathways can help 
constrain the solution space into one that is feasible and computationally efficient (Orth 
et al., 2010). Figure 8 depicts a system of three different reactions (the x, y, and z axes). 
The unbounded model is shown in Figure 8a, where any solution is feasible, the solution 
space is infinite, and therefore unable to be computed. Figure 8b illustrates how each 
reaction can be constrained, limiting the available solutions to being within the ‘flux cone’. 
Furthermore, the optimal solutions exist on each vertex of the flux cone and these optimal 
solutions can be efficiently found using developed techniques such as flux balance analysis 
(FBA), which uses mixed integer linear programming to optimally solve the matrix 
according to an objective function, such as maximisation of biomass production (Baart 
and Martens, 2012; Orth et al., 2010). Parsimonious flux balance analysis (pFBA) builds 
upon regular FBA by finding solutions that have the lowest net fluxes, resulting in the 
most efficient pathways being found, and results closer to experimentally observed data 
are returned (Lewis et al., 2010). 
 
Metabolic models of cellular metabolism are used to model cells in silico and can be used 
to simulate how genetic perturbations may affect the phenotypic landscape of a host strain. 
Once experimental data, such as protein or flux data, have been obtained, these can be 
applied to the model, further improving the accuracy of that model for subsequent 
predictions (Kim et al., 2017; Orth et al., 2010).  
 
Genome-scale metabolic models (GEMs) can vary heavily in both size and quality, 
potentially limiting their applicability in metabolic engineering (Kim et al., 2017). The first 
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GEM to be constructed for S. cerevisiae covered 1,175 metabolic reactions, and 708 open 
reading frames (Förster et al., 2003). After a decade of improvements, the Yeast7 model 
increased the total metabolic reaction count to 3,493 reactions (Aung et al., 2013). 
However, an increase in captured metabolic reactions does not necessarily mean a higher 
quality model. One issue faced by GEMs is that they do not take into account the protein 
allocation or enzymatic constraints that cells are faced with. Progress towards integrating 
such constraints has led to models capable of more accurate predictions of cellular growth 
and phenotype (Lerman et al., 2012; Sánchez et al., 2017). A recently built enzyme 
constrained version of the Yeast7 model was able to achieve predictions that were much 
closer to experimental results than the unconstrained model (Sánchez et al., 2017). Using 
a standard GEM, it is not possible to capture the Crabtree effect in yeast (for more detail 
on the Crabtree effect see section 1.1.2). Incorporating enzymatic constraints into a GEM 
renders it able to resolve this phenomenon and accurately predict the conditions necessary 
for the switch from aerobic respiration to fermentation (Sánchez et al., 2017). 
 
Figure 8. Constraining the solution space. An unconstrained S-matrix (a) will have an unlimited 
number of feasible solutions. By constraining the rates of fluxes for some reactions, the feasible 
solution space becomes solvable (b). Optimal solutions exist on each vertex of the ‘flux cone’, 
with linear programming algorithms capable of finding the solutions that optimise the objective 
function (e.g. biomass production). Adapted from Orth et al. (2010). 
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With a functioning GEM, computational tools can be used to predict strategies for the 
rational design or alteration of production strains. Many tools have been developed for the 
computational design and prediction of heterologous pathways, and while out of scope for 
this thesis, a detailed review of these tools can be found in (Wang et al., 2017). Tools also 
exist for the prediction of gene deletion strategies. One commonly used tool is OptKnock, 
that predicts gene knock-outs that can be beneficial to optimising a given objective 
function e.g. production of a compound of interest (Burgard et al., 2003). Soon after the 
introduction of this method, Fong et al., (2005) developed lactate producing E. coli strains 
based on OptKnock predictions, which after adaptive evolution were capable of producing 
up to 1.75 g L-1 lactate from 2 g L-1 glucose. In a more recent study, OptKnock was used 
to construct a strain of E. coli, where the production of the compound of interest (1,4-
butanediol) was linked to the growth of the host organism. This successful strategy resulted 
in a strain producing 18 g L-1 of 1,4-butanediol (Yim et al., 2011). Such a tool can hopefully 
help to minimise the number of designs that are constructed in the wet lab, and therefore 
help to speed-up the “Design-Build-Test-Learn” cycle. Research article 3 of this thesis uses 
the OptKnock algorithm to design gene deletion strategies in a yeast strain capable of high 
3HP titres.  
 
1.2.1.2 Biological “Parts” 
 
The following is one loose definition of synthetic biology; “Synthetic biology is the 
engineering of biology: the synthesis of complex, biologically based (or inspired) systems, 
which display functions that do not exist in nature”, (NEST, 2005). It is seen as a field that 
has engineering principles at its core, and attempts to apply these engineering principles in 
practice (Endy, 2005). Analogies may be made to the field of electrical engineering. Both 
fields deal with circuits, whose elements augment the behaviour of said circuit. Electrical 
engineers rely on having characterised parts that can be used interchangeably and whose 
performance in a new environment is predictable. These parts, and the relationships 
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between them can be represented visually and in a standardised format, so that an engineer 
on one side of the world can quickly understand and follow what an engineer has 
constructed on the other side of the world. In a similar way, synthetic biology aims to 
create standardised biological “parts” and introduce standardised methods to visualise 
biological circuits. Such standardisation is important in metabolic engineering, as it can 
help increase the reproducibility within the field, a common issue across the biological 
Figure 9. An example of a common “gene circuit”. The repressilator circuit introduced by 
Elowitz and Liebler (2000). Three genetic elements in turn repress each other, with tetR also 
repressing the output signal (GFP). This circuit was modelled in silico, and tested in vivo, where 
it showed oscillatory behaviour. The diagram is drawn using the standards of the synthetic 
biology open language. Genetic ‘parts’ are represented by different symbols, and so a genetic 
circuit can be easily understood by anyone familiar with the SBOL convention. In this simple 
scheme, the bent arrow denotes the promoter region, followed by the semi-circle of the ribosomal 
binding site. The thick coloured arrows represent coding sequences (CDS), and the T shape at 
the end denotes a terminator sequence. Lines from the CDS to promoters represent the repression 
of the promoters by the gene products. The output macromolecule (GFP) is denoted by the 
circular shape. 
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sciences (Baker, 2016; Begley and Ellis, 2012; França and Monserrat, 2018; Sene et al., 
2017). Figure 9 shows the design of a repressilator circuit (Elowitz and Leibler, 2000), one 
of the earliest examples of synthetic biology, as an example of how biological circuits can 
be visualised according to the synthetic biology open language (SBOL) (Quinn et al., 2015). 
Such a genetic circuit can be read an understood, and then implemented by a biological 
engineer in a different lab. Attention has also been paid towards improving the 
standardisation of the physical biological parts, often referred to as biobricks. The Registry 
of Standard Biological Parts attempts to catalogue and define biobricks, with each 
preferably having a detailed specification sheet outlining their characteristics 
(http://parts.igem.org/Main_Page). Basic biobricks for the engineering of yeast are 
promoter, gene, and terminator sequences, that can then be used interchangeably and have 
relatively well defined characteristics.  
 
Some applications of synthetic biology for metabolic engineering include; genetic 
manipulation of host genomes, the creation of synthetic promoter libraries for tuneable 
pathway control, biosensor development to aid in the rapid screening of production 
strains, and dynamic control of production pathways (Curran et al., 2014; DiCarlo et al., 
2013; Maury et al., 2018; Skjoedt et al., 2016). Synthetic biology tools for the manipulation 
of the yeast genome are discussed further in the following section. 
 
1.2.2 Build 
 
1.2.2.1 Genetic manipulation of yeast 
 
Natural S. cerevisiae isolates display a wide variation in ploidy, with the majority being 
diploid but with several isolates having been reported to be haploid, triploid, tetraploid, or 
higher (Codon et al., 1998; Peter et al., 2018). They can also exhibit degrees of aneuploidy, 
leading to complications in their genetic manipulation. Laboratory strains used in 
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metabolic engineering are therefore commonly haploid and, unless stated otherwise, the 
following techniques are most commonly applied to haploid laboratory strains of yeast. A 
common method for the expression of genes in yeast is to clone the genes into a plasmid, 
which can then be maintained and expressed in S. cerevisiae (Gunge, 1983; Polumienko et 
al., 1986; Stinchcomb et al., 1982). Plasmids can have different origins of replication which 
determine whether the plasmid is kept in high or low copy numbers within the cell. For 
example, plasmids containing the 2µ origin are maintained at high copy numbers, while 
plasmids with the CEN/ARS origin of replication are maintained at lower copy numbers 
(Chan et al., 2013; Karim et al., 2013). Plasmid based expression can be noisy, with 
heterogeneous populations producing different levels of protein expression based on 
variation in plasmid copy numbers between individuals (Jensen et al., 2014; Karim et al., 
2013). Integration of genetic material into the chromosomes of yeast at defined loci can 
produce populations that are far more homogenous than plasmid based expression (Jensen 
et al., 2014). With this technique, the copy number of each inserted gene is pre-defined 
making it simpler to compare results across strains – apart from when insertion into a yeast 
retrotransposon is performed to simultaneously introduce genes in multiple copies into 
the genome (Jensen et al., 2014; Maury et al., 2016).   
 
Several tools for manipulation of the chromosomal genetic material of S. cerevisiae have 
been well established (Gietz and Schiestl, 2007; Guldener et al., 1996; Jensen et al., 2014; 
Da Silva and Srikrishnan, 2012). These tools rely on introducing DNA containing a 
selectable marker into the yeast genome via its native homologous recombination 
machinery. By having upstream and downstream regions that are homologous to the site 
of insertion, it is possible to precisely target the locus where the DNA should be 
incorporated. The inclusion of loxP sites into these sequences confers the ability of marker 
cassettes to be looped out of the genome, enabling the markers to be used once more in 
further transformations (Sauer, 1987). Two different types of marker cassettes may be used 
in yeast, either dominant or auxotrophic markers. Dominant markers confer antibiotic 
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resistance to the host strain, such as the commonly used kanMX cassette whose gene 
product protects cells against the action of the gentamicin analogue G418 (Wach et al., 
1994). This has been further developed to contain loxP sites to enable Cre recombinase 
mediated excision (Guldener et al., 1996). This dominant marker cassette is routinely used 
for generation of gene deletion mutants, and was used to generate the yeast knock-out 
collection (Giaever et al., 2002).  
 
Auxotrophic markers, on the other hand, aim to confer the ability to synthesise amino 
acids that the parental strain is otherwise unable to synthesise. Selection is achieved by 
growing the transformed strain on plates lacking the relevant amino acids. Histidine 
autotrophy can be selected for by using the HIS3 gene from Schizosaccharomyces pombe 
(Wach et al., 1997). Uracil and leucine autotrophies can be selected for by insertion of 
URA3 and LEU2 from Kluyveromyces lactis (Gueldener et al., 2002). Auxotrophic 
markers allow for multiple markers to be used without requiring the markers to be looped 
out between transformations. However, the use of auxotrophic markers can cause issues 
that may impact on the experimental results. Firstly, the strain must have been engineered 
to be auxotrophic for specific amino acids. This is trivial when working with common lab 
strains where auxotrophy has already been established, but becomes a severe drawback 
when working with new, prototrophic, or non-haploid strains (Vickers et al., 2013). There 
can be further problems when screening for phenotypes, as the insertion of these selection 
genes can alter host physiology, potentially leading to unreliable results (Alam et al., 2016; 
Baganz et al., 1998; Çakar et al., 1999; Gonzalez et al., 2008; Leng and Song, 2016).  
 
Recently, the development of clustered regularly interspaced short palindromic repeats 
(CRISPR) technologies have enabled yeast strains to be constructed without inserting 
markers into the genome, circumventing some of the restraints of traditional methods for 
genomic integration. A double stranded break (DSB) introduced by the CRISPR-
associated protein 9 (Cas9) acts as a negative selection system since S. cerevisiae cannot 
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survive a DSB unless it is repaired (Jakočiūnas et al., 2015; Jessop-Fabre et al., 2016 - 
Research article 1 in this thesis; Mans et al., 2015; Reider Apel et al., 2017; Stovicek et al., 
2015, Stovicek et al., 2017). This cheap and efficient technology allows for precise cutting 
at user defined sequences, and has seen widespread adoption within synthetic biology and 
metabolic engineering (Cho et al., 2018; Lian et al., 2018).  
 
CRISPR-Cas systems were discovered in E. coli and have since been shown to be a 
bacterial and archaean adaptive defence system protecting them against viral infections 
(Garneau et al., 2010; Ishino et al., 1987). The CRISPR repeat sequences are separated by 
spacer regions often containing DNA sequences of phage origin, giving rise to the theory 
that it may be related to immunity of some kind (Bolotin et al., 2005; Mojica et al., 2005). 
In brief, the system functions by having a DNA sequence, e.g. from a phage, inserted into 
Figure 10. Mechanism of CRISPR-Cas9. The Cas9/sgRNA complex binds to the 20bp 
recognition sequence that is complementary to the sequence carried on the sgRNA. The presence 
of a PAM site upstream of the DNA/RNA binding region then promotes the Cas9 nuclease to 
introduce a double stranded break in the DNA. In S. cerevisiae, a double stranded break in the 
chromosome is lethal and so must be fixed. The presence of a length of DNA with homology 
regions to either side of the break can be used by the native homologous recombination 
machinery to repair the DSB. Abbreviations; Cas9 – CRISPR associated protein 9, tracrRNA – 
trans-activating CRISPR RNA.  
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the CRISPR locus during an infection. Afterwards, when a cell line that has previously 
encountered the phage gets infected again by the same phage, the DNA from the CRISPR 
loci are transcribed into RNA molecules, which are then matured and associate with the 
Cas9 protein. If the RNA molecule matches a sequence on the phage DNA, the Cas9 
complex can then bind and introduce a DSB into the phage DNA, preventing the cell 
from further infection (Marraffini, 2015; Rath et al., 2015). 
  
The RNA that binds to the Cas9 protein consists of a structural region, recognised by the 
Cas9 protein, and a recognition sequence that binds the foreign DNA (Figure 10). In the 
type II CRISPR system, this RNA is expressed in two parts; the CRISPR RNA (crRNA) 
that contains the DNA recognition sequence, and the transactivating CRISPR RNA 
(tracrRNA) necessary for correct binding to Cas9 (Deltcheva et al., 2011; Jinek et al., 2012). 
To make this system into one that is simple to port to different host organisms for 
synthetic biology purposes, the crRNA and tracrRNA regions from Streptococcus 
pyogenes were fused to create a single guide RNA (sgRNA) (Jinek et al., 2012).  
 
Important in the CRISPR-Cas9 system is the requirement for the protospacer adjacent 
motif (PAM). This is a three base long sequence located immediately after the recognition 
sequence and for the S. pyogenes system this sequence is NGG. Without it, Cas9 will not 
introduce a DSB at the recognition site. CRISPR-Cas9 has become an established tool in 
the genetic manipulation of S. cerevisiae with methods developed early for the functional 
expression of gRNAs and Cas9 (DiCarlo et al., 2013). This method has allowed for quick, 
cheap, and precise creation of DSBs along the yeast genome and many tools have been 
developed that allow for the introduction, or removal of genes to/from the yeast genome 
(Jakočiūnas et al., 2015; Jessop-Fabre et al., 2016 - Research article 1 in this thesis; Mans 
et al., 2015; Reider Apel et al., 2017; Vanegas et al., 2017). The recognition sequence of the 
sgRNA (20bp) is the only sequence that needs to be modified depending on the target of 
interest and so can be introduced easily through common cloning procedures. The relative 
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ease, low-cost, and speed of creation of vectors targeting new sites are some of the biggest 
factors contributing to the popularity of the technology, with CRISPR-Cas9 quickly having 
overtaken the two other programmable nuclease technologies – transcription activator-
like effector nucleases (TALENs) and zinc finger nucleases (ZFNs) (Figure 11). This thesis 
contributes to the development of CRISPR-Cas9 technologies is yeast, through the 
creation of a vector set for CRISPR-Cas9 mediated genomic integrations in research article 
1. 
 
1.2.3 Test/Learn – Omic technologies 
 
Systems biology aims to understand biological phenomena from a top-down approach, 
and as such is reliant on experimental techniques capable of generating organism-level data 
sets. Such tools now exist and can be collected under the “-omic” technologies that cover 
Figure 11. The popularity of CRISPR based DNA editing. CRISPR based technologies have been 
widely adopted, and have quickly become more popular than the two other most popular 
programmable nuclease technologies; Transcription activator-like effector nucleases (TALEN) 
and zinc finger nucleases (ZFN). Figures are generated from a PubMed search for articles 
containing the keyword in their titles or abstracts. 2018 totals are for the year to August. 
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the range of different hierarchies present in a cell. From the genome, to transcriptome, to 
proteome, to fluxome, and metabolome (and many more), each can be measured 
quantitatively to provide an understanding of cellular phenomena. Two of these 
technologies relevant to this thesis, transcriptomics and fluxomics, are introduced in 
further detail in the following sections.  
 
1.2.3.1 Transcriptomics 
 
Transcriptomic technologies are used to measure the gene transcript levels in a cell or 
population at a specific point in time. By isolating RNA, and reverse transcribing it into 
complementary DNA (cDNA) it can be read via microarray or next-generation sequencing 
(NGS) platforms, with transcriptional abundances calculated (Ozsolak and Milos, 2010). 
Transcriptomic analysis has the ability to shed light on a strain’s regulatory network, and 
how this network reacts once perturbed by the insertion/deletion of genes, by specific 
growth conditions, or by the presence or absence of specific metabolites. Such information 
can be used to identify where there might be opportunities for further strain improvement. 
Transcriptomic technologies are widely used within metabolic engineering and have 
contributed important knowledge to the field. However, one limitation of transcriptomics 
is the lack of correlation between transcript levels and the levels of its associated protein 
in vivo (Bai et al., 2015). In this way, transcriptomics becomes limited to providing 
information on transcriptional abundances and regulation, whereas other methods, such 
as proteomics or fluxomics, must be employed to quantify changes in protein abundances 
or fluxes, respectively. 
 
Transcriptomic analysis is routinely used in metabolic engineering, often helping to 
characterise the stress responses of production organisms. In a recent study into the 
transcriptome of a mutant strain of Propionibacterium acidipropionici, Guan et al., (2018) 
reported that this strain is able to withstand higher than wild-type (WT) levels of propionic 
acid, and transcriptomic profiling resulted in the discovery of the potential mechanisms 
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for acid tolerance. An array of different enzymes and transcriptional regulators related to 
lactate and acetate production have strongly downregulated expression profiles compared 
to the WT strain. Deletion of the pyruvate oxidase gene poxB in the WT strain significantly 
decreased the levels of acetate formed, and increased propionic acid titres by 19.1% (Guan 
et al., 2018). 
 
Transcriptomics has also been used to study the stress responses of E. coli in response to 
high levels of 3HP. Under 3HP stress E. coli adopts the arginine tolerance mechanism, 
which helps to boost the intracellular pH levels to try and combat the low extracellular pH 
caused by 3HP (Yung et al., 2016). Such knowledge may help researchers develop 
production strains showing higher tolerances to 3HP and other acids.  
 
A combination of genomic and transcriptomic techniques can be powerful when analysing 
mutant strains. Adaptive laboratory evolution has generated yeast mutants that are capable 
of  growing in up to 50 g L-1 3HP (Kildegaard et al., 2014). Through transcriptomic 
analysis, many oxidative stress genes were found to be highly upregulated in the mutant 
strains, suggesting the importance of these pathways in 3HP detoxification. Two genes 
were found to be mutated in all three evolved strains, with non-silent point mutations in 
genes ACH1 and SFA1. The mutated SFA1 appears to confer a majority of the observed 
3HP tolerance, with the replacement of the WT SFA1 with SFA1C276S or SFA1M283I 
enabling the strains to grow in 40 g L-1 3HP (Kildegaard et al., 2014). 3HP detoxification 
in the evolved strains is thought to occur through a similar process to that of formaldehyde 
detoxification, a pathway that Sfa1p is known to participate in (Kildegaard et al., 2014; 
Mack et al., 1988; Wehner et al., 1993).   
 
The impact of the malonyl-CoA 3HP production pathway (Figure 5) on the transcriptome 
of S. cerevisiae revealed that the ATP and redox cofactor requiring pathway caused large 
transcriptional changes in the engineered strain compared to the non-producing WT strain 
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(Kildegaard et al., 2016). The pentose phosphate (PP) pathway, and the TCA cycle were 
both upregulated in the engineered strain suggesting compensation for the increased ATP 
and NADPH requirements.  
 
1.2.3.2 13C-based metabolic flux analysis (Fluxomics) 
 
13C-based metabolic flux analysis (MFA) is the method of quantifying fluxes through 
metabolic pathways via the uptake of an isotopically labelled substrate. A commonly used 
substrate for this technique is isotopically labelled glucose. Glucose contains six carbon 
atoms, and can be synthesised so that individual, a combination, or all of these carbon 
atoms are the 13C isotope instead of the natural 12C. Labelled glucose is then fed to yeast 
during cultivation, which assimilates and converts it into metabolic intermediates in the 
same manner as it would naturally labelled glucose. These metabolic intermediates can 
themselves be measured by mass-spectrometry or nuclear magnetic resonance (NMR), 
with the resulting distribution of isotopomers (isotopic isomers) being used to constrain a 
stoichiometric model of the central metabolic pathways (Stephanopoulos, 1999; Yang, 
2013; Zamboni et al., 2009). Proteinogenic amino acids can also be used to determine the 
central carbon metabolism fluxes since the carbon building blocks for proteins are derived 
from central carbon metabolism. The amino acid isotopomer distribution can be measured 
through gas chromatography-mass spectrometry (GC-MS). The resulting isotopomer 
ratios are then combined with a stoichiometric matrix of the reactions of central carbon 
metabolism to accurately predict through which pathways the amino acid precursors were 
generated from, and therefore the flux distribution (Antoniewicz, 2015; Nanchen et al., 
2007; Sauer, 2004; Yang, 2013; Zamboni et al., 2009). With this approach, it is possible for 
metabolic engineers to analyse how fluxes are distributed through their pathways, where 
flux control points may occur, where toxic intermediates may be accumulating, or where 
competing reactions are drawing flux away from the engineered pathways (Kim et al., 2008; 
Lee et al., 2011).  
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13C- MFA has provided insights into hydroxy acid production in yeast, such as a study into 
the malonyl-CoA route for 3HP production by (Kildegaard et al., 2016). Engineering of 
this pathway enabled a strain to produce up to 13 g L-1 3HP with a C-mol yield of 0.26 
mol mol-1 glucose when cultivated in a bioreactor. Through combining 13C-MFA with 
genome scale modelling, flux distributions were analysed in more depth than is possible 
using only MFA. The TCA cycle of this engineered strain had an increased relative flux 
compared to the WT of 12%, and an increased flux of 23% through the PP pathway, with 
both of these pathways regenerating NADPH that can be used for 3HP synthesis. 
However, even with this increased activity and the overexpression of a heterologous 
NADP+-dependent glyceraldehyde-3-phosphate the attempts to balance the redox state of 
the producing strain were not fully successful. Although the NADPH/NADP+ ratio 
increased, so did the NADH/NAD+ ratio, with glycerol production being observed, 
opening up new directions and targets for future redox engineering efforts (Kildegaard et 
al., 2016). 
 
In an MFA study on lactate production, engineered Crabtree-negative (PDC1 and PDC5 
deletion) and Crabtree-positive lactate producing yeast strains have been analysed under 
micro-aerobic conditions (Nagamori et al., 2013). Under these conditions, both the 
Crabtree-negative and Crabtree-positive strains were estimated to maintain similar flux 
distributions across upper central carbon metabolism, but begin to diverge at the pyruvate 
node, where the Crabtree-negative strains are able to divert more flux into lactate rather 
than acetaldehyde production (Nagamori et al., 2013). Under these micro-aerobic 
conditions, none of the tested strains showed appreciable flux through the TCA cycle, nor 
through the PP pathway. 
 
Zelle et al., (2008) performed 13C-MFA on a malate producing Crabtree-negative strain, 
derived from the TAM strain (see section 1.1.2 for more information on the TAM strain). 
The details of this strain design and performance can be found in section 1.1.4.2. The 
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malate producing strain was verified to be only producing relevant levels of malate through 
the engineered non-oxidative pathway, and not through the oxidative TCA cycle. The non-
oxidative pathway in this strain contributes the bulk of malate production, while a 
significant proportion of the carbon flux is still lost through pyruvate secretion, and 
cytosolic fumarate production that is transported into the mitochondria. However, the 
estimated high conversion of malate into fumarate in the yeast cytosol may not be an 
accurate reflection of the actual flux distribution, as cytosolic fumarase is believed to only 
convert fumarate to malate (Pines et al., 1996). 
 
The following research articles aim to contribute to the topics outlined in this introduction. 
Research article 1 has a focus on developing CRISPR-Cas9 tools for yeast. This work 
presents a toolkit for the insertion of DNA into the yeast chromosome at the specific loci 
of the EasyClone system. This paper also investigates some mechanisms of cytosolic 
acetyl-CoA production and the impact of these strategies on the production of 3HP via 
the malonyl-CoA route. The expression of a bacterial PDH complex from E. faecalis 
proved to be an efficient strategy, and may be a key enzyme for further research. 
 
Research articles 2 and 3 are contributions to the fields of transcriptomics and 13C-MFA 
with research article 2 using 13C-MFA to help characterise hydroxy acid producing variants 
of the TAM strain. This work compares the effects of heterologous production of lactate, 
malate, and 3HP, and shows that these inserted pathways cause widespread changes in the 
host metabolic flux networks. Research article 3 uses 13C-MFA and transcriptomic data to 
generate predictions for gene deletions that are carried out in vivo. This article shows how 
-omic data can successfully be used to increase 3HP titres. 
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Abstract 
 
Saccharomyces cerevisiae is an established industrial host for production of recombinant 
proteins, fuels and chemicals. To enable stable integration of multiple marker-free 
overexpression cassettes in the genome of S. cerevisiae, we have developed a vector toolkit 
EasyClone-MarkerFree. The integration of linearized expression cassettes into defined 
genomic loci is facilitated by CRISPR/Cas9. Cas9 is recruited to the chromosomal location 
by specific guide RNAs (gRNAs) expressed from a set of gRNA helper vectors. Using our 
genome engineering vector suite, single and triple insertions are obtained with 90–100% 
and 60–70% targeting efficiency, respectively. We demonstrate application of the vector 
toolkit by constructing a haploid laboratory strain (CEN.PK113-7D) and a diploid 
industrial strain (Ethanol Red) for production of 3-hydroxypropionic acid, where we tested 
three different acetyl-CoA supply strategies, requiring overexpression of three to six genes 
each. Among the tested strategies was a bacterial cytosolic pyruvate dehydrogenase 
complex, which was integrated into the genome in a single transformation. The publicly 
available EasyClone-MarkerFree vector suite allows for facile and highly standardized 
genome engineering, and should be of particular interest to researchers working on yeast 
chassis with limited markers available. 
 
  
Graphical abstract 
 
 
 59 
 
 
Graphical abstract 
  
1 Introduction 
 
 
 60 
1 Introduction 
 
The yeast S. cerevisiae is widely applied in industrial biotechnology for production of fuels, 
chemicals, and pharmaceutical ingredients and it is also used for fundamental research as 
a eukaryotic model organism [1-3]. Genetic manipulation of S. cerevisiae is greatly 
facilitated by its efficient inherent homologous recombination (HR) machinery for DNA 
double-strand break (DSB) repair [4]. As a result, many genome engineering tools have 
been developed that take advantage of HR for targeted integration of heterologous DNA 
into the yeast genome [5, 6]. Chromosomal gene integration has several benefits over 
plasmid-based approaches, such as increased strain stability, better control of gene 
expression level and lower population heterogeneity [5]. However, though the HR 
machinery has a high fidelity, selection is still necessary to identify the colonies that have 
been successfully engineered. This has the fundamental drawback that selection markers 
need to be recycled if multiple genome edits are needed. Also, both dominant and 
auxotrophic markers have been reported to have an effect on cell physiology [7, 8]. 
Moreover, antibiotic-based selection markers are undesirable in industrial strains due to 
the risk of spreading drug resistance. A way to improve homology-directed chromosomal 
integration of heterologous gene fragments is by using DNA endonucleases for targeted 
DSB as this has been shown to increase recombination events by approximately three 
orders of magnitude [9-12]. Recently, the Clustered Regularly Interspaced Short 
Palindromic Repeats (CRISPR) Type II system from bacteria has been adopted for genetic 
engineering of yeast [13]. This system consists of two components: guide RNA (gRNA) 
and CRISPR-associated endonuclease (Cas9). Upon expression in the cell, the 
gRNA/Cas9 complex is recruited to DNA by base-pairing of the gRNA recognition 
sequence (typically 20 bp) and the complementary DNA stand, after which the Cas9 
introduces a DSB break. The target DNA sequence must be immediately followed by a 
protospacer adjacent motif (PAM) (i.e. NGG for Streptococcus pyogenes-derived Cas9); 
Cas9 makes a blunt cut three nucleotides upstream of the PAM site [14]. There have been 
many recently published examples of CRISPR-Cas9-based tools for yeast genome 
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engineering [15-21] that are reviewed in Jakočiūnas et al. [22]. The work presented here 
builds on the previously reported method EasyClone for single-step targeted integration 
of multiple expression cassettes [5, 6]. The EasyClone method allows targeted genomic 
integration of up to three vectors in a single transformation event using auxotrophic or 
dominant selection markers. These target sites are located in the intergenic regions and are 
interspaced by essential genes to ensure that the integrated DNA fragments are not at risk 
of being removed by HR [23]. Moreover it has been confirmed that integration into these 
sites ensures a high-level of expression and does not interfere with cellular growth [23]. 
The selection markers can be removed via Cre-LoxP-mediated recombination, which 
requires one extra transformation with CreA-vector, cultivation to induce the CreA 
expression and finally screening of the resulting clones on selection plates to confirm the 
loss of the marker; the marker removal procedure has a turnaround time of about five 
days. Once the selection markers are eliminated, the strain is ready for the next integration 
event or for other genetic modifications. Marker removal, as well as being time consuming, 
can also cause genome instability [24, 25]. 
Here we present the EasyClone-MarkerFree method, which takes advantage of CRISPR-
Cas9 for introduction of double-strand DNA breaks in the defined integration sites, which 
causes very efficient integration of expression cassettes and thus bypasses the need for 
selection. The gRNA helper vectors, expressing gRNA molecules that recruit Cas9 to the 
particular chromosomal locations, can be easily removed from the strain by growth on 
non-selective medium, after which the strain is ready for the next modification. This 
shortens the turnaround time to only one or two days. Additional advantages are: 
simplified experimental design for cloning, because the choice of selection markers does 
not need to be taken into consideration; elimination of the effect of the selection markers 
on strain physiology; and moreover a possibility to iterate gene integrations with other 
edits guided by CRISPR/Cas9, e.g. gene deletions. The use of predefined and characterized 
chromosomal target sites dispenses with the need for the experimenter to identify suitable 
regions in which to integrate their genes of interest. Furthermore, we demonstrate the 
2 Materials and methods 
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utility of the method by engineering 3-hydroxypropionic acid producing strains with 
improved precursor supply strategies. 
 
2 Materials and methods 
 
2.1 Strains 
 
Two different strains of S. cerevisiae were used: the haploid laboratory strain CEN.PK113-
7D (MATaURA3 HIS3 LEU2 TRP1 MAL2-8c SUC2; obtained from Peter Kötter, Johann 
Wolfgang Goethe University Frankfurt, Germany), and the diploid industrial Ethanol Red 
strain (MATa/α; obtained from Fermentis, A Lesaffre division). E. coli strain DH5α alpha 
was used to clone, propagate, and store the plasmids. 
2.2 Construction of plasmids 
 
The codon-optimized genes, encoding the pyruvate dehydrogenase complex and lipoate-
protein ligase from Enterococcus faecalis, were ordered from GenScript (sequences can 
be found in Supporting information, Table S5). The genes encoding ATP-dependent 
citrate lyase and the mitochondrial citrate transport protein, were amplified from the 
genomic DNA of Yarrowia lipolytica DSM-8218, obtained from the DSMZ collection 
(www.dsmz.de). All of the primers, biobricks and plasmids constructed and used in this 
study can be found in Supporting information, Tables S1–S3. 
The EasyClone-MarkerFree vectors were created by amplifying the EasyClone 2.0 vectors 
[6] with primers that were designed to attach to either side of the selection markers, 
creating a fragment that no longer contained the marker. These fragments were then 
ligated to form the marker-less vectors. Seven of the resulting vectors (named 
“Intermediate vectors” in Table S3) contained PAM sites in the integration regions, which 
were removed by site-directed mutagenesis using the QuikChange II XL Site-Directed 
Mutagenesis Kit (Agilent Technologies) according to the manufacturers' protocol. 
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gRNA cassettes targeting particular integration loci (chromosomal coordinates can be 
found in Supporting information, Table S4) were ordered as double-stranded gene blocks 
from IDT DNA. These cassettes were amplified using primers 10525(TJOS-62 [P1F]) and 
10529(TJOS-65 [P1R]) and USER-cloned into pCfB2926 (pTAJAK-71) [15] to give single 
gRNA helper vectors. For construction of triple gRNA helper vectors, three gRNA 
cassettes were amplified using three primer pairs (10525(TJOS-62 [P1F]) and 10530(TJOS-
66 [P2R]) for the first, 10526(TJOS-63 [P2F]) and 10531(TJOS-67 [P3R]) for the second, 
and 10527(TJOS-64 [P3F]) and 10529(TJOS-65 [P1R]) for the third gRNA cassette) and 
cloned into pCfB2926 (p-TAJAK-71) [15]. Single gRNA helper vectors for Ethanol Red 
were constructed by PCR amplification of the template plasmid pCfB3041 using primers 
indicated in Supporting information, Table S1 as described in [17]. All of the cloning steps 
for creating gRNA helper vectors and EasyClone-MarkerFree vectors were performed in 
E. coli. Correct cloning was confirmed by Sanger sequencing. 
For expression of the Cas9 gene we used an episomal vector pCfB2312 with CEN-ARS 
replicon and KanMX resistance marker [17]. 
The EasyClone-MarkerFree vectors for expression of fluorescent protein or 3HP pathway 
genes were cloned as described in [5, 26]. The vectors were linearized with NotI, the 
integration fragment (part of the expression vector without E. coli ori and AmpR) was gel-
purified and transformed, along with a gRNA helper vector, into yeast carrying the Cas9 
plasmid (pCfB2312) via the lithium acetate method [27]. After the heat shock the cells 
were recovered for two hours in YPD medium and then plated on YPD agar containing 
200 mg/L G418 and 100 mg/L nourseothricin. For yeast transformations with a single 
vector we routinely use 500 ng of the linear integration fragment along with 500 ng of the 
relevant gRNA helper plasmid. For yeast transformations with three vectors we use 1 µg 
of linear integration fragments and 1 µg of triple gRNA helper plasmid. Correct integration 
2.3 Media and growth conditions 
 
 
 64 
of the vectors into the genome was verified by colony PCR using primers listed in 
Supporting information, Table S1. 
2.3 Media and growth conditions 
 
The E. coli strains containing the plasmids were grown in Luria–Bertani (LB) media 
supplemented with 100 µg/mL ampicillin. Yeast strains were grown in liquid YPD media, 
or on YPD agar plates with 20 g/L glucose (Sigma-Aldrich). When needed the medium 
was supplemented with antibiotics G418 (200 mg/L) for the selection of the Cas9 plasmid, 
and/or nourseothricin (100 mg/L) for selection of the gRNA plasmid. Synthetic complete 
medium with 20 g/L glucose was prepared using drop-out powder from Sigma-Aldrich. 
The strains were screened for production of 3HP as following. Single colonies were grown 
in 500 µL synthetic complete media in 96 deep-well plates with air-penetrable lids 
(EnzyScreen, Germany) at 30°C with 250 rpm shaking overnight. The overnight cultures 
were then inoculated into 50 mL of either mineral media (MM) with 60 g/L glucose [5], 
or a simulated fed-batch media (feed-in-time, FIT) in 500 mL-shake flasks with baffles to 
a starting OD600 of 0.1. The feed-in-time (FIT) medium M-Sc.syn-1000 synthetic FIT 
was purchased from M2P labs GmbH (Germany). All the media for 3HP cultivations were 
supplemented with 500 ng/mL of DL-α-lipoic acid (Sigma Aldrich). The strains were 
cultivated in MM or FIT media at 30°C with 250 rpm for 168 h. Samples were taken every 
12 h (every 1–2 h during the exponential phase in MM), with the optical density OD600 
being measured on a 20-fold diluted culture broth. Samples were then centrifuged at 3000 
×g for 30 min and the supernatant was stored at −20°C until HPLC analysis. Cultivations 
were carried out in triplicate. 
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2.4 Analytical procedures 
 
Strains expressing gfp were analyzed using a BioTek Synergy MX microplate reader. 
Excitation wavelength was set at 485 nm, and emission was read at 530 nm. Optical density 
was measured at 600 nm. Concentration of 3-hydroxypropionic acid in the broth was 
measured by HPLC, using a method previously reported in [28]. 
2.5 Integration Stability 
 
Strains that had been transformed with gfp-containing vectors were grown in 500 µL of 
YPD in 96 deep-well plates with air-penetrable lids at 30°C with 250 rpm shaking 
overnight. The following morning, 50 µL of each culture was passed to 500 µL of fresh 
YPD. This was repeated for a total of five passages. At the end of the passages, the culture 
was plated onto YPD agar, and the fluorescent colonies were counted. 
2.6 Determination of gene copy number by qPCR 
 
Quantitative PCR was performed on the Ethanol Red strain containing the genes from 
Enterococcus faecalis. Primers were designed using the PrimerQuest® tool 
(https://eu.idtdna.com/Primerquest/Home/Index). Details of the primers used can be 
found in Supporting information, Table S1. Genomic DNA was prepared using the ZR 
Fungal/Bacterial DNA MiniPrep™ kit (Zymo Research) according to the manufacturer's 
protocol. Each reaction contained 10 µL of 2xSYBR Green qPCR MasterMix (Life 
Technologies), 1 µL of each primer, 0.1 µL of diluted reference dye, and 7.7 µL of genomic 
DNA. Reactions were carried out in triplicate, with 5 pg of gDNA present in each reaction. 
ALG9 was used as a control, as well as a no template control where the gDNA was 
replaced with nuclease-free PCR grade water. The experiment was carried out using a 
Stratagene Mx3005P qPCR system with the following settings; 10 min pre-incubation at 
95°C, 40 cycles of denaturation at 95°C for 20 s and annealing and elongation at 60°C for 
22 s, and the final step of 95°C for 1 min, 55°C for 30 s, 95°C for 30 s. The Stratagene 
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MxPro software was used to quantify the original amount of DNA present for each gene, 
which could then be related to the copy number. 
3 Results and discussion 
 
To enable rapid iterative cycles of metabolic engineering, we developed a new vector 
toolkit EasyClone-MarkerFree, which allows integration of genes into specific sites of the 
yeast chromosome without integration of a selection marker. This simplifies strain design 
and reduces the turnaround time in comparison to the previously published EasyClone 
methods [5, 6]. The method employs CRISPR-Cas9 to introduce one or several DSBs into 
the host chromosome, ensuring efficient integration. For this system to be active in S. 
cerevisiae, it is necessary to have a Cas9 expression plasmid, as well as a gRNA helper 
vector. The DSB is repaired by the host cell using the native HR machinery, which 
incorporates the EasyClone-MarkerFree vector(s) into the target loci via double cross-
over. 
3.1 Construction of EasyClone-MarkerFree vector toolkit 
 
Construction of the EasyClone vector set required that 11 gRNA helper vectors were built, 
one to target each of the EasyClone chromosomal integration sites in the S. cerevisiae 
CEN.PK strain. Furthermore, three triple gRNA helper vectors were built that can target 
three sites simultaneously. The EasyClone 2.0 vectors were modified to remove the 
selection markers and, where necessary, to mutate the PAM sites in the integration sites. 
The vectors contain a USER cloning site surrounded by bi-directional terminators. Genes 
and promoters can be cloned into the vectors using USER cloning as described below or 
other methods, such as Gibson assembly, in-fusion, MoClo, etc. [29]. 
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3.2 Workflow 
 
The suggested workflow is illustrated on Fig. 1. For USER cloning, the EasyClone-
MarkerFree vectors are prepared by linearization with AsiSI and nicking with Nb.BsmI in 
order to obtain vector backbones with sticky ends. The treated vector backbones are stored 
at −20°C. Compatible biobricks, encoding genes and promoters, are prepared by PCR 
amplification using oligos with a uracil base, 7–10 bases downstream of the 5' end of the 
primers (Fig. 1a). We routinely use the overhangs as specified in [5] for all of our genes 
and promoters, which simplifies standardization and exchange of biobricks between 
scientists in our laboratory. We store the library of ready-to-use genes and promoters at 
−20°C. 
To clone promoters and genes into the expression vector, the AsiSI/Nb.BsmI-treated 
vector backbones are mixed with the desired promoter(s) and gene(s) and treated with 
USER enzyme. The USER enzyme excises uracils in the overhangs of genes and 
promoters, thus producing sticky ends compatible with the EasyClone vectors (Fig. 1b). 
The USER reaction mix is transformed into E. coli, which ligates the expression vector 
(Fig. 1c). The plasmids can then be isolated, confirmed by sequencing and linearized with 
NotI (or another suitable) restriction enzyme to produce linear integration fragments 
containing expression cassettes flanked with ~500-bp-long integration regions (Fig. 1d). 
The linear integration fragment(s) and the corresponding helper vector are then 
transformed into the yeast host cell already carrying a Cas9 expression plasmid (Fig. 1e). 
The transformants are selected on medium with G418 and nourseothricin to select for the 
Cas9 and gRNA helper vector, respectively. If further CRISPR-Cas9 mediated engineering 
rounds are desired, the gRNA helper vector is removed by cultivating the cells in liquid or 
solid medium containing G418 to maintain the selection for Cas9 (Fig. 1f). gRNA helper 
vectors are 2µ-based and according to our experience are easily lost by growing the cells 
overnight in liquid medium with G418 only. The resulting culture is diluted and plated on 
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G418 plates to obtain single colonies. The loss of the gRNA helper vector is confirmed 
by replica plating onto nourseothricin agar plates. The strains are then ready for the next 
round of Cas9-mediated gene insertions or other manipulations (e.g. knock-outs, etc.). If 
no further genetic modifications are desired, the strains can be cultivated on non-selective 
medium to eliminate both Cas9 and gRNA helper vectors. 
 
 
Figure 1 (Over page). An overview of the EasyClone-MarkerFree method. The BioBricks 
encoding genes and promoters are generated by PCR-amplification with uracil-containing 
primers (a). The BioBricks are assembled with the integration vectors via USER cloning (b) and 
the reaction mixture is transformed into E. coli (c). The resulting plasmids are isolated from E. 
coli and confirmed by sequencing, then they are linearized and transformed into Cas9-expressing 
S. cerevisiae along with a helper gRNA vector, which causes double-stranded breaks at the 
designated integration sites (d–e). Yeast cells are selected on plates with G418 and 
nourseothricin and correct integration of the vector(s) is confirmed by PCR. The helper gRNA 
vector can be eliminated by growth in the absence of nourseothricin selection and the resulting 
strain, which still expresses Cas9, can be further engineered. Once the desired genetic 
modifications are accomplished the Cas9 vector is removed by growth on non-selective medium 
and the final strain, not containing selection markers, is obtained (f). G, gene; P, promoter; T, 
terminator; H, homology region. A detailed protocol is provided in Supporting information. 
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3.3 Validation of the vector toolkit 
 
To verify the integration efficiency and gene expression levels at each site, gfp was cloned 
into each of the EasyClone vectors and transformed into the CEN.PK113-7D strain. The 
integrations were tested by colony PCR for 20 randomly picked clones, and 95–100% 
correct integrations were obtained for all the integration sites (Fig. 2). This is comparable 
with the previous versions of EasyClone, where the targeting efficiency was 80–100% [5, 
6]. However, we should note that wrong clones in the EasyClone-MarkerFree system were 
not fluorescent and hence they did not contain the designed integration cassettes in their 
genomes, while for the EasyClone system with selection markers, the integration cassette 
would always be integrated in the genome, however sometimes it would not be targeted to 
the designed integration site. Further, the transformed colonies were each checked for 
fluorescence, with 99% of the colonies showing fluorescence (84–559 colonies were 
obtained and tested per transformation). Fluorescence levels showed some smaller 
variations for different integration sites (Fig. 2) as we also observed previously [6]. Another 
observation was that among those clones with an integrated fragment, all clones were 
fluorescent, which differs from the results we obtained with CRISPR-Cas9-mediated 
insertion of expression fragments with short homology arms (40 bp), where only half of 
the clones were fluorescent [17]. We suggest that the high fidelity of correct integration is 
due to the long homology arms of ~0.5 kb present in the EasyClone vectors. 
We further tested the stability of the integrations of the gfp gene in each of the sites. After 
five passages, the population retained 100% of fluorescent colonies, reinforcing the notion 
that these sites are stable due to their location in-between essential genes. 
The simultaneous targeting of three integration sites, assisted with triple gRNA helper 
vectors, resulted in 60–70% targeting efficiencies, which is also comparable with previously 
reported efficiencies for CRISPR-Cas9 methods for multi-loci integration [16, 18]. We  
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previously observed for the EasyClone system with selection markers that targeting 
efficiency into the same chromosome was only 44%, however the efficiency is higher for 
simultaneous integration into different chromosomes (unpublished results). We believe 
that simultaneous targeting of three sites that are closely positioned on the same 
chromosome, may lead to genome instability. Therefore to achieve the best targeting 
efficiencies, triple gRNA helper vectors were designed to target distinct chromosomes. 
 
 
Figure 2. Validation of the EasyClone-MarkerFree vector toolkit. The laboratory strain, CEN.PK 
117-7D, was transformed with the EasyClone-MarkerFree vectors carrying gfp gene under 
control of a constitutive PTEF1 promoter. Specific fluorescence was measured to evaluate the 
expression level at each of the eleven integration sites. The error bars show standard deviation 
between nine or ten replicates. The percentage of clones with correct integration is shown for 
each site n = 20. 
3.4 Application of EasyClone-MarkerFree vector toolkit for engineering of 
precursor supply for 3-hydroxypropionic acid production 
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3.4 Application of EasyClone-MarkerFree vector toolkit for engineering of 
precursor supply for 3-hydroxypropionic acid production 
 
As a test case, a pathway to produce 3HP was inserted into two different S. cerevisiae 
strains, CEN.PK113-7D and Ethanol Red, and the strains were further engineered for 
improved acetyl-CoA supply. The basic pathway strains were constructed by inserting a 
modified acetyl-CoA carboxylase ACC1S659A,S1157A and a malonyl-CoA reductase MCR 
from Chloroflexus aurantiacus. Three different strategies to boost acetyl-CoA production 
in the cytosol were compared (Fig. 3A). One of the strategies relied on expression of a 
functional bacterial pyruvate dehydrogenase complex from Enterococcus faecalis in the 
cytoplasm, which required expression of genes encoding subunits E1α, E1β, E2, and E3 
of PDH complex, as well as two genes involved in lipoylation of E2 [30]. Another strategy 
was based on overexpression of the pyruvate dehydrogenase bypass, namely pyruvate 
decarboxylase PDC1, aldehyde dehydrogenase ALD6 and acetyl-CoA synthase from 
Salmonella enterica ACSSE [31]. The third strategy encompassed overexpression of ATP-
dependent citrate lyase, consisting of two subunits ACL1 and ACL2, and a mitochondrial 
citrate transporter protein from Y. lipolytica. The genes required for different strategies 
were cloned into three EasyClone-MarkerFree plasmids and transformed into yeast strains 
expressing basic 3HP pathway along with the triple gRNA helper vector (pCfB3052 for 
CEN.PK and pCfB4668 for Ethanol Red). 
Overexpression of the cytoplasmic PDH complex proved to be the most successful 
strategy in CEN.PK, with an improvement in 3HP final titer of 19% over the basic strain 
in mineral medium, and 95% in the simulated fed-batch medium (Fig. 3). The PDH bypass 
showed no improvement. The ACL strategy performed worse than the basic pathway in 
MM, but interestingly showed an improvement of 60% in FIT (Fig. 3B). Growth profiles 
can be found in Supporting information, Fig. S1. 
In the diploid industrial strain (Ethanol Red), the PDH complex also performed well, with 
an improvement of 23% over the basic strain (Supporting information, Fig. S2). These 
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results confirm that the bacterial PDH complex from Enterococcus faecalis is a robust 
and efficient way to improve cytosolic acetyl-CoA levels in yeast. We confirmed that 
EasyClone-MarkerFree method integrates the expression cassettes on both homologous 
chromosomes, when applied in diploid strains. We performed qPCR on the diploid 
industrial strain (Ethanol Red) carrying the genes for the PDH complex. All of the six 
genes were shown to have a copy number of 2. The PDH bypass seems to have performed 
poorly, contradicting previous works. This may be due to the low activity of the 3HP 
biosynthetic genes in this work, as we only integrated ACC1 and MCR in single copies. In 
other studies, where we expressed ACC1 and MCR from either a high-copy episomal 
Figure 3. Effect of acetyl-CoA supply strategies on the production of 3-hydroxypropionic acid. 
(A) Three different pathways taken to produce acetyl-CoA in the cytosol; 1. The PDH bypass, 2. 
The PDH complex of E. faecalis, 3. The ATP-dependent citrate lyase strategy from Y. lipolytica. 
Colored arrows denote which promoter was used, and the direction of the arrow indicates in 
which direction the gene is transcribed. A left facing arrow signifies that the gene is translated 
on the anti-sense strand and vice versa. The box at the end of the gene represents which 
terminator sequence is used. (B) Production of 3-hydroxypropionic acid over time in the 
engineered laboratory strain in mineral or simulated fed-batch medium. The cultivations were 
carried out in triplicate, the error bars show standard deviation. 
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vector or integrated them in multiple copies into the genome, the overexpression of PDH 
bypass did have a positive effect on the 3HP production [32-34]. 
4 Concluding remarks 
 
The EasyClone-MarkerFree vector toolkit can be used to simultaneously introduce one to 
three integration cassettes into the genome of S. cerevisiae without the use of selection 
markers. Using standardized BioBricks, the integration cassettes can be constructed for 
overexpression of one or two genes per integration site. In this study we successfully 
integrated up to six genes in a single transformation with 60–70% targeting efficiency. The 
system is well suited for strain construction via multiple iterative metabolic engineering 
cycles. We have shown that it performs well in both the haploid laboratory CEN.PK strain, 
and also in the diploid industrial Ethanol Red strain. The EasyClone-MarkerFree vector 
toolkit can be obtained from AddGene. 
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Table S1. List of primers used in this study  
 
ID NAME SEQUENCE (5'->3') APPLICATION 
Primers used for construction of EasyClone-MarkerFree plasmids and gRNA helper plasmids 
401 ID401pIntFwdU ACCCAAUTCGCCCTATAGTGA
GTCG 
For amplification of the EasyClone vectors minus the 
markers 
402 ID402pintRevU ACGCGAUCTTCGAGCGTCCC
AAAACC 
For amplification of the EasyClone vectors minus the 
markers 
10277 gRNArev 
GATCATTTATCTTTCACTGCG
GAGAAG 
universal primer for amplification of gRNA cassette 
carrying plasmid 
11150 X-2_gRNAerFW 
CTCTCGAAGTGGTCACGTGT
GTTTTAGAGCTAGAA 
For amplification of X-2 targeting gRNA helper vector 
for ethanol red, used with 10277 
11151 X-4_gRNAerFW CGCCATTCAAGAGTAGCAAC
GTTTTAGAGCTAGAA 
For amplification of X-2 targeting gRNA helper vector 
for ethanol red, used with 10277 
11152 XI-2_gRNAerFW TTGATCAGTTGATCAGTTGA
GTTTTAGAGCTAGAA 
For amplification of X-2 targeting gRNA helper vector 
for ethanol red, used with 10277 
11153 XI-5_gRNAerFW 
TGAGAATAATGTTGTAAAAC
GTTTTAGAGCTAGAA 
For amplification of X-2 targeting gRNA helper vector 
for ethanol red, used with 10277 
10525 TJOS-62 (P1F) 
CGTGCGAUAGGGAACAAAA
GCTGGAGCT 
Amplify 1st gRNA expression sequence for triple 
gRNA vectors 
10526 TJOS-63 (P2F) AGTGCAGGUAGGGAACAAA
AGCTGGAGCT 
Amplify 2nd gRNA expression sequence for triple 
gRNA vectors 
10527 TJOS-64 (P3F) ATCTGTCAUAGGGAACAAAA
GCTGGAGCT 
Amplify 3rd gRNA expression sequence for triple 
gRNA vectors 
10529 TJOS-65 (P1R) 
CACGCGAUTAACTAATTACAT
GACTCGA 
Amplify 3rd gRNA expression sequence for triple 
gRNA vectors 
10530 TJOS-66 (P2R) 
ACCTGCACUTAACTAATTACA
TGACTCGA 
Amplify 1st gRNA expression sequence for triple 
gRNA vectors 
10531 TJOS-67 (P3R) ATGACAGAUTAACTAATTACA
TGACTCGA 
Amplify 2nd gRNA expression sequence for triple 
gRNA vectors 
Primers used for PAM site removal by site-directed mutagenesis 
11399 TJOS-120 ATTAATGCCTCAGCACTAGT Universal primer for PAM site removal in EasyClone 
vectors 
11354 TJOS-89F CCACTTTTCAATGAAACGGA Primer to remove PAM site in pCfB2900 
11395 TJOS-116 ACATGGGAAGATTCGCTTTT Primer to remove PAM site in pCfB2901 
11396 TJOS-117 AGTTTCTTGGCATTGGCAAT Primer to remove PAM site in pCfB2902 
11397 TJOS-118 CTATTGGCTGCTTCATAGTA Primer to remove PAM site in pCfB2905 
11398 TJOS-119 AGTTTACTCAATTCTTGAAG Primer to remove PAM site in pCfB2908 
11400 TJOS-121 CGTGAATCAACTGCACATAC Primer to remove PAM site in pCfB2906 
11355 TJOS-90F CGACTCTCTCGAAATTTTTC Primer to remove PAM site in pCfB2907 
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Primers used for amplification of gene and promoter BioBricks 
6 PTEF1_rv 
 
CACGCGAUGCACACACCATA
GCTTC 
For amplification of the TEF1 promoter 
7 PPGK1_fw 
 
CGTGCGAUGGAAGTACCTTC
AAAGA 
For amplification of the PGK1 promoter 
53 ACC1m_fw CGT GCG AUT CAT TTC AAA 
GTC TTC AAC AAT TT 
For amplification of ACC1** gene 
177 CaMCR_rv_NEW 
CACGCGAUTCAGACTGTAAT
GGCTCTACCTC For amplification of MCR gene 
312 GFPopt_rv 
CACGCGAU TCA 
TTTGTAGAGCTCATCCATGC For amplification of GFP gene 
645 
ACSse_U1_rv 
(ID645) 
CGTGCGAUTCATGATGGCAT
AGCAATAG 
For amplification of ACS gene 
739 ald6_U2_rv 
(ID739) 
CACGCGAUTCACAACTTAATT
CTGACAGCTTTTAC 
For amplification of ALD6 gene 
842 YlAcly1_U1_rv 
(ID842) 
CGTGCGAU TCA 
TGATCGAGTCTTGGCCTTG 
For amplification of ACL1 gene 
844 YlAcly2_U2_rv 
(ID844) 
CACGCGAU TCA 
AACTCCGAGAGGAGTGGAA
G 
For amplification of ACL2 gene 
846 
YlCtp1_U1_rv 
(ID846) 
CGTGCGAU TCA 
AAGAATCTCCATGATCTTC 
For amplification of CTP1 gene 
1188 pdc1_U1longer_r
v (ID1188) 
CGTGCGAUTCATTGCTTAGC
GTTGGTAGCAGCAGTC 
For amplification of PDC1 gene 
1564 
PTEF1->_fw 
(ID1564) 
CGTGCGAUGCACACACCATA
GCTTC For amplification of TEF1 promoter 
10549 lplA_U2_fw 
ATCTGTCAUAAAACAATGAG
ATACGTTATCATGCAATCC For amplification of LPLA gene 
10550 lplA_U_rv 
CACGCGAUTCATTAGTCAACC
AACAAGTGGACG 
For amplification of LPLA gene 
10684 pdhB_U2_fw 
ATCTGTCAUAAAACAATGGC
ACAAAAGACTATGATCCAAG
C 
For amplification of PDHB gene 
10685 pdhB_U_rv 
CACGCGAUTCATTAAAATTCA
ACAATTTCTCTGG For amplification of PDHB gene 
10686 pdhA_U1_fd 
AGTGCAGGUAAAACAATGGC
AAAAGCAAAGAAGC For amplification of PDHA gene 
10687 pdhA_U_rv 
CGTGCGAUTTACTTTGATTCT
TTGGCTTCG 
For amplification of PDHA gene 
10688 aceF_U2_fw ATCTGTCAUAAAACAATGGC
CTATCAATTCAAGTTGCC 
For amplification of ACEF gene 
10689 aceF_U_rv 
CACGCGAUTCAACCTTCCATC
AATAA For amplification of ACEF gene 
10690 lpd_U1_fw 
AGTGCAGGUAAAACAATGGT
TGTTGGTGAC For amplification of LPD gene 
10691 lpd_U_rv 
CGTGCGAUTCATTAGATATG
TATAGGCAAACC 
For amplification of LPD gene 
Sequencing primers 
891 XII-1-up-out-sq 
ID891 
CTGGCAAGAGAACCACCAAT Verifies UP region of chromosome site XII-1 with 
ID2221 
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893 
XII-2-up-out-sq 
ID893 CGAAGAAGGCCTGCAATTC 
Verifies UP region of chromosome site XII-2 with 
ID2221 
897 XII-4-up-out-sq 
ID897 
GAACTGACGTCGAAGGCTCT Verifies UP region of chromosome site XII-4 with 
ID2221 
899 XII-5-up-out-sq 
ID899 
CCACCGAAGTTGATTTGCTT Verifies UP region of chromosome site XII-5 with 
ID2221 
901 
X-2-up-out-sq 
ID901 
TGCGACAGAAGAAAGGGAA
G 
Verifies UP region of chromosome site X-2 with 
ID2221 
903 
X-3-up-out-
sqID903 TGACGAATCGTTAGGCACAG 
Verifies UP region of chromosome site X-3 with 
ID2221 
905 X-4-up-out-
sqID905 
CTCACAAAGGGACGAATCCT Verifies UP region of chromosome site X-4 with 
ID2221 
907 Ny-XI-1-up-
sqID907 
CTTAATGGGTAGTGCTTGAC
ACG 
Verifies UP region of chromosome site XI-1 with 
ID2221 
909 XI-2-sq-fwID909 GTTTGTAGTTGGCGGTGGAG 
Verifies UP region of chromosome site XI-2 with 
ID2221 
911 
XI-3- up-out-
sqID911 GTGCTTGATTTGCGTCATTC 
Verifies UP region of chromosome site XI-3 with 
ID2221 
2221 
JM234_ColoPCR_
vec_TADH1_tow
ards out 
GTTGACACTTCTAAATAAGC
GAATTTC Verifies UP regions of chromosome sites 
8418 verif ChrXI-5_up 
(JM269) 
CTCAATGATCAAAATCCTGAA
TGCA 
Verifies UP region of chromosome site XI-5 
qPCR Primers 
14120 ALG9_qPCR_fw CCGTTGCCATGTTGTTGTAT
G 
Primer to use as a control for qPCR  
14121 ALG9_qPCR_rv 
GCCAGGAAATTGTACGCTAA
AC Primer to use as a control for qPCR 
15553 
(AceF qPCR) 
FWD 
GCGACTTCTGGGTAGTTGAT
AA 
For amplification of a short section of the E. faecalis 
AceF gene 
15554 (AceF qPCR) REV TAACCGCACAAGATATGAGA
GAC 
For amplification of a short section of the E. faecalis 
AceF gene 
15555 (lpd qPCR) FWD GCCTTCACAGACCCTGAATTA For amplification of a short section of the E. faecalis 
lpd gene 
15556 (lpd qPCR) REV CTCTACCGTTACCAGCGAATG 
For amplification of a short section of the E. faecalis 
lpd gene 
15557 
(pdhA qPCR) 
FWD GTCGTCACCGGACAAAGTAT 
For amplification of a short section of the E. faecalis 
pdhA gene 
15558 (pdhA qPCR) 
REV 
AGCCAAGGAAGCAAGAGATT For amplification of a short section of the E. faecalis 
pdhA gene 
15559 (lplA qPCR) FWD CCATGCGTTATCTTGGGTAG
AA 
For amplification of a short section of the E. faecalis 
lplA gene 
15560 (lplA qPCR) REV CACCACCACCAGACAATCTT 
For amplification of a short section of the E. faecalis 
lplA gene 
15561 
(lplA2 qPCR) 
FWD GCACCATCAGCAACATTCATC 
For amplification of a short section of the E. faecalis 
lplA2 gene 
15562 (lplA2 qPCR) 
REV 
CAGAAACTGGGACTGGAACT
AC 
For amplification of a short section of the E. faecalis 
lplA2 gene 
15563 (pdhB qPCR) 
FWD 
CAGAGAAGAAGTCCCAGATG
AAG 
For amplification of a short section of the E. faecalis 
pdhB gene 
15564 
(pdhB qPCR) 
REV 
CATGGCACCGTAGGTTATAA
TAGA 
For amplification of a short section of the E. faecalis 
pdhB gene 
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Table S2. List of BioBricks used in this study  
 
ID Name 
Primers 
used Template Description 
BB8 <-TEF1  5, 6 p0029 TEF1 promoter in position P1 
BB157 
pTEF1-
ACC1_pP
GK1-
CaMCR 
53, 177 p0298 
acc1 - double mutant under control of TEF1 promoter in position 1. 
mcr gene from Chloroflexus aurantiacus under control of PGK1 
promter in position 2 
BB183 ctp1<-  845, 846 Y. lipolytica 
genomic DNA 
Mitochondrial citrate transporter from Y. lipolytica in position 1 
BB867 pTEF1-
GFP 
1564, 312 p2199 GFP protein under control of TEF1 promoter in position 2 
BB903 
pTDH3-
>  10720, 279 p2525 TDH3 promoter in position 2 to fuse to a promoter in position 1 
BB904 <-pdhA  
10686, 
10687 
Codon 
optimised 
pdhA gene 
string 
pdhA subunit of PDH complex from E. faecalis in position 1 
BB905 pdhB->  10684, 
10685 
Codon 
optimised 
pdhB gene 
string 
pdhB subunit of PDH complex from E. faecalis in position 2 
BB906 <-lpd  
10690, 
10691 
Codon 
optimised lpd 
gene string 
lpd subunit of PDH complex from E. faecalis in position 1 
BB907 aceF->  10688, 
10689 
Codon 
optimised aceF 
gene string 
aceF subunit of PDH complex from E. faecalis in position 2 
BB908 <-pTEF1  10721, 1750 p0029 TEF1 promoter in position 1 to fuse to a promoter in position 2 
BB909 pPGK1->   10722, 293 p0029 PGK1 promoter in position 1 to fuse to a promoter in position 1 
BB918 <-pTPI1 
10764, 
10765 
S. cerevisiae 
genomic DNA TPI1 promoter in position 1 to fuse to a promoter in position 2 
BB1021 <-pPGI1  
10545, 
10546 
S. cerevisiae 
genomic DNA PGI1 promoter in position 1 to fuse to a promoter in position 2 
BB1022 lplA->  10549, 
10550 
Codon 
optimised 
pdhA gene 
string 
lplA lipoylation gene of PDH complex from E. faecalis in position 1 
BB1023 <-lplA2  10547, 
10548 
Codon 
optimised 
pdhA gene 
string 
lplA2 lipoylation gene of PDH complex from E. faecalis in position 2 
BB1127 
ylacly1<-
pTEF1 842, 6 p0626 
acly2 gene from Y. lipolytica under the control of TEF1 promoter in 
position 1 
BB1128 
pPGK1-
>ylacly2  
844, 7 p0626 
acly1 gene from Y. lipolytica under the control of TEF1 promoter in 
position 2 
BB1449 pdc1<-
pTEF1  
1188, 6 p0382 pdc1 gene under control of TEF1 promoter in position 1 
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BB1450 pPGK1-
>ALD6  
739, 7 p0380 ald6 gene under control of PGK1 promoter in position 2 
BB1451 ACSse<-
pTEF1  
645, 6 p0380 acs from S. enterica under control of TEF1 promoter in position 1 
  
 
Table S3. List of plasmids used in this study  
 
ID Name Description Addgene 
reference 
Source 
 Cas9 expression plasmid 
pCfB2312 TEF1p-Cas9-
CYC1t_kanMX 
Episomal plasmid for Cas9 expression  [17] 
 Intermediate  vectors 
pCfB2900 X-3-intermediate 
for MF  
Amplified from plasmid pCfB127, using primers 401 and 402 . 
Contains PAM site 
 This study 
pCfB2901 
X-4-intermediate 
for MF 
Amplified from plasmid pCfB2070, using primers 401 and 402 
. Contains PAM site 
 
This study 
pCfB2902 
XI-1-intermediate 
for MF 
Amplified from plasmid pCfB2328, using primers 401 and 402 
. Contains PAM site 
 
This study 
pCfB2905 XI-5-intermediate 
for MF 
Amplified from plasmid pCfB387, using primers 401 and 402 . 
Contains PAM site 
 This study 
pCfB2906 
XII-1-
intermediate for 
MF 
Amplified from plasmid pCfB2072, using primers 401 and 402 
. Contains PAM site 
 
This study 
pCfB2907 
XII-2-
intermediate for 
MF 
Amplified from plasmid pCfB120, using primers 401 and 402 . 
Contains PAM site 
 
This study 
pCfB2908 
XII-4-
intermediate for 
MF 
Amplified from plasmid pCfB130, using primers 401 and 402 . 
Contains PAM site 
 
This study 
 EasyClone-MarkerFree vectors 
pCfB2899 
X-2-MarkerFree 
backbone Amplified from plasmid pCfB126 ,using primers 401 and 402.  73271 
This 
study 
pCfB2903 XI-2-MarkerFree Amplified from plasmid pCfB384 ,using primers 401 and 402.  73275 This 
study 
pCfB2904 XI-3-MarkerFree Amplified from plasmid pCfB2118 ,using primers 401 and 402.  73276 This 
study 
pCfB2909 XII-5-MarkerFree Amplified from plasmid pCfB2073 ,using primers 401 and 402.  73281 
This 
study 
pCfB3034 X-3-MarkerFree PAM site in pCfB2900 mutated with primers 11399 and 11354 73272 
This 
study 
pCfB3035 X-4-MarkerFree PAM site in pCfB2901 mutated with primers 11399 and 11395 73273 This 
study 
pCfB3036 XI-1-MarkerFree PAM site in pCfB2902 mutated with primers 11399 and 11396 73274 This 
study 
pCfB3037 XI-5-MarkerFree PAM site in pCfB2905 mutated with primers 11399 and 11397 73277 
This 
study 
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pCfB3038 XII-1-MarkerFree PAM site in pCfB2906 mutated with primers 11399 and 11400 73278 
This 
study 
pCfB3039 XII-2-MarkerFree PAM site in pCfB2907 mutated with primers 11399 and 11355 73279 This 
study 
pCfB3040 XII-4-MarkerFree PAM site in pCfB2908 mutated with primers 11399 and 11398 73280 This 
study 
 Single target gRNA helper vectors 
pCfB3020 gRNA-X-2 gRNA sequence for targetting site X-2 USER cloned into 
pCfB2926 
73282 This 
study 
pCfB3041 gRNAX-3 
gRNA sequence for targetting site X-3 USER cloned into 
pCfB2926 73283 
This 
study 
pCfB3042 gRNAX-4 
gRNA sequence for targetting site X-4 USER cloned into 
pCfB2926 73284 
This 
study 
pCfB3043 gRNAXI-1 gRNA sequence for targetting site XI-1 USER cloned into 
pCfB2926 
73285 This 
study 
pCfB3044 gRNAXI-2 gRNA sequence for targetting site XI-2 USER cloned into 
pCfB2926 
73286 This 
study 
pCfB3045 gRNAXI-3 
gRNA sequence for targetting site XI-3 USER cloned into 
pCfB2926 73287 
This 
study 
pCfB3046 gRNAXI-5 
gRNA sequence for targetting site XI-5 USER cloned into 
pCfB2926 73288 
This 
study 
pCfB3047 gRNAXII-1 gRNA sequence for targetting site XII-1 USER cloned into 
pCfB2926 
73289 This 
study 
pCfB3048 gRNAXII-2 gRNA sequence for targetting site XII-2 USER cloned into 
pCfB2926 
73290 This 
study 
pCfB3049 gRNAXII-4 
gRNA sequence for targetting site XII-4 USER cloned into 
pCfB2926 73291 
This 
study 
pCfB3050 gRNAXII-5 
gRNA sequence for targetting site XII-5 USER cloned into 
pCfB2926 73292 
This 
study 
pCfB3588 EthanolRed 
gRNA X-2 
Amplified with primers 10277 and 11150 , using pCfB3041 as 
template  
 This 
study 
pCfB3589 EthanolRed 
gRNA X-4 
Amplified with primers 10277 and 11151, using pCfB3041 as 
template  
 This 
study 
pCfB3590 
EthanolRed 
gRNA XI-2 
Amplified with primers 10277 and 11152 , using pCfB3041 as 
template  
 This 
study 
pCfB3591 
EthanolRed 
gRNA XI-5 
Amplified with primers 10277 and 11153 , using pCfB3041 as 
template  
 This 
study 
 Triple target gRNA helper vectors 
pCfB3051 gRNAX-3XI-
2XII-2 
Three different target site cassettes amplified using primers 
10525 and 10530, 10526 and 10531, 10527 and 10529  . Sections 
are amplified from the respective single gRNAs 
73293 This 
study 
pCfB3052 
gRNAX-4XI-
3XII-5 
Three different target site cassettes amplified using primers 
10525 and 10530, 10526 and 10531, 10527 and 10529  . Sections 
are amplified from the respective single gRNAs 
73294 
This 
study 
pCfB3053 
gRNAX-2XI-
5XII-4 
Three different target site cassettes amplified using primers 
10525 and 10530, 10526 and 10531, 10527 and 10529  . Sections 
are amplified from the respective single gRNAs 
73295 
This 
study 
pCfB4668 
Ethanol Red p-
gRNA X-4 XI-3 
XII-5 
Three different target site cassettes amplified using primers 
10525 and 10530, 10526 and 10531, 10527 and 10529  . Sections 
are amplified from the respective single gRNAs 
 
This 
study 
 GFP Vectors 
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pCfB3008 
X-2-MarkerFree-
GFP Biobrick 867, USER cloned into plasmid pCfB2899 
 This 
study 
pCfB3009 X-3-MarkerFree-
GFP 
Biobrick 867, USER cloned into plasmid pCfB3034  This 
study 
pCfB3010 X-4-MarkerFree-
GFP 
Biobrick 867, USER cloned into plasmid pCfB3035  This 
study 
pCfB3011 
XI-1-MarkerFree-
GFP Biobrick 867, USER cloned into plasmid pCfB3036 
 This 
study 
pCfB3012 
XI-2-MarkerFree-
GFP Biobrick 867, USER cloned into plasmid pCfB2903 
 This 
study 
pCfB3013 XI-3-MarkerFree-
GFP 
Biobrick 867, USER cloned into plasmid pCfB2904  This 
study 
pCfB3014 XI-5-MarkerFree-
GFP 
Biobrick 867, USER cloned into plasmid pCfB3037  This 
study 
pCfB3015 
XII-1-
MarkerFree-GFP Biobrick 867, USER cloned into plasmid pCfB3038 
 This 
study 
pCfB3016 
XII-2-
MarkerFree-GFP Biobrick 867, USER cloned into plasmid pCfB3039 
 This 
study 
pCfB3017 XII-4-
MarkerFree-GFP 
Biobrick 867, USER cloned into plasmid pCfB3040  This 
study 
pCfB3018 XII-5-
MarkerFree-GFP 
Biobrick 867, USER cloned into plasmid pCfB2909  This 
study 
 Production vectors 
pCfB3069 X-3-MF-MCR-
ACC1 
Biobrick 157, USER cloned into plasmid pCfB3034  This 
study 
pCfB3472 pdhA-pdhB 
Biobricks 904, 905, 903, 918, USER cloned into plasmid 
pCfB3035 
 This 
study 
pCfB3473 aceF-lpd 
Biobricks 906, 907, 908, 909, USER cloned into plasmid 
pCfB2904 
 This 
study 
pCfB3479 lplA2-lplAXII-5 Biobricks 1022, 1023, 1021, 909, USER cloned into plasmid 
pCfB2909 
 This 
study 
pCfB3584 X-4 ylacly1<-
pTEF1 
Biobrick 1127, USER cloned into plasmid pCfB3035  This 
study 
pCfB3585 
XI-3 pPGK1-
>ylacly2 Biobrick 1128, USER cloned into plasmid pCfB2904 
 This 
study 
pCfB3587 pdc X-4 Biobrick 1449, USER cloned into plasmid pCfB3035 
 This 
study 
pCfB3592 pPGK1->ALD6 Biobrick 1450, USER cloned into plasmid pCfB2904  This 
study 
pCfB3593 ACS-pPGK1 
XII-5 
Biobrick 1451, USER cloned into plasmid pCfB2909  This 
study 
pCfB3594 
ylCtp1<-pTEF1 
XII-5 Biobricks 183, 8 USER cloned into plasmid pCfB2909 
 This 
study 
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Table S4. Chromosomal coordinates of the EasyClone-MarkerFree integration 
sites  
 
Integration site or 
Gene name 
Chromosomal coordinates according 
to Saccharomyces genome database 
(http://www.yeastgenome.org/).  
X-2 Chr X: 194944..195980 
 
X-3 Chr X: 223616..224744 
 
X-4 Chr X: 236336..237310 
 
XI-1 Chr XI: 67491..68573 
 
XI-2 Chr XI: 91575..92913 
 
XI-3 Chr XI: 93378..94567 
 
XI-5 Chr XI: 11779..118967 
 
XII-1 Chr XII: 795787..796720 
 
XII-2 Chr XII: 808805..809939 
 
XII-4 Chr XII:830227..831248 
 
XII-5 Chr XII: 839226..840357 
 
 
  
Table S5. Sequences of E. faecalis PDH complex genes 
 
 
 83 
Table S5. Sequences of E. faecalis PDH complex genes 
 
Gene Sequence (5’->3’) 
pdhA atggcaaaagcaaagaagcaaaaacctatagatttcaaagaattgatggctaaagtagacgcagatttccctacattccaaatattagatcaagacggtaaaatagttaacgaag
atttggtcccagatttgtctgacgaagaattggttgaattgatgacaagaatggtatggtctagagttttggatcaaagatcaaccgcattgaacagacaaggtagattaggtttct
ttgctccaaccgcaggtcaagaagcatcccaattagccagtcaattcgctatggaaaaggaagattatttgttgccaggttacagagacgtccctcaattggtacaacatggttt
gcctttaagagaagctttcttatggtcaagaggtcacgttgctggtaattattacgcagaagatttgaacgccttaccacctcaaattataatcggtgcccaatatattcaagctgc
aggtgtcgctttgggtttgaagaaaagaggtaaagaaaacgttgtctttacttacacaggtgacggtggttcttcacagggtgacttctacgaagcaattaatttcgccggtgctt
accaagctaacggtgtttttattatccaaaacaacggtttcgctatatccacaccaagagaaaaacaaacagccgctaagaccttggcccaaaaagctgttgcagccggtatac
caggtatccaagtagatggtatggaccctttagctgtttatgcaatagccaaggaagcaagagattggagtgctgctggtaatggtccagtcttgatcgaaaccttaacttataga
tacggtccacatactttgtccggtgacgaccctacaagatatcgtagtaaggaaatggatgacgaatgggttcaaaaagatcctttaaccagattcagaaagtacttgactgata
aaggtttatggtccgaagcaaaggaagaagaaatcatcgaaaagactaaggaagaaattaaggttgctatagcagaagccgataaagctccaaaacaaaaggtctctgacttt
ttgaagaacatgttcgaagtacaacctcaaacaatcaaagaacaaatagcattctacgaagccaaagaatcaaagtaa 
pdhB atggcacaaaagactatgatccaagctataactgacgccttagccttagaattagaaaaagatgaaaatgtattgatattcggtgaagatgtaggtaataacggtggtgtttttag
agccacagaaggtttgcaagaaaagtttggtgaagatagagttttcgacaccccattggctgaatccggtataggtggtttagcttttggtttggcattacaaggttatagaccag
ttcctgaaatccaatttttcggttttgtcttcgaagtattcgatgaaattgtcggtcaaatggctagaactagatacagaatgggtggtaccagaaatatgccaattactgtaagag
caccttttggtggtggtgttcatacaccagaattacactctgataacttggaaggtttaatagcacaatcccctggtgttagagttgtcatcccaagtaatccttatgatgccaagg
gtttgttgatctcttcaatcagatccaacgacccagtagtttatttggaacatatgaagttgtacagaagtttcagagaagaagtcccagatgaagcatatgaagtacctttggaca
aagctgcagttactagagaaggtacagatgtctctattataacctacggtgccatggttagagaagctattaaagccgctgattctttagcaaaggacaatatatcagccgaaat
cattgatttgagaacagttgctcctttagacgtcgaaaccataatcaactcagttgaaaagactggtagagtcgtagttgtccaagaagcccaaaagcaagctggtgttggtgca
atggtagtttccgaaattagtgaaagagctgtcttgtctttagaagcaccaataggtagagtatcagcaccagatactatctttcctttcggtcaagccgaaaatatttggttgcct
aacgctaaagacatcgaagcaaaggccagagaaattgttgaattttaa 
lpd atggttgttggtgactttgctattgaattggatacagtagttattggtgccggtcctggtggttatgttgccgccatcagagccgcagaaatgggtcaaaaggttgctatcatcga
aagagaatacatcggtggtgtttgtttgaacgtcggttgcataccatcaaaagctttgatcgctgcaggtcatcactaccaagaagcacaagattcttcaacttttggtgtcacag
caaagggtgtaaaattagacttcgccaagacccaagattggaaagacaataccgttgtcaagtctttgacttcaggtgtaggcatgttgttgaagaaacataaggttgaaatcat
cgaaggtgaagcctttttcgtagatgaaaacacattgagagttattcacccagactctgcacaaacttactcttttaataacgcaatcgttgccacaggttctagaccaatcgaaa
ttcctggttttaagttcggtggtagagttttggattcaactggtggtttgaatttgaaggaagttcctaaaaagttcgtcataatcggtggtggtgttattggtgctgaattaggtggt
gcttatgcaaacttgggttctgaagtcacaatcttagaaggttccccaagtattttgcctacctacgaaaaggatatggttaaagtagttactgatgacttcaaaaagaaaaatgta
accattgttacttctgccatggctaaagaagctgttgataatggtgactcagtcactgtaaagtatgaagtcaacggtaaagaagaatctgtagaagctgattacgttatggtcac
agtaggtagaagaccaaataccgatgacttgggtttagaacaagcaggtgttgaaattggtgaaagaggtttaataccagttgataaccaaggtagaacaaacgtcaaaaacat
cttcgctatcggtgacatcgttcctggtgccgctttggctcataaggcatcctatgaagccaaaatcgcagccgaagctattagtggtaaaaaggttgcagtcgattacaaggcc
atgccagcagttgccttcacagaccctgaattagcatccgttggtatgaccgttgctgaagcaaaagaagctggtattgaagcaaagggttacaaatttccattcgctggtaacg
gtagagcaatctcattggataagactgaaggttttatgagattggtcactacagtagaagacaacgtcattataggtgcccaaattgctggtgtaggtgcttccgatatgataagt
gaattggccttagctatcgaatccggtatgaatgccgaagatattgctttaacaatacatccacaccctagtttgggtgaaattacaatggataccgcagaattggccttaggttt
gcctatacatatctaa 
aceF atggcctatcaattcaagttgcctgacatcggtgaaggtatcgcagaaggtgaaatcgtaaaatggtttgtaaagcctggtgacacaatcaacgaagatgacactttgttggaag
ttcaaaacgataagtctgtcgaagaaataccatcacctgtaaccggtactgttaaaaatatcgttgtccctgaaggtacagtcgctaacgtaggtgacgttttgattgaaatagac
gcaccaggtcacgaagataatgacgctgcaccagccgctcctgcacaagaacaaactccagcccaacctgcagccgttcctactacagaagctgcaggtggtttctttcaatt
caaattgccagatataggtgaaggtatagctgaaggtgaaattgtcaaatggttcgtaaaggcaggtgacactataaatgaagatgactctttgttggaagtacaaaacgataag
tccgttgaagaaatcccaagtcctgttacaggtaccgtcaaaaatattgtagttccagaaggtactgttgccaatgttggtgacgttttggtcgaaattgacgcaccaggtcataa
ttctgccgctccagcagccgctgcacctgctactgatgcaccaaaagccgaagcttccgcaccagccgctagtacaggtgtcgtagcagccgctgatcctaacaagagagtc
ttagcaatgccatcagttagacaatatgccagagaaaaagatgtagacattacacaagttactgctactggtaaaggtggtagagttatcaaggccgatattgacgcttttgtttc
cggtggtagtcaagcagcccctgctactgaagctgcagccacagaagctgcaccaaaagctgaagccgctgcaccaaaagccgctcctaaggcattcacatccgatttgggt
gaaatggaaaccagagaaaagatgacccctactagaaaagccattgctaaggcaatggttaattccaaacataccgctccacacgttactttgcatgatgaagtagaagttagt
aagttgtgggatcacagaaagaagtttaaagacgttgcagccgctaatggtacaaaattgaccttcttaccttatgttgtcaaagctttgacatctaccgttcaaaagttcccaatc
ttgaacgcatcaatagatgacgcagcccaagaaatagtttacaagaactacttcaacatcggtattgctactgatacagaccatggtttgtacgttccaaacgtcaaaaatgctaa
cacaaagtcaatgtttgccatagctgatgaaatcaacgaaaaagctgcattggctattgagggtaaattaaccgcacaagatatgagagacggtaccataactatctctaatata
ggttcagttggtggtggttggttcacccctgttatcaactacccagaagtcgctatcttaggtgtaggtactattgcccaagaaccagtagttaatgctgatggtgaaattgtcgta
ggtagaatgatgaagttgtctttgtcattcgatcatagaatcgttgacggtgcaactgcccaaaaagctatgaacaacattaaaagattattggcagacccagaattattattgatg
gaaggttga 
lplA atgagatacgtcatcatgcaatccagagacatcagagaaaatttggctaccgaagattacttgttgaacaccttgtctttcgaagaaccattggtcttgttctacattcaagaacca
tgcgttatcttgggtagaaatcaaaacgcctacgaagaaattgatttggcttacgctagagaaaagggtatcgttatcactagaagattgtctggtggtggtgctgtttatgatgat
ttgggtaatgtctccttctcattcgttgttcaagaaggtcatcaagctttcggtgattttaaggctttcaccaagccaattattgaagccttgcataagatgggtgctactggtgctg
aaatttctggtagaaacgatttgttgatcgacggtaaaaagttctctggtaatgctatgtacaccaaaaagggtaagatgtacactcacggtactttgatgtacgatgttgacttgg
ctgaagttcaaagagttttgaccgtttccaagaagaagatcgaatctaagggtactaagtccgttagaggtagagttacaaacttaagaccatacttggacggtaaataccaaca
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attgaccatcgaagaattcagaaacagattattgatggaattattcgatgtcgaatccttgaccgaaatcgccgaaaaagaatacgttttgactaagaccgaccaacaagaaatc
agaaagttggttgctgaagtctacggtaatgaagcttggatttttggtgaagctccaaagttcaccatcaagaaagaagaaaagttcaagggtggtatcgttgatgctagattga
ctgttgaaaaaggtaaaatcatcgaattgactatctacggtgattacttcgctaagaaagaaaccgctgaaatagttgctgctttgttgggtgttgattaccaatactcttctatttg
gcaagctttggctgctttcaacttcgaagattatttcgtcaacatcaccaaagaagaattcgtccacttgttggttgactaa 
lplA-2 gtcatcttcgtcccaaacgaaaacaacgatccaagagttaacttggccattgaaacttacttgttgaccgaaatgccattggatgaacctatcttgttgttctacatcaacgaacc
atccatcatcatcggtagaaatcaaaacaccatcgaagaaatcaacaaagaatacgttgacgaacacggtatccacgttgttagaagattgtctggtggtggtgctgtttatcat
gatcacggtaatttgaacttctcattcatcatgccagatgacggtaactcttttagagatttcgctaaggttacccaacctattattcaagccttgcatgatttgggtgttgaaggtg
ctgaattgaagggtagaaatgatttggttatcaacgacatgaagttctccggtaatgctatgtatgctaccaatggtagaatgttcgctcatggtactttgatgttcgattccgatat
cgatgaagttgtcaacaccttgaaagtcagaaaggacaagattgaatccaagggtatcaagtccgttagatctagagttaccaacatcaagccattcttgtccgaagataagca
agaaatgactaccgaagaattcagacaagaaatcttgttgaagattttcggtgtcgactccatcgatcaagttaagacttatgaattgaccgatcaagattgggctgccattaaca
aaatctccgaacaatattacagaaactgggactggaactacggtaaatctccagcttttaacttggaaagaagacacagattcccaatcggttccattgaaatgaagatgaatgt
tgctgatggtgccattcaagaaatcaagatcttcggtgattttttcggtttgggtgaaatcaaggatgtcgaagatattttgaccggtgttaagtacgataaggcctctttggaaga
agccattgatcaaatcgatgtcaagaagtactttggtaacatcgaaaaagaagatttgttgggtttgatctat 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1.  Growth profile of the 3-HP-producing laboratory strains in mineral medium (i), and 
in simulated fed-batch medium (ii). 
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Supplementary material: The EasyClone-MarkerFree Manual is not included due to length 
in this thesis but can be found with the online version of this paper. 
  
Figure S2.  Final titres of 3-hydroxypropionic acid in the engineered industrial Ethanol Red strains. 
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Abstract 
Background 
 
Saccharomyces cerevisiae has long been of industrial importance due to its robustness as a host 
organism, its tolerance to large-scale fermentations, and because of its high degree of 
characterisation as a model organism. When fed on high concentrations of glucose, S. 
cerevisiae produces large amounts of ethanol via fermentation, even under highly aerobic 
conditions. To minimise the amount of carbon lost to ethanol, it is possible to produce 
strains that do not produce any ethanol by deleting pyruvate decarboxylase (PDC) activity. 
Such Pdc- mutants accumulate high levels of pyruvate and as such are good potential hosts 
for the production of pyruvate derived products, such as hydroxy acids.  
 
Results 
 
In this study, we introduce pathways for the production of three common hydroxy acids; 
lactate, malate, and 3-hydroxypropionic acid (3HP) into an evolved Pdc- strain (the TAM 
strain) that is capable of growth on high concentrations of glucose. We observed titres of 
16.5 ± 0.1 g L-1 pyruvate in the host strain, 30.2 ± 2.2 g L-1 lactate in the lactate producing 
strain, and 26.8 ± 0.3 g L-1 malate in the malate producer. Two strains for 3HP production 
were tested, both sharing the same pathway but with one of the pathway enzymes either 
using NADH or NADPH as cofactor. The NADH-dependent pathway produced 3.4 ± 
0.2 g L-1 3HP, and the NADPH-dependent pathway produced 3.7 ± 0.1 g L-1. Addition of 
a lactate or malate production pathway into the Pdc- host strain recovered some growth 
defects of the TAM strain, most likely due to the replacement of missing NAD+ 
regeneration pathways. We employed 13C-based metabolic flux analysis to probe the 
physiological and metabolic responses of the strains to their engineered pathways. All 
strains showed considerable flux into the pentose phosphate pathway under shake flask 
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fermentation conditions – with negligible glucose-6-phosphate isomerase activity, while 
TCA cycle fluxes are found to remain low across all strains. 
 
Conclusions 
 
An analysis of fermentation characteristics showed that insertion of both the malate and 
lactate pathways could restore some of the growth performance of the TAM strain, 
presumably through recycling NADH. This effect was not observed in the 3HP strains, 
even in the strain capable of regenerating NADH. Through 13C-based metabolic flux 
analysis, we have shown how the different energetic and redox demands of each pathway 
cause shifts in flux through central carbon metabolism. We hope that the information 
gathered here will help in future metabolic engineering efforts in Crabtree-negative strains, 
and in the production of hydroxy acids in particular. 
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1 Introduction 
Saccharomyces cerevisiae has long been used as a production organism, perhaps most notably 
for its role in ethanol production. When grown on high concentrations of glucose, yeast 
will ferment and produce ethanol even in abundant oxygen conditions (Pronk et al., 1996). 
This is known as the Crabtree effect, and while such a trait has proven useful for bio-
ethanol production, ethanol is considered as an unwanted side-product in the bio-based 
production of many other chemicals (Flikweert et al., 1997; Kim and Hahn, 2015; Nevoigt, 
2008). Under fermentative growth on glucose, a large part of the flux from pyruvate passes 
through the three main pyruvate decarboxylases (PDC) to be converted into acetaldehyde, 
which is in turn reduced to ethanol via alcohol dehydrogenases (ADH), with Adh1p as the 
major ADH isozyme (de Smidt et al., 2008). Pyruvate decarboxylase activity is conferred 
through the three major PDC isozymes; Pdc1p, Pdc5p, and Pdc6p (Hohmann, 1991; 
Schmitt and Zimmermann, 1982; Seeboth et al., 1990).  
 
A successful strategy for the removal of ethanol formation has been to eliminate pyruvate 
flux into acetaldehyde by deleting all three major PDC isozymes (Flikweert et al., 1996, 
1997). Such a Pdc- strain is hyper-sensitive to glucose and can not grow on high 
concentrations of glucose without the addition of a C2 compound such as ethanol or 
acetate (Flikweert et al., 1999). van Maris et al., (2004a) performed directed evolution on a 
Pdc- strain to eliminate its dependency on C2 compounds, and to improve its glucose 
tolerance and growth characteristics. While some of the WT growth characteristics were 
rescued, the resulting strain (referred to as the TAM strain) still has a much slower growth 
rate than WT; 0.20 h-1 vs. 0.33 h-1 (van Maris et al., 2004a). Oud et al., (2012) later sequenced 
the genome of the TAM strain and revealed that much of the observed phenotype of the 
TAM strain was due to a large deletion in the glucose sensing transcriptional regulator 
MTH1. This deletion is hypothesised to reduce the degradation rate of Mth1p, and 
overexpression of MTH1 in a non-evolved Pdc- strain restores growth on high glucose 
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concentrations and without the need for C2 supplementation, providing strong evidence 
for the role of Mth1p as the major driver of the TAM strain’s observed phenotype (Oud 
et al., 2012). 
 
The TAM strain is a pyruvate over-producer, since much of the pyruvate flux is converted 
to ethanol in Crabtree-positive WT strains, rendering it an attractive host for the 
production of pyruvate derived chemicals (van Maris et al., 2004a). Pyruvate is a central 
carbon metabolite, acting as precursor into three major pathways by being converted to; 
oxaloacetate, mitochondrial acetyl-CoA, and acetaldehyde (Pronk et al., 1996). Pyruvate 
can serve as precursor for many different heterologous pathways producing compounds 
of industrial relevance such as the hydroxy acids; malate, lactate, and 3-hydroxypropionic 
acid (Abbott et al., 2009; Borodina et al., 2015; Ishida et al., 2005; Zelle et al., 2008).  
 
In the present study, we characterised these three different hydroxy acid production 
pathways and the impact of the added pathways on the metabolism and physiology of the 
host TAM strain.  
 
Lactate, a three carbon α-hydroxy acid, can be produced from pyruvate in a single 
enzymatic step by lactate dehydrogenase (LDH) with NADH as the cofactor. This enzyme, 
most commonly taken from Lactobacillus origin, has been shown to produce high levels of 
lactate in both Pdc+ and Pdc- S. cerevisiae strains (Branduardi et al., 2006; Colombié et al., 
2003; Ishida et al., 2005; van Maris et al., 2004b; Nagamori et al., 2013). The TAM strain 
has a redox imbalance due to NAD+ not being regenerated through the formation of 
ethanol. The addition of the Lactobacillus plantarum ldh1 gene in a Pdc- strain can provide 
the cell with NAD+, re-balancing the redox state of the cell. However, this redox balancing 
has been shown to not be able to recover anaerobic growth, with lactate production being 
highly dependent on oxygen availability (van Maris et al., 2004b). Lactate transport, unlike 
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ethanol, is assumed to be dependent on ATP, and so cannot be exported under anaerobic 
conditions where ATP production is limited (van Maris et al., 2004). 
 
High levels of malate production, a four carbon α-hydroxy acid, can be achieved with the 
overexpression of three genes. The overexpression of the native NADH-dependent malate 
dehydrogenase MDH3 lacking the peroxisomal targeting sequence (McAlister-Henn et al., 
1995), the native pyruvate carboxylase gene PYC1, and the malate transporter from 
Schizosaccharomyces pombe MAE1,  allows for high malate titres when expressed in the TAM 
strain, with reported titres of up to 59 g L-1 (Zelle et al., 2008). The activity of Mdh3p in 
the cytosol also regenerates NAD+, improving the growth rate compared to the parental 
TAM strain. Malate transport is assumed to be ATP-dependent, and with the carboxylation 
of pyruvate to oxaloacetate also requiring ATP, this pathway is more energetically 
demanding than the lactate production pathway (Abbott et al., 2009; Camarasa et al., 2001; 
Casal et al., 2008). The export energetics are also different for monocarboxylic and 
dicarboxylic acids, and export of malate may have a greater ATP requirement that export 
of lactate (Abbott et al., 2009). 
A three carbon β-hydroxy acid, 3-hydroxypropionic acid (3HP), can be produced from at 
least four different intermediate compounds, with a pathway via β-alanine identified as 
having a high potential for 3HP production (Kumar et al., 2013). This pathway was 
implemented in a Pdc+ S. cerevisiae strain, proving capable of titres close to 14 g L-1 in 
controlled bioreactor fermentations (Borodina et al., 2015). This pathway requires five 
enzymatic steps to produce 3HP from pyruvate, three of which require heterologous genes 
(Figure 1). The final enzymatic step in this pathway, the conversion of malonic 
semialdehyde to 3HP, can be performed either by a 3-hydroxyisobutyrate dehydrogenase 
(HIBADH) that uses NADH as cofactor or a 3-hydroxypropionate dehydrogenase 
(HPDH) that uses NADPH. In Pdc+ S. cerevisiae, the HPDH class of enzymes tends to 
outperform the HIBADH enzymes, possibly due to the cytosolic ratios of the redox 
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cofactors in the cytosol favouring NADPH utilisation (Borodina et al., 2015). The cytosolic 
ratio of NADH/NAD+ in WT S. cerevisiae has been found to be very low at ~1/100 
(Canelas et al., 2008). However, a Pdc- strain is unable to regenerate cytosolic NAD+ 
through ethanol production, and as such is likely to have a relative excess of NADH, 
potentially making it more suited than the Pdc+ strains for expression pathways using 
NADH as cofactors, such as lactate, malate, and the HIBADH route of 3HP biosynthesis. 
Figure 1. Metabolic routes for the production of three different hydroxy acids in S. cerevisiae. 
Lactate, malate, and 3HP are produced from pyruvate in the Pdc-, pyruvate overproducing host 
strain (TAM strain) through the implementation of heterologous pathways. Metabolites are 
shown in white square boxes, while overexpressed genes shown in the oval boxes. 
Overexpressed enzymes are shown in orange oval boxes. Enzyme abbreviations; L-LDH – L-
lactate dehydrogenase, PYC – pyruvate carboxylase, MDH – malate dehydrogenase, MAE – 
malate transporter, AAT – aspartate amino transferase, PAND – aspartate decarboxylase, 
BAPAT – β-alanine pyruvate amino transferase, HIBADH – 3-hydroxyisobutarate 
dehydrogenase (NADH-dependent), HPDH – 3-hydroxypropionic acid dehydrogenase 
(NADPH-dependent. Metabolite abbreviations; 3HP – 3-hydroxypropionic acid. 
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In this study we characterise and compare both the HIBADH and HPDH based pathways 
for 3HP biosynthesis. 
2 Materials and methods 
2.1 Strains 
Escherichia coli DH5α was used to clone, propagate, and store the plasmids. A derivative of 
CEN.PK, the TAM strain was a kind gift of Prof. Jack Pronk (Delft Technical University, 
Holland). A description of each strain used in this study is shown in Table 1. For the 
respiration experiments, the CEN.PK Pdc+ strain (MATaURA3 HIS3 LEU2 TRP1 
MAL2-8c SUC2) was used as reference. This was a kind gift from Peter Kötter, Johann 
Wolfgang Goethe University, Frankfurt, Germany.  
2.2 Plasmid construction and yeast transformation 
Each of the plasmids used to create the hydroxy acid producing strains were constructed 
using the EasyClone vector set for chromosomal gene integrations with auxotrophic 
selection markers as described in (Jensen et al., 2014). Yeast promoter biobricks were 
amplified from the genomic DNA of CEN.PK113-7D via PCR, using primer overhangs 
for cloning as described in (Jensen et al., 2014). ST7031 was built with the insertion of the 
Lactobacillus plantarum ldh1 under the control of the TDH3 promoter for the conversion of 
pyruvate to lactate. Strain ST5413 was constructed from the TAM strain with the insertion 
of MDH3 lacking the SKL mitochondrial targeting sequence, under control of the TDH3 
promoter. This gene was amplified from the genomic DNA of S. cerevisiae with primers 
pr7011 and pr7012 to amplify the region lacking the mitochondrial targeting sequence. 
The native S. pombe malate transporter gene mae1 was also inserted under the control of 
the TEF1 promoter, along with the native PYC1 and PYC2 genes under the control of the 
TEF1 and PGK1 promoters, respectively. ST2779 and ST2780 were engineered for 3HP 
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production, following the designs of (Borodina et al., 2015). Native PYC1 and PYC2 were 
overexpressed (under the control of the TEF1 and PGK1 promoters), along with the 
aspartate-1-dehydrogenase gene (panD) from Tribolium castaneum under the control of the 
TEF1 promoter, and the β-alanine-pyruvate amino transferase (BAPAT) from Bacillus 
cereus (yhxA) under the control of the TEF1 promoter. For the final enzymatic step of the 
3HP biosynthetic pathway in ST2779, a 3-hydroxypropionate dehydrogenase (HPDH) 
from E. coli (ydfG) that uses NADPH as cofactor was expressed under the control of the 
PGK1 promoter. For ST2780, a 3-hydroxyisobutyrate dehydrogenase (HIBADH) from 
Pseudomonas putida (hibdh) was inserted that uses NADH as cofactor, under the control of 
the PGK1 promoter. Heterologous genes were codon optimised and synthesised by 
GeneArt (Thermo Fisher Scientific, USA). Sequences of these genes can be found in the 
supplementary materials. Details and sequences of the genes used to create the 3HP strains 
can be found in (Borodina et al., 2015). PCR amplification was performed on each gene, 
using the primers as described in the supplementary materials with corresponding primer 
overhangs to be compatible with the promoter biobricks (Jensen et al., 2014).  
After successful amplification of the required promoters and genes, they were USER 
cloned into EasyClone vectors (details of which are found in the supplementary materials) 
previously digested with SfaAI (Thermo Scientific, USA) and Nb.BsmI (New England 
Biolabs, USA) (Jensen et al., 2014). USER cloning (New England Biolabs, USA) was 
performed as previously reported, and cloned plasmids were transformed into the E. coli 
cloning strain DH5α via heatshock at 42 ˚C for 1 minute (Jensen et al., 2014; Nour-Eldin 
et al., 2010). Cells were plated on lysogeny broth (LB) agar plates with 100 µg ml-1 
ampicillin and incubated at 37 ˚C overnight. The next day, individual colonies were tested 
by PCR for the correct sized plasmid insertions using the verification primers outlined in 
the supplementary materials. All plasmids were additionally confirmed by Sanger 
sequencing to verify the correct sequences. Confirmed plasmids were stored as glycerol 
stocks kept at -80 ˚C. 
2.3 Media 
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Plasmids for transformations were first digested with NotI (Thermo Scientific, USA) to 
produce linear DNA fragments. The fragments containing the genes to be transformed 
were purified from the vector backbone by gel electrophoresis followed by band excision 
and gel purification. All yeast transformations were carried out using the lithium acetate 
chemical transformation protocol as described in (Gietz and Schiestl, 2007). After 
heatshock, the cells were plated directly onto synthetic complete (SC) agar plates lacking 
the relevant amino acid required for selection. After 2-3 days, plates were examined for 
growth, and correct isolates were identified via performing PCR on individual colonies 
using the verification primers outlined in (Jensen et al., 2014).  
Complete lists of plasmids, biobricks, and primers used in this study are included in the 
supplementary materials. 
2.3 Media 
For selection of E. coli, LB agar plates were made to contain 100 µg mL-1 ampicillin. For 
plasmid propagation, LB broth was used with the same concentration of ampicillin.  
To select for S. cerevisiae transformants and for solid culture, SC agar plates were prepared 
with pre-mixed amino acid drop-out powders, with a final glucose concentration of 20 g 
L-1. For the creation of pre-cultures, liquid SC media was prepared with pre-mixed amino 
acid drop-out powders, also with a final glucose concentration of 20 g L-1. For the 
respiration experiments, liquid complete synthetic mixture (CSM) was prepared from 
drop-out powders purchased from Sunrise Science (USA), with 20 g L-1 glucose. 
2.4 Cultivation conditions 
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S. cerevisiae shake flask fermentations were performed with batch production media 
optimised for acid production, prepared according to (Zelle et al., 2008), with 100 g L-1 
glucose as the carbon source.  
2.4 Cultivation conditions 
For shake flask fermentation experiments, single colonies of each strain were taken from 
plates and inoculated into 5 mL of liquid SC media with appropriate amino acid selection 
in 12 mL culture tubes and incubated at 30 °C, 250 rpm for 2 days. Shake flasks were 
prepared as follows; 5 g CaCO3 was added to each 500 mL baffled shake flask before the 
flasks were autoclaved. Once cool, 100 mL of the sterile batch production media was 
added to each shake flask. The prepared flasks were inoculated from the precultures to a 
starting OD600 of 0.5. Fermentations were carried out at 30 ˚C, and shaking set to 250 rpm, 
for 5 days with samples taken every ~12 hrs and measured for optical density at 600 nm 
in an Implen P300 spectrophotometer (dilutions were made to keep measurements within 
the linear range of the equipment). Part of each sample was centrifuged at 11,000 xg for 5 
min, and the supernatant was stored at -20 °C until HPLC analysis. Each strain was 
fermented in triplicate in a shaking incubator for 120 hrs at 30 ˚C and 250 rpm. 
2.5 13C-based metabolic flux analysis 
For 13C-based metabolic flux analysis (MFA), the same media was used as in the shake 
flask fermentations, except that ammonia was used as the nitrogen source instead of urea, 
no CaCO3 was added (to prevent non-labelled carbon interference), and l3C-labelled 
glucose was used to a final concentration of 10 g L-1. 250 mL shake flasks were filled with 
10 mL of media, and inoculated with the strains to a starting OD600 of 0.06. Samples for 
analysis were taken once the OD600 of the cells had reached 2.00. 0.3 mg CDW was 
removed and washed in 0.9% NaCl before storage at -80 ˚C. Each strain was cultured in 
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quadruplicate, with one culture grown on 20% U-13C and 80% unlabelled glucose, and the 
three other cultures grown on 20% U-13C and 80% 1-13C glucose. Labelled glucose was 
purchased from Euriso-Top (France). The same cultivation was performed in triplicate 
without labelled glucose, where samples were taken regularly during growth and measured 
by HPLC for the rates of secreted products, used to constrain the stoichiometric model 
for metabolic flux analysis. 
The frozen cell pellets were resuspended in 150 µl HCL (6M) before being transferred to 
a silanized glass vial. The samples were left to hydrolyse at 105 ˚C for 6 hrs, before the 
remaining liquid was evaporated at 80 ˚C. The pellets were resuspended in 30 µl 
acetonitrile. Derivatisation was performed by adding N-methyl-N-tert-butyldimethylsilyl-
trifluoroacetamide to a final ratio of 1:1, and incubating at 85 ˚C for 1 hr. GC-MS analysis 
of the amino acid content was performed on the derivatised samples as previously reported 
(Kildegaard et al., 2016). 
The raw GC-MS data were corrected before flux determination was carried out by the 
iMS2Flux software for the PERL programming language (Poskar et al., 2012). Steady-state 
metabolic flux analysis was performed with the INCA toolbox for MATLAB (Young, 
2014). A previously reported model metabolic network for S. cerevisiae was adjusted to fit 
the central carbon metabolism of each acid producing strain and used as the model 
network input for INCA (Wasylenko and Stephanopoulos, 2015). The full list of included 
reactions is included in the supplementary information. 
The calculated fluxes from INCA were used to constrain a modified version of the 
iMM904 genome scale metabolic model (GEM) of S. cerevisiae (Mo et al., 2009). This model 
was modified by deleting the PDC reaction to eliminate ethanol production, and the 
heterologous pathways for each strain were added to the reactions in the model, producing 
a different model for each strain. These models were used to determine the remainder of 
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the fluxes using parsimonious flux balance analysis (pFBA) implemented in the Cameo 
toolbox for Python (Cardoso et al., 2018; Lewis et al., 2010).  
2.6 Analytical methods 
The concentrations of extracellular metabolites were measured by HPLC. The supernatant 
was removed and transferred to Nunc 96-well plates with rubber sealing top (Thermo 
Scientific, USA). 30 µL of each sample was analysed for 30 minutes with an Aminex HPX-
87H ion exclusion column (Bio-Rad, USA) at 60 °C, with a flow rate of 600 µL min-1. 5 
mM H2SO4 was used as eluent, and the compounds were detected with a Dionex RI-101 
Refractive Index Detector at 45 °C. UV was detected with a DAD-3000 Diode Array 
Detector at 210 nm (Dionex, USA). For analysis of 3HP, the same protocol was run apart 
from that 1 mM H2SO4 was used as eluent, with a longer run time of 45 minutes. Due to 
the overlapping spectra of pyruvate and malate in this method, malate concentrations were 
verified using the L-malic acid assay kit (K-LMAL-116A, Megazyme, Republic of Ireland). 
Pyruvate was verified using a pyruvic acid assay kit (K-PYRUV, Megazyme, Republic of 
Ireland).  
2.7 Respiration monitoring 
To analyse the respiration characteristics of the hydroxy acid production strains, each strain 
was tested in a respiration activity monitoring system (RAMOS) (Anderlei et al., 2004). 
Individual colonies of each strain were inoculated into 5 mL of CSM lacking the 
appropriate amino acids. The following day the RAMOS was calibrated and checked for 
correct function following the manufacturer guidelines. The RAMOS shake flasks were 
inoculated to a starting OD600 of 0.2 and set to shake at 300 rpm with the temperature set 
to remain constant at 30 °C. The fermentations lasted for 48 hrs, with oxygen and carbon 
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dioxide automatically measured every 30 mins. Samples were taken for analysis and tested 
for optical density every ~12 hrs. Each experiment was performed in triplicate. 
2.8 Statistics 
The fermentation data in this study were analysed, and statistics calculated using GraphPad 
Prism software version 7 (GraphPad Software, Inc.). Significance was calculated with 
Tukey’s multiple comparisons test for one-way ANOVA. All values are expressed as the 
mean average ± SD.  
2.9 Chemicals 
Unless otherwise stated, all reagents and chemicals were purchased from Sigma-Aldrich, 
USA. 
3 Results and discussion 
3.1 Physiological characterization of hydroxy acid-producing Pdc- S. cerevisiae 
We constructed different hydroxy acid producing strains, with an evolved glucose tolerant 
Pdc- strain as the host – referred to as the TAM strain (van Maris et al., 2004a). The un-
engineered host produces and excretes high levels of pyruvate, and so we chose three 
hydroxy acids that are commonly produced via pyruvate; lactate, malate, and 3HP. We 
reconstructed previously published designs for high level production of lactate, and malate 
from the TAM strain (Lui and Lievense, 2005; Zelle et al., 2008). Two different versions 
of the β-alanine route to 3HP biosynthesis were constructed, each utilising a different 
cofactor in the final enzymatic step of the pathway (Borodina et al., 2015), so that five total  
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strains were tested against each other (see Figure 1 for details on the implemented 
pathways). 
To first characterise the production performances of the hydroxy acid producing strains, 
we performed shake flask fermentations using a batch media composition that has 
previously been shown to be suitable for the production of malate to high titres in the 
TAM strain (Zelle et al., 2008). These were performed with 100 g L-1 of glucose as the 
carbon source. The results of these fermentations are shown in Figure 2, with Table 1 
listing the key fermentation parameters of each strain. 
Biomass accumulation was similar across most of the strains, apart from the lactate 
producing strain (ST7031) that showed a significantly higher final optical density than all 
Strain ST2803 ST7031 ST5413 ST2779 ST2780 
Description 
Parental 
TAM strain 
Lactate producer Malate Producer 
3HP producer 
(HPDH) 
3HP producer 
(HIBADH) 
Max Product Titre 
(g L-1) 
16.5 ± 0.1 30.2 ± 2.2 26.8 ± 0.3 3.7 ± 0.1 3.4 ± 0.2 
Product Yield 
(mol mol-1 
glucose) 
0.340 ± 0.004 0.600 ± 0.091 0.363 ± 0.010 0.070 ± 0.005 0.067 ± 0.007 
Glucose Uptake 
Rate (mmol-1 
gDW-1 h-1) 
0.640 ± 0.125 2.317 ± 0.696 4.145 ± 0.519 0.573 ± 0.080 0.497 ± 0.063 
Final OD600 63.9 ± 2.2 86.2 ± 2.4 58.6 ± 2.2 51.6 ± 0.5 56.5 ± 1.6 
Maximum specific 
growth rate (h-1) 
0.080 ± 0.006 0.131 ± 0.007 0.096 ± 0.007 0.063 ± 0.003 0.059 ± 0.004 
Succinate (g L-1) 0.17 ± 0.06 0.42 ± 0.02 3.97 ± 0.08 0.70 ± 0.06 0.91 ± 0.09 
Glycerol (g L-1) 6.00 ± 0.05 0.25 ± 0.01 2.54 ± 0.06 2.07 ± 0.20 2.93 ± 0.18 
Table 1. Fermentation parameters of the hydroxy acid production strains. Results in the table 
show the analysed parameters of 120 hour shake flask fermentations. Batch mineral media was 
used, with a starting glucose concentration of 100 g L-1. Results are from fermentation run in 
triplicate ± SD. Max product titre refers to the main or target secreted metabolite of each strain; 
ST2308 – Pyruvate, ST7031 – Lactate, ST5413 – Malate, ST2779 and ST2780 – 3HP. 
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other strains (p < 0.001). The NADPH-dependent 3HP producer (ST2779) showed a 
slightly lower biomass accumulation (p < 0.05) compared to the parental strain (ST2803). 
Growth rates, however, showed considerable variation with ST7031 producing the fastest 
growth rate of 0.131 ± 0.007 h-1. Both ST7031 and the malate production strain (ST5413 
- growth rate of 0.096 ± 0.007 h-1) showed significantly improved growth rates over 
ST2803 (0.080 ± 0.006 h-1), while both ST2779 and ST2780 showing significantly lower 
growth rates than ST2803 (0.063 ± 0.003, and 0.059 ± 0.004 h-1 for the ST2779 and 
ST2780 strains, respectively). The insertion of NAD+ regeneration reactions improved the 
growth rates in both ST7031 and ST5413. The extra ATP requirement of malate over 
lactate production may be the main factor contributing to the lower growth rate of ST5413 
compared to ST7031. There was no significant difference between the growth rates of the 
3HP producing strains. A slight growth improvement of the HIBADH (ST2780) strain 
over the HPDH strain (ST2779) may have been expected due to ST2780 regenerating 
NAD+ during 3HP synthesis, but no such difference between the strains was observed. 
The lower than ST2803 growth rates suggest that both 3HP pathways are deleterious to 
the fitness of the host, and this effect together with the much lower titres of 3HP compared 
to the other hydroxy acids, may cancel any positive effects provided by NAD+ 
regeneration. Glucose was consumed rapidly in both ST7031 and ST5413, but with 
ST5413 having consumed all of the glucose ~20 hours earlier than ST7031. Both 3HP 
producing strains, and the parental strain took much longer to deplete the glucose in the 
media, occurring only at the end of the fermentations.  
ST2803, ST7031, and ST5413 saw growth coupled production of their acids, which 
stopped on glucose depletion. ST7031 and ST5413 both produced high levels of their 
products, with a final measured lactate and malate concentrations of 30.2 ± 2.2, and 26.8 
± 0.3 g L-1 respectively. This was higher than the pyruvate production in the parental strain, 
which had a maximum titre of only 16.5 ± 0.1 g L-1.  
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Pyruvate yields on glucose were reported in the original TAM publication to be 0.92 mol 
mol-1 glucose (van Maris et al., 2004a). In this study we recorded yields of only 0.34 mol 
mol-1 glucose. This difference may be due to the original paper using a multiple glucose 
feeding approach to maximise pyruvate yields. Lactate production from a TAM strain 
expressing a bacterial LDH has been reported to produce up to 50 g L-1 lactate in shake 
flask fermentations with only 70 g L-1 glucose, a yield of 1.44 mol mol-1 glucose (Lui and 
Lievense, 2005). This is much higher than the yields we report (0.60 mol mol-1 glucose), 
although there are multiple experimental differences, perhaps the most important being 
that in our study we use a chromosomally integrated LDH gene present in a single copy, 
whereas in the previous work they express an LDH from a high copy number plasmid, as 
well as this study using different fermentation parameters (Lui and Lievense, 2005). 
Although the construction of ST5413, and the media used for fermentation, were almost 
identical to that previously published by (Zelle et al., 2008), we achieved a slightly lower 
yield of malate (0.36 vs. 0.42 mol mol-1 glucose). This difference may be due to differences 
in glucose or CaCO3 concentrations used between the studies, as well as the difference in 
expression methods between the two studies (single gene integration into the yeast 
chromosome in the present study vs. high copy number plasmid expression in the original 
publication). These figures are also from 300 hour long fermentations, whereas this study 
ran 120 hour fermentations (by which point the glucose appeared to have been fully 
consumed). Pdc+ S. cerevisiae expressing the HPDH version of the 3HP pathway produced 
a yield of 0.09 mol mol-1 glucose in batch media conditions, slightly higher than the same 
pathway expressed in the TAM strain – ST2779 (0.07 mol mol-1 glucose) (Borodina et al., 
2015). The poorer performance of the TAM based strains compared to the Pdc+ host is 
surprising, and perhaps due to the media conditions not being optimal for 3HP 
production. However, the 3HP titres were much higher than those previously published 
under batch fermentation conditions (Borodina et al., 2015). 
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Figure 2. Fermentation profiles of the hydroxy acid production strains. Time-course 
fermentations showing a) ST2803 - parental TAM strain, b) ST7031 - TAM strain with lactate 
production pathway, c) ST5413 - TAM strain with malate production pathway, d) ST2779 - TAM 
strain with HPDH-dependent 3HP pathway, e) ST2780 - TAM strain with HIBADH-dependent 
3HP pathway. Each fermentation was run for 120 hrs and in triplicate. Values shown are the 
mean average for each time point ± SD. Glucose (p), Product (q), Glycerol (p), Succinate 
(l), OD600 (n) 
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ST2779 and ST2780 showed continued 3HP production into stationary phase. The two 
3HP strains produced similar levels of 3HP by the end of fermentation, 3.7 ± 0.13, and 
3.4 ± 0.17 g L-1 respectively. When these enzymes were expressed in a Pdc+ strain, there 
was a greater difference between the performance of these two enzymes, with the strain 
carrying HPDH producing ~4-fold higher titres of 3HP than a strain carrying the 
HIBADH enzyme (Borodina et al., 2015). This observation is consistent with expectations 
as the Pdc- strain exhibits an NADH imbalance, and therefore the NAD+ regenerating 
pathway in ST2780 is expected to perform relatively better in the TAM strain. 
ST2803 produced barely detectable levels of secreted by-products, with the exception of 
glycerol. Glycerol production occurred late in the fermentation, with ~6 g L-1 measured at 
the end of 120 hours. Glycerol is formed from the splitting of fructose-1,6-bisphosphate 
into dihydroxy-acetone-phosphate (DHAP), and glyceraldehye-3-phosphate. DHAP can 
be converted to glycerol, yielding 1 mol NAD+, and glyceraldehyde-3-phosphate can be 
converted to pyruvate, yielding 1 mol NADH and 2 mol ATP. Over accumulation of 
pyruvate may then shift some flux into glycerol production. It may also be a consequence 
of redox imbalance in the cell, regenerating more NAD+. Glycerol production is lower in 
most of the other strains, apart from ST5413, which produced a maximum of ~4.5 g L-1, 
which then partly appears to have been re-assimilated. The final molar yield of lactate in 
ST7031 was ~66% greater than that of malate in ST5314 (0.60 vs. 0.36 mol mol-1 glucose), 
potentially leading to higher level of available NAD+ in the ST7031. Unlike lactate, malate 
can feed in to the TCA cycle, and also into the glyoxylate shunt (Zelle et al., 2008). 
Overproduction of malate may cause perturbations, where by-products accumulate but are 
not able to be processed due to low NAD+ levels. This may account for the higher secreted 
succinate production, produced in both the TCA cycle and glyoxylate shunt, which is 
observed in only in ST5413 (final concentration of 4 g L-1).  
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Differences in by-product secretion are found between the two 3HP producing strains. 
Both produced similar levels of succinate (~0.8 g L-1), but ST2780 produces 50% more 
glycerol than ST2779 (3 g L-1 and 2 g L-1 respectively).  The cause for this is not readily 
apparent, as the conversion of DHAP to glycerol-3-phosphate generates NAD+, as does 
the final 3HP catalysing step of the NADH-dependent producer. It may then be expected 
that the NADPH dependent strain would produce more glycerol to compensate for a lack 
of NAD+ generation through ethanol production.  
3.2 RAMOS 
The respiration activity monitoring system (RAMOS) is capable of measuring both the 
oxygen and carbon transfer rates (OTR and CTR) during microbial fermentations, and 
from this determine the respiratory quotients (RQ) of the strains (Anderlei et al., 2004). 
Figure S1f shows the fermentation profile of the Pdc+ CEN.PK strain, where it is apparent 
that the OTR and CTR are highly uncoupled, leading to a high RQ during glucose 
assimilation. ST2803 shows a tightly linked OTR and CTR as it progresses through the 
fermentations, with an RQ of 1. All of the tested strains had near identical OTR’s during 
the first 10 hours of the fermentations. ST7031 was the first Pdc- strain to show a slow 
down of OTR, beginning to slow at ~18 hours (Figure 3). However, later in the 
fermentation, the OTR of ST7031 begins to rise again. At between 28.5 and 31 hours, the 
RQ is 0.79 ± 0.04, which could suggest that it is assimilating a secreted product such as 
glycerol (with an RQ of 0.86) along with glucose. There is also a second similarly sized 
increase in activity at the end of the fermentations (Figure 3). The marked difference in 
the ST7031 OTR profiles as compared to ST5413 is interesting, as both produce additional 
NAD+. Additionally, ST7031, similar to the Pdc+ strain, is able to metabolise all of the 
glucose with lower levels of total oxygen consumption, while ST5413 retains the higher 
demand for oxygen that is found in the parental TAM strain (Figure S3).  
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3.3 13C-based metabolic flux analysis 
To further characterise hydroxy acid production in Pdc- yeast, we employed 13C-based 
metabolic flux analysis combined with genome scale modelling to identify flux distribution 
variation between hydroxy acid producing strains. Each strain was cultivated in defined 
liquid batch media that has previously shown to be beneficial for malate production, 
containing 13C-labelled glucose as the carbon source (Zelle et al., 2008). The strains were 
cultivated in shake flasks, and samples taken when each strain reached mid-exponential 
phase. Once collected, samples were analysed by GC-MS and the fluxes were calculated 
using the iMS2flux, and INCA programs (Poskar et al., 2012; Young, 2014). The iMM904 
genome scale model of S. cerevisiae was constrained with the calculated fluxes to estimate 
flux distribution for each strain on a global metabolic level (Figure 4). Glucose uptake rates 
for ST2803 and both 3HP producing strains were comparable, but ST7031 and ST5413 
showed 3.5 fold and 6.5 fold faster uptake rates, respectively (Table 1). Growth rates were 
likewise higher on both ST7031 and ST5413, showing that both pathways help to 
Figure 3. Respiration characteristics of the hydroxy acid production strains. Average oxygen 
transfer rate (OTR) profiles over the course of the fermentations were measured for each 
production strain, the parental TAM strain, and a Pdc+ WT CEN.PK strain (ST001) for 
reference. For strain references, refer to Table 1. Results shown are the mean average of 
fermentations run in triplicate.  
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recover some growth capabilities. Under respiro-fermentative growth, as is expected to be 
experienced during shake flask cultivations, flux through the pentose phosphate (PP) 
pathway and TCA cycle are low in Pdc+ WT strains (Gombert et al., 2001; Maaheimo et 
al., 2001). In comparison to Pdc+ WT strains, all strains analysed in the present study 
diverted most of the carbon flux (>90%) into the PP pathway. However, flux through the 
TCA cycle remained low, especially in both 3HP producing strains.  
Both 3HP strains showed higher relative fluxes into glycerol-3-phosphate from DHAP, 
and from the reverse reaction of erythrose-4-phosphate and fructose-6-phosphate. The 
increased flux into glycerol-3-phosphate then appears to be diverted away from the central 
pathway, and into glutamate biosynthesis from 3-phosphoglycerate. ST7031 and ST5413 
are able to keep a high proportion of their carbon flux through 3-phosphoglycerate to 
pyruvate, presumably due to the presence of a suitable carbon sink. From pyruvate, both 
the 3HP strains show flux ratios similar to ST5413 for oxaloacetate synthesis, suggesting 
that PYC1 and PYC2 overexpression is correctly functioning to push flux into oxaloacetate 
in these strains, but they are unable to convert this additional flux into 3HP production. 
ST2780 shows higher pyruvate carboxylase flux than the ST2779, but both strains show 
near identical fluxes through the aspartate transaminase step, with the reaction only 
processing around half of the flux supplied from the pyruvate carboxylase reaction. This 
Figure 4 (Over page). 13C-based metabolic flux analysis of the hydroxy acid production strains. 
Crabtree negative S. cerevisiae strains (TAM – ST2803) producing different hydroxyacids; 
lactate (ST7031), malate (ST5413), and 3HP (ST2779 and ST2780) were analysed for their 
relative flux distributions. Bar charts next to each reaction show the relative flux values for each 
strain (normalised over glucose uptake rate). GLC glucose, G6P glucose-6-phosphate, 6PGL D-
6-phospho-glucono-δ-lactone, 6PGC 6-phospho-D-gluconate, RU5P ribulose-5-phosphate, 
XU5P xylulose-5-phosphate, R5P ribose-5-phosphate, S7P sedoheptulose-7-phosphate, G3P 
glyceraldehyde-3-phosphate, E4P erythrose-4-phosphate, F6P fructose-6-phosphate, FDP 
fructose-1,6-diphosphate, DHAP dihydroxy-acetone-phosphate, GLYC3P glycerol-3-phosphate, 
GLYC glycerol, 13DPG 1,3-diphosphateglycerate, 3PG 3-phosphoglycerate, 2PG 2-
phosphoglycerate, PEP phosphoenolpyruvate, PYRcyt pyruvate (cytosolic), ACALD 
acetaldehyde, EtOH ethanol, AC acetate, PYRmit pyruvate (mitochondrial), ACoAmit acetyl-
CoA (mitochondrial), CIT citrate, ICIT isocitrate, AKG α-ketoglutarate, SUCCoA succinyl-CoA, 
SUC succinate, FUM fumarate, MAL malate, OAA oxaloacetate.  
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could suggest that AAT2 overexpression, or work to remove regulation of this gene may 
improve the flux to aspartate, with positive results reported previously for the 
overexpression of the native AAT2 in the Pdc+ background (Borodina et al., 2015). 
However, it is also clear that there is further room for improvement in the final three 
enzymatic steps of the pathway, as only a relatively low flux is carried from aspartate (see 
Figure S4). The impaired growth of both 3HP strains may be due in part to a toxic build 
up of malonic semialdehyde, with the detoxofication by HPDH/HIBADH unable to 
proceed quickly enough to allow the cell to grow rapidly (Dalwadi et al., 2017; Kim et al., 
2010). Investigations into the transport mechanisms of 3HP from the cytosol could help 
to pull flux from malonic semialdehyde and restore growth. Another strategy may be to 
engineer a malonic semialdehyde sensor to dynamically control flux through the pathway, 
similar to previous work carried out on 3HP biosensors (Hanko et al., 2017; Rogers and 
Church, 2016).  
Transcriptomics can provide valuable insight into how a strain may try to adapt to genetic 
modifications. A deeper understanding of stresses faced by each strain during 
fermentation, and solutions for minimising the stress factors, may be provided through 
transcriptomic analysis. Future work in this area may reveal where regulatory networks are 
acting to prohibit higher product formation in each strain. 
4 Conclusions and future perspectives 
In this study, we have provided a characterisation of hydroxy acid production pathways in 
a Crabtree-negative, pyruvate overproducing S. cerevisiae strain – the TAM strain. 
Introduction of a lactate or malate production pathway restores some of the growth 
defects found in the TAM strain by re-supplying cytosolic NAD+. The energetic 
requirements of lactate and malate transport, combined with the mutation found in MTH1, 
prevents full restoration of growth rate to that of Pdc+ S. cerevisiae. However, NADH-
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dependent production of 3HP in ST2780 was unable to provide any growth restoration, 
and both 3HP producing strains had reduced growth rates compared to ST2803.  
The presence of malate or lactate as a carbon sink allowed these strains to achieve a higher 
relative flux through lower glycolysis than the TAM strain. This was not the case for the 
3HP producers, and so further research must be undertaken to improve the downstream 
capacity of the 3HP pathways. 
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Figure S1. Respiration profiles of each hydroxy acid production strain. a) ST2803 - Parental 
TAM strain, b) ST7031 - Lactate producing strain, c) ST5413 - Malate producing strain, d) 
ST2779 - NADPH-dependent 3HP producing strain, e) ST2780 - NADH-dependent 3HP 
producing strain, f) ST001 - CEN.PK Pdc+ WT strain. Respiratory Quotient is designated by 
the black lines, oxygen transfer rate by the green, and carbon dioxide transfer rate by red. 
Experiments were carried out in triplicate.  
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Figure S2. Optical density profiles of the respiration experiments. The measured OD600 for each 
strain was taken from triplicate experiments run in the RAMOS system to measure the respiration 
characteristics during fermentation. Starting OD600 was set to 0.2. 
 
 
 
Figure S3. Total gas exchanges after 37.5 hours. The volume of oxygen taken up by the strains 
in the respiration experiments is shown by the black bars, and the total volume of carbon 
dioxide released is shown by the grey bars. The wild-type CEN.PK Pdc+ - ST001, strain is used 
as a control. 
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Figure S4. 3HP pathway fluxes from pyruvate, shown for both 3HP strains. Result of the 13C-
based metabolic flux analysis for the 3HP production pathway in the two strains tested. PC 
pyruvate carboxylase; ASPTA aspartate transaminase; PAND aspartate-1-decarboxylase; 
BAPAT β-alanine-pyruvate aminotransferase; HIBADH/HPDH 3-hydroxypropanoate 
dehydrogenase (NADH or NADPH dependent). 
Table S1. List of primers used in this study  
ID Name Sequence (5’->3’)  Application 
652 TcPAND_U1_fw AGTGCAGGUAAAACAATGCCAGCTAC
TGGTG 
Forward primer for TcPanD biobrick 
653 TcPAND_U1_rv CGTGCGAUTCACAAATCGGAACCCAA
TC 
Reverse primer for TcPanD biobrick 
5 pTEF1_fw<- ACCTGCACUTTGTAATTAAAACTTAG Forward primer for TEF promoter 
6 pTEF1_rv<- CACGCGAUGCACACACCATAGCTTC Reverse primer for TEF promoter 
8 pPGK1_rv-> ATGACAGAUTTGTTTTATATTTGTTG Reverse primer for PGK1 promoter 
7 pPGK1_fw-> CGTGCGAUGGAAGTACCTTCAAAGA Forward primer for PGK1 promoter 
11657 BcBAPAT_U1_fw<- AGTGCAGGUAAAACAATGCACTTGCA
AACTAAGACC 
Forward primer for BcBAPAT 
11658 BcBAPAT_U1_rv<- CGTGCGAUTCACAATTGGGAGATGGA
TTC 
Reverse primer for BcBAPAT 
PC
AS
PT
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ND
BA
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HI
BA
DH
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PD
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0.0
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704 EcYdfg_U2_fw-> ATCTGTCAUAAAACAATGATCGTTTTA
GTAACTGGAG 
Forward primer for EcYDFG 
705 EcYdfg_U2_rv-> CACGCGAUTTACTGACGGTGGACATT
C 
Reverse primer for EcYDFG 
670 ScPYC1_U1_fw<- AGTGCAGGUAAAACAATGTCGCAAAG
AAAATTCG 
Forward primer for PYC1 
671 ScPYC1_U1_rv<- CGTGCGAUTCATGCCTTAGTTTCAACA
G 
Reverse primer for PYC1 
672 ScPYC2_U2_fw-> ATCTGTCAUAAAACAATGAGCAGTAG
CAAGAAATTG 
Forward primer for PYC2 
673 ScPYC2_U2_rv->  CACGCGAUTTACTTTTTTTGGGATGG
G 
Reverse primer for PYC2 
82 pE2_NEW_fw-> ATCTGTCAUGGTACCAAAACAATG Forward primer for PpHIBADH 
12 pE2_rv-> CACGCGAUGTCGACTCA Reverse primer for PpHIBADH 
7011 ScMdh3deltaSKL_U1_
fw<- 
AGTGCAGGUAAAACAATGGTCAAAGT
CGCAATTC 
Forward primer for MDH3, without 
mitochondrial localisation sequence 
7012 ScMdh3deltaSKL_U1_
rv<- 
CGTGCGAUTTAAGAGTCTAGGATGAA
ACTCTTG 
Reverse primer for MDH3, without 
mitochondrial localisation sequence 
278 pTDH3_fw-> CGTGCGAUATAAAAAACACGCTTTTTC
AGTTCG 
Forward primer for the promoter of 
TDH3 
279 pTDH3_rv-> ATGACAGAUTTTGTTTGTTTATGTGT
GTTTATTCGA 
Reverse primer for the promoter of 
TDH3 
1852 pTDH3_fw<- CACGCGAUATAAAAAACACGCTTTTTC
AG 
Forward primer for the promoter of 
TDH3 
1853 pTDH3_rv<- ACCTGCACUTTTGTTTGTTTATGTGTG
TTTATTC 
Reverse primer for the promoter of 
TDH3 
7029 SpMae1_U2_fw-> ATCTGTCAUAAAACAATGGGTGAACT
CAAGGAAATC 
Forward primer for SpMAE1 
7030 SpMae1_U2_rv-> CACGCGAUTTAAACGCTTTCATGTTCA
C 
Reverse primer for SpMAE1 
294 pTEF1_fw-> CGTGCGAUGCACACACCATAGCTTCA
AAATG 
Froward primer for the promoter of 
TEF1 
295 pTEF1_rv-> ATGACAGAUTTGTAATTAAAACTTAG
ATTAGATTGCTATG 
Reverse primer for the promoter of TEF1 
905 X-4-up-out-sq CTCACAAAGGGACGAATCCT Primer for verification of integrations into 
site X-4 
906 X-4-down-out-sq GACGGTACGTTGACCAGAG Primer for verification of integrations into 
site X-4 
907 Ny-XI-1-up-sq CTTAATGGGTAGTGCTTGACACG Primer for verification of integrations into 
site XI-1 
908 Ny-XI-1-down-sq GAAGACCCATGGTTCCAAGGA Primer for verification of integrations into 
site XI-1 
Table S2. List of plasmids used in this study 
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901 X-2-up-out-sq TGCGACAGAAGAAAGGGAAG Primer for verification of integrations into 
site X-2 
902 X-2-down-out-sq  GAGAACGAGAGGACCCAACAT Primer for verification of integrations into 
site X-2  
224 ADH1_test_fw GAAATTCGCTTATTTAGAAGTGTC A primer that together with CYC1_test_rv 
primer can be used to test cloning into 
yeast expression vectors 
225 CYC1_test_rv CTCCTTCCTTTTCGGTTAGAG A primer that together with 
ADH1_test_fw primer can be used to test 
cloning into yeast expression vectors 
 
Table S2. List of plasmids used in this study  
Details of integration sites can be found in (Mikkelsen et al., 2012), except for the yeast 
retrotransposon site TY4, which can be found in (Maury et al., 2016). 
 
ID Name Parental 
vector 
Biobricks Description Source 
pCfB799 pTY4-TcPanD<-
PTEF1 
pCfB322 tcPanD<-pTEF1 Integration into TY4 
carrying TcPanD under 
influence of TEF1 promoter 
with Ura marker 
(Borodina et 
al., 2015) 
pCfB800 pX-4-loxP-SpHiS5-
BcBAPAT<-
PTEF1-PPGK1-
>EcYdfG 
pCfB258 bcBAPAT<-pTEF1-
pPGK1->ecYdfG 
Integration into site X-4 of 
BcBAPAT under pTEF1 
control, and EcYDFG under 
pPGK1 control with His 
marker 
(Borodina et 
al., 2015) 
pCfB743 pXI-1-loxP-
KlLEU2-PYC1<-
PTEF1-PPGK1-
>PYC2 
pCfB358 PYC1<-pTEF1-
pPGK1->PYC2 
Integration into site XI-1 of 
PYC1 under pTEF1 control, 
and PYC2 under pPGK1 
control with Leu marker 
(Borodina et 
al., 2015) 
pCfB801 pX-4-loxP-SpHiS5-
BcBAPAT<-
PTEF1-PPGK1-
>PpHIBADH 
pCfB258 bcBAPAT<-pTEF1-
pPGK1->ppHIBADH 
Integration into site X-4 of 
bcBAPAT under pTEF1 
control, and ppHIBADH 
under pPGK1 control with 
His marker 
(Borodina et 
al., 2015) 
pCfB2154 pX-2-loxP-ura3-
ScMdh3deltaSKL-
SpMae1 
pCfB255 scMdh3deltaSKL<-
pTDH3-pTEF1-
>spMae1 
Integration into site X-2 of 
MDH3 lacking peroxisomal 
localisation sequence under 
This study 
Table S3. List of strains used in this study 
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pTDH3 control, and 
Schizosaccharomyces pombe 
malate transporter MAE1 
under pTEF1 control with 
Ura marker 
pCfB2226 X-4-loxP-
SpHIS5syn 
pCfB258 SpHIS5syn Integration into site X-4 of 
His marker, used to close 
His auxotrophy 
This study 
pCfB7866 X-4pTDH3-
>lpLLDH 
pCfB258 TDH3->lpLLDH Integration into site X-4 of 
Lactobacillus plantarum L-
LDH under pTDH3 control 
with URA marker 
This study 
pCfB322 pTY4-KlURA3-
TAG 
N/A N/A Backbone vector for 
multiple cassette integration 
into yeast retrotransposon 
site TY4 
(Maury et al., 
2016) 
pCfB258 pX-4-LoxP-SpHiS5 N/A N/A Backbone vector for cassette 
integration into site X-4 
(Jensen et 
al., 2014) 
pCfB388 pXI-1-LoxP-LEU N/A N/A Backbone vector for cassette 
integration into site XI-1 
(Jensen et 
al., 2014) 
pCfB255 pX-2-loxP-KlURA3 N/A N/A Backbone vector for cassette 
integration into site X-2 
(Jensen et 
al., 2014) 
Table S3. List of strains used in this study 
ID Name Description Plasmids Source 
ST001 CEN.PK113-7D CEN.PK WT strain without auxotrophies N/A Petter Kötter 
ST2606 TAM -Ura Pdc- strain with uracil auxotroph used as the 
parental strain for ST7031 
N/A 
(van Maris et al., 
2004a) 
ST2681 TAM –Ura –His -
Leu 
Pdc- strain with uracil, histidine, and leucine 
auxotroph used as the parental strain for 
ST2779, 2780, and 5413 
N/A This study 
ST2803 TAM Pdc- strain with all markers closed, used for 
13C- MFA 
N/A This study 
ST2779 3HP Producer – 
HPDH 
3HP producing strain with the HPDH 
(NADPH dependent, from Escherichia coli) 
3HP dehydrogenase 
pCfB799 
pCfB800 
pCfB743 
This study 
ST2780 3HP Producer - 
HIBADH 
3HP producing strain with the HIBADH 
from (NADH dependent, from 
Pseudomonas putida) 3HP dehydrogenase 
pCfB799 
pCfB801 
pCfB743 
This study 
ST5413 Malate Producer Malate producer, with native PYC1, PYC2, 
and MDH3 (lacking peroxisomal localisation 
pCfB743 
pCfB2154 
This study 
Table S4. Sequences of heterologous genes used in this study 
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tag) overexpressed, and S. pombe MAE1 
expression. 
pCfB2226 
ST7031 Lactate Producer Lactate producer, with L. plantarum L-LDH 
expressed. 
pCfB7866 This study 
 
Table S4. Sequences of heterologous genes used in this study 
For the sequences used in the 3HP producing strains, please refer to the supplementary 
materials found in (Borodina et al., 2015). 
 
ID Source 
Lactobacillus 
plasntarum 
ldh1 
AAAACAATGTCCTCTATGCCAAACCATCAAAAGGTTGTATTGGTTGGTGATGGTGCTGTTGGTTC
TTCTTATGCTTTTGCTATGGCTCAACAAGGTATTGCCGAAGAATTTGTTATCGTTGATGTTGTCA
AGGACAGAACTAAGGGTGATGCTTTGGATTTGGAAGATGCTCAAGCTTTTACTGCCCCAAAAAA
GATCTATTCCGGTGAATACTCTGATTGCAAGGATGCTGATTTGGTTGTTATTACTGCTGGTGCTC
CACAAAAACCAGGTGAATCAAGATTAGATTTGGTCAACAAGAACTTGAACATCTTGTCCTCAATC
GTTAAGCCAGTTGTTGATTCTGGTTTCGATGGTATTTTCTTGGTTGCTGCTAACCCAGTTGATAT
TTTGACTTACGCTACTTGGAAGTTCTCTGGTTTTCCAAAGGATAGAGTTATCGGTTCTGGTACTT
CTTTGGACTCTTCTAGATTGAGAGTTGCTTTGGGTAAGCAATTCAATGTTGATCCAAGATCCGTT
GATGCCTACATTATGGGTGAACATGGTGATTCTGAATTCGCTGCTTATTCTACTGCTACCATTGG
TACTAGACCAGTTAGAGATGTTGCTAAAGAACAAGGTGTTTCCGATGAAGATTTGGCCAAGTTA
GAAGATGGTGTTAGAAACAAGGCCTACGACATTATTAACTTGAAGGGTGCTACTTTCTACGGTA
TTGGTACTGCTTTGATGAGAATTTCCAAGGCCATTTTGAGAGATGAAAACGCTGTTTTGCCAGTT
GGTGCTTATATGGATGGTCAATACGGTTTGAACGATATCTACATTGGTACACCAGCTGTTATTGG
TGGTACAGGTTTGAAGCAAATTATCGAATCTCCATTGTCCGCCGATGAATTGAAAAAGATGCAA
GATTCTGCTGCCACCTTGAAAAAGGTTTTAAACGATGGTTTAGCCGAATTGGAAAACAAATGA 
Saccharomyces 
cerevisiae  
MDH3ΔSKL 
AAAACAATGGTCAAAGTCGCAATTCTTGGCGCTTCTGGTGGCGTGGGACAACCGCTATCATTACT
GCTAAAATTAAGCCCTTACGTTTCCGAGCTGGCGTTGTACGATATCCGAGCTGCGGAAGGCATT
GGTAAGGATTTATCTCACATCAACACCAACTCAAGTTGTGTCGGTTATGATAAGGATAGTATTGA
GAACACCTTGTCAAATGCTCAGGTGGTGCTAATACCGGCTGGTGTTCCCAGAAAGCCCGGTTTA
ACTAGAGATGATTTGTTCAAGATGAACGCCGGTATTGTCAAAAGCCTGGTAACCGCTGTTGGAA
AGTTCGCACCAAATGCGAGGATTTTAGTCATTTCAAACCCTGTAAACAGTTTGGTCCCTATTGCT
GTGGAAACTTTGAAGAAAATGGGTAAGTTCAAACCTGGAAACGTTATGGGTGTGACGAACCTTG
ACCTGGTACGTGCAGAAACCTTTTTGGTAGATTATTTGATGCTAAAAAACCCCAAAATTGGACAA
GAACAAGACAAAACTACAATGCACAGAAAGGTCACTGTTATTGGGGGTCATTCAGGGGAAACCA
TTATCCCAATAATCACCGACAAATCGCTGGTATTTCAACTTGATAAGCAGTACGAGCACTTCATTC
ATAGGGTCCAGTTCGGAGGTGATGAAATTGTCAAAGCTAAACAGGGCGCCGGTTCCGCCACGTT
GTCCATGGCGTTCGCGGGGGCCAAGTTTGCTGAAGAAGTTTTGAGGAGCTTCCATAATGAGAAA
CCAGAAACGGAGTCACTTTCCGCATTCGTTTATTTACCAGGCTTAAAAAACGGTAAGAAAGCGCA
Table S5. Flux calculations from INCA used to constrain a genome scale 
metabolic model of S. cerevisiae. 
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GCAATTAGTTGGCGACAACTCTATTGAGTATTTTTCCTTGCCAATTGTTTTGAGAAATGGTAGCG
TAGTATCCATCGATACCAGTGTTCTGGAAAAACTGTCTCCGAGAGAGGAACAACTCGTTAATACT
GCGGTCAAAGAGCTACGCAAGAATATTGAAAAAGGCAAGAGTTTCATCCTAGACTCTTGA 
Schizosaccharo
myces pombe 
mae1 
AAAACAATGGGTGAACTCAAGGAAATCTTGAAACAGAGGTATCATGAGTTGCTTGACTGGAATG
TCAAAGCCCCTCATGTCCCTCTCAGTCAACGACTGAAGCATTTTACATGGTCTTGGTTTGCATGTA
CTATGGCAACTGGTGGTGTTGGTTTGATTATTGGTTCTTTCCCCTTTCGATTTTATGGTCTTAATA
CAATTGGCAAAATTGTTTATATTCTTCAAATCTTTTTGTTTTCTCTCTTTGGATCATGCATGCTTTT
TCGCTTTATTAAATATCCTTCAACTATCAAGGATTCCTGGAACCATCATTTGGAAAAGCTTTTCAT
TGCTACTTGTCTTCTTTCAATATCCACGTTCATCGACATGCTTGCCATATACGCCTATCCTGATACC
GGCGAGTGGATGGTGTGGGTCATTCGAATCCTTTATTACATTTACGTTGCAGTATCCTTTATATA
CTGCGTAATGGCTTTTTTTACAATTTTCAACAACCATGTATATACCATTGAAACCGCATCTCCTGC
TTGGATTCTTCCTATTTTCCCTCCTATGATTTGTGGTGTCATTGCTGGCGCCGTCAATTCTACACA
ACCCGCTCATCAATTAAAAAATATGGTTATCTTTGGTATCCTCTTTCAAGGACTTGGTTTTTGGGT
TTATCTTTTACTGTTTGCCGTCAATGTCTTACGGTTTTTTACTGTAGGCCTGGCAAAACCCCAAGA
TCGACCTGGTATGTTTATGTTTGTCGGTCCACCAGCTTTCTCAGGTTTGGCCTTAATTAATATTGC
GCGTGGTGCTATGGGCAGTCGCCCTTATATTTTTGTTGGCGCCAACTCATCCGAGTATCTTGGTT
TTGTTTCTACCTTTATGGCTATTTTTATTTGGGGTCTTGCTGCTTGGTGTTACTGTCTCGCCATGG
TTAGCTTTTTAGCGGGCTTTTTCACTCGAGCCCCTCTCAAGTTTGCTTGTGGATGGTTTGCATTCA
TTTTCCCCAACGTGGGTTTTGTTAATTGTACCATTGAGATAGGTAAAATGATAGATTCCAAAGCT
TTCCAAATGTTTGGACATATCATTGGGGTCATTCTTTGTATTCAGTGGATCCTCCTAATGTATTTA
ATGGTCCGTGCGTTTCTCGTCAATGATCTTTGCTATCCTGGCAAAGACGAAGATGCCCATCCTCC
ACCAAAACCAAATACAGGTGTCCTTAACCCTACCTTCCCACCTGAAAAAGCACCTGCATCTTTGGA
AAAAGTCGATACACATGTCACATCTACTGGTGGTGAATCGGATCCTCCTAGTAGTGAACATGAAA
GCGTTTAA 
Table S5. Flux calculations from INCA used to constrain a genome scale metabolic 
model of S. cerevisiae. 
 ST2803 ST7031 ST5413 ST2779 ST2780 
Reaction Equation Flux Std Error Flux 
Std 
Error Flux 
Std 
Error Flux 
Std 
Error Flux 
Std 
Error 
Glc.ext -> G6P 0.80945 0.18805 2.99605 0.71735 4.16395 1.36405 0.8062 0.1088 0.6736 0.0952 
AcCOOH -> AcCOOH.ext 0.00905 0.00595 0.01895 0.01215 0.0103 0.0055 0.0069 0.0037 0.0056 0.003 
Glyc -> Glyc.ext 0.5154 0.2584 2.11435 0.99645 4.07965 2.43555 0.45105 0.15965 0.37225 0.13135 
0.459*Ala + 0.161*Arg + 0.102*Asn + 0.297*Asp + 
0.007*Cys + 0.105*Gln + 0.302*Glu + 0.29*Gly + 
0.066*His + 0.193*Ile + 0.296*Leu + 0.286*Lys + 
0.051*Met + 0.134*Phe + 0.165*Pro + 0.185*Ser + 
0.191*Thr + 0.028*Trp + 0.102*Tyr + 0.265*Val + 
0.519*Glycogen + 0.023*Trehalose + 0.808*Mannan 
+ 1.135*Glucan + 0.051*AMP + 0.05*CMP + 
0.051*GMP + 0.067*UMP + 0.0036*DAMP + 
0.0024*DCMP + 0.0024*DGMP + 0.0036*DTMP + 
0.0066*TAG + 0.0007*ergosterol + 
0.0015*zymosterol + 0.0006*PA + 0.0062*PC + 
0.0046*PE + 0.0055*PI + 0.0017*PS + 
0.4623*AcCoA.c -> Biomass 
0.06835 0.01645 0.13005 0.01375 0.0961 0.0137 0.0602 0.0056 0.05255 0.00705 
0*Pyr.c -> Pyr.mnt 0.51195 0.20945 0.1565 0.1565 0.0108 0 0.000114355 
1.65E-
07 0 0 
0*Pyr.m -> Pyr.mnt 0.02585 0.00265 0.24445 0.24445 0.0299 0 0.00009959 4.1E-08 0.0026 0 
Pyr.mnt -> Pyr.fix 0.5413 0.2065 0.46875 0.20025 0.0407 0 0.000213945 
1.75E-
07 0.0026 0 
G6P <-> F6P -0.09375 0.14405 -0.0836 0.1451 
-
0.14355 0.36825 -0.0345 0.053 -0.0239 0.0417 
Table S5. Flux calculations from INCA used to constrain a genome scale 
metabolic model of S. cerevisiae. 
 
 
 124 
 ST2803 ST7031 ST5413 ST2779 ST2780 
Reaction Equation Flux Std Error Flux 
Std 
Error Flux 
Std 
Error Flux 
Std 
Error Flux 
Std 
Error 
F6P <-> FBP 0.38775 0.12145 1.7028 0.4702 2.5606 0.9089 0.4009 0.0731 0.3329 0.0605 
FBP <-> DHAP + G3P 0.38775 0.12145 1.7028 0.4702 2.5606 0.9089 0.4009 0.0731 0.3329 0.0605 
DHAP <-> G3P -0.12865 0.15265 
-
0.40755 0.58175 
-
1.51235 1.57915 -0.0486 0.0947 -0.0383 0.0802 
G3P -> PG3 0.55175 0.13295 2.4339 0.5401 2.33 0.7313 0.60595 0.07615 0.50505 0.06705 
PG3 -> PEP 0.5384 0.1299 2.411 0.5394 2.28575 0.73145 0.59295 0.07505 0.4941 0.066 
PEP -> Pyr.c 0.50245 0.12145 2.34065 0.53845 2.23375 0.73025 0.56125 0.07335 0.46655 0.06345 
DHAP -> Glyc3P 0.51695 0.25845 2.11755 0.99655 4.08215 2.43555 0.45255 0.15965 0.37345 0.13125 
Glyc3P -> Glyc 0.5154 0.2584 2.11435 0.99645 4.07965 2.43555 0.45105 0.15965 0.37225 0.13135 
G6P -> CO2 + Ru5P 0.7492 0.2322 2.8035 0.7368 4.0405 1.4303 0.71665 0.11945 0.5949 0.1003 
Ru5P <-> R5P 0.26905 0.07945 0.97315 0.24605 1.3762 0.4765 0.25685 0.04015 0.2136 0.0339 
Ru5P <-> X5P 0.48055 0.15315 1.8296 0.4907 2.66395 0.95415 0.4597 0.0797 0.38115 0.06655 
X5P <-> G3P + TKC2 0.48055 0.15315 1.8296 0.4907 2.66395 0.95415 0.4597 0.0797 0.38115 0.06655 
F6P <-> E4P + TKC2 -0.232 0.0758 -0.89695 0.24495 
-
1.31895 0.47695 -0.222 0.0397 -0.1838 0.033 
S7P <-> R5P + TKC2 -0.24845 0.07725 
-
0.93195 0.24565 
-
1.34485 0.47685 -0.2377 0.0398 -0.1973 0.0334 
F6P <-> G3P + TAC3 -0.24845 0.07725 
-
0.93195 0.24565 
-
1.34485 0.47685 -0.2377 0.0398 -0.1973 0.0334 
S7P <-> E4P + TAC3 0.24845 0.07725 0.93195 0.24565 1.34485 0.47685 0.2377 0.0398 0.1973 0.0334 
Mal -> Pyr.m + CO2 0.00265 0.00265 0.0044 0.0044 0.09365 0.03545 0.0045 0.0045 0.00505 0.00505 
Pyr.c + CO2 -> OAA.c 0.1928 0.0471 0.3666 0.0454 1.68765 0.64325 0.3092 0.0594 0.2545 0.0452 
AcCHO -> AcCOOH 0.0055 0.0055 0.0118 0.0118 0.00505 0.00505 0.00355 0.00355 0.00285 0.00285 
AcCHO -> AcCoA.c 0.05535 0.01625 0.1021 0.0248 0.02365 0.00785 0.0459 0.0081 0.04075 0.00805 
Pyr.m -> AcCoA.m + CO2 0.19325 0.05045 0.51365 0.08985 0.47495 0.11495 0.1506 0.0225 0.1258 0.0215 
OAA.m + AcCoA.m -> Cit 0.17 0.0435 0.46955 0.07875 0.38785 0.11155 0.1284 0.0189 0.10645 0.01755 
Cit -> ICit 0.17 0.0435 0.46955 0.07875 0.38785 0.11155 0.1284 0.0189 0.10645 0.01755 
ICit -> AKG + CO2 0.17 0.0435 0.46955 0.07875 0.38785 0.11155 0.1284 0.0189 0.10645 0.01755 
AKG -> Suc + CO2 0.1009 0.0291 0.33785 0.07095 0.2896 0.1109 0.06725 0.01705 0.0531 0.0137 
Suc <-> Fum 0.10135 0.02925 0.3387 0.071 0.2903 0.1109 0.0677 0.0171 0.05345 0.01365 
Fum <-> Mal 0.1278 0.0345 0.3889 0.0738 0.3271 0.1106 0.09105 0.01765 0.07385 0.01485 
Mal <-> OAA.m 0.12705 0.03435 0.38715 0.07335 0.2338 0.0995 0.0886 0.0174 0.0706 0.0147 
PG3 + Glu -> Ser + AKG 0.01475 0.00525 0.0289 0.0099 0.04675 0.00775 0.014 0.0034 0.01205 0.00315 
Ser <-> Gly + C1 -0.0008 0.0038 -0.0009 0.0094 0.02425 0.00535 0.00015 0.00295 0.00015 0.00255 
Gly <-> CO2 + C1 0.02675 0.00755 0.04895 0.01165 0.0106 0.0044 0.02195 0.00385 0.0194 0.0038 
Pyr.c -> Pyr.m 0.30485 0.07955 0.70425 0.11725 0.54815 0.11395 0.2415 0.0369 0.2048 0.0361 
OAA.c <-> OAA.m 0.0435 0.0108 0.0832 0.0101 0.15275 0.03845 0.04105 0.00645 0.03685 0.00755 
AcCoA.c <-> AcCoA.m -0.00615 0.00805 
-
0.01175 0.01955 -0.0589 0.0109 
-
0.00643
435 
0.00626
565 
-
0.00557
355 
0.00532
645 
AKG -> Glu 0.3663 0.0881 0.69775 0.07405 0.48565 0.06965 0.46115 0.06225 0.38565 0.05355 
Glu -> Gln 0.062 0.0149 0.1179 0.0125 0.0871 0.0124 0.05455 0.00505 0.04765 0.00645 
Glu -> Pro 0.0113 0.0027 0.02145 0.00225 0.01585 0.00225 0.00995 0.00095 0.00865 0.00115 
Table S5. Flux calculations from INCA used to constrain a genome scale 
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 ST2803 ST7031 ST5413 ST2779 ST2780 
Reaction Equation Flux Std Error Flux 
Std 
Error Flux 
Std 
Error Flux 
Std 
Error Flux 
Std 
Error 
Glu + Glu + CO2 + Gln + 
Asp -> AKG + Arg + Glu + 
Fum 
0.011 0.0026 0.0209 0.0022 0.0155 0.0022 0.0097 0.0009 0.00845 0.00115 
OAA.c + Glu -> Asp + AKG 0.14945 0.03675 0.28315 0.03715 0.1538 0.0236 0.27005 0.05795 0.2185 0.0436 
Asp + Gln -> Asn + Glu 0.00695 0.00165 0.0133 0.0014 0.0098 0.0014 0.00615 0.00055 0.00535 0.00075 
Pyr.c + Glu -> Ala + AKG 0.01835 0.01835 0.03255 0.03255 0.01205 0.01205 0.01485 0.01485 0.0133 0.0133 
Pyr.m + Glu -> Ala + AKG 0.01915 0.01915 0.03225 0.03225 0.03425 0.01505 0.0149 0.0149 0.01345 0.01345 
Asp -> Thr 0.083 0.0214 0.15505 0.02695 0.0615 0.0123 0.06995 0.00935 0.0617 0.0099 
Thr -> Gly + AcCHO 0.05645 0.01565 0.10355 0.02375 0.0252 0.0089 0.04645 0.00785 0.0411 0.0079 
Ser + AcCoA.c + Asp + CO2 -
> Cys + AcCOOH + Suc + 
CO2 
0.00047
8435 
0.00011
4935 
0.00090
6935 
0.00009
3065 
0.00067
245 
0.00009
581 
0.00042
1335 
0.00003
8995 
0.00036
7735 
0.00004
9565 
Asp + C1 + AcCoA.c -> Met + 
AcCOOH 0.00345 0.00085 0.0066 0.0007 0.0049 0.0007 0.0031 0.0003 0.00265 0.00035 
AKG + AcCoA.c + Glu + Glu 
-> Lys + CO2 + AKG + AKG 0.01955 0.00465 0.0372 0.0039 0.0275 0.0039 0.0172 0.0016 0.015 0.002 
AcCoA.m + Pyr.m + Pyr.m + 
Glu -> Leu + CO2 + CO2 + 
AKG 
0.02025 0.00485 0.0385 0.0041 0.02845 0.00405 0.01785 0.00165 0.01555 0.00205 
Thr + Pyr.m + Glu -> Ile + 
CO2 + AKG 0.0132 0.0032 0.02505 0.00265 0.01855 0.00265 0.0116 0.0011 0.01015 0.00135 
Pyr.m + Pyr.m + Glu -> Val + 
CO2 + AKG 0.01815 0.00435 0.03445 0.00365 0.02545 0.00365 0.01595 0.00145 0.0139 0.0019 
PEP + PEP + E4P + Glu -> 
Phe + CO2 + AKG 0.0092 0.0022 0.01745 0.00185 0.01285 0.00185 0.00805 0.00075 0.00705 0.00095 
PEP + PEP + E4P + Glu -> 
Tyr + CO2 + AKG 0.00695 0.00165 0.0133 0.0014 0.0098 0.0014 0.00615 0.00055 0.00535 0.00075 
Ser + R5P + PEP + E4P + 
PEP + Gln -> Trp + CO2 + 
G3P + Pyr.c + Glu 
0.00195 0.00045 0.00365 0.00035 0.0027 0.0004 0.00165 0.00015 0.0015 0.0002 
R5P + C1 + Gln + Asp -> His 
+ AKG + Fum 0.0045 0.0011 0.0086 0.0009 0.0063 0.0009 0.00395 0.00035 0.00345 0.00045 
CO2 + Asp + R5P + Gln -> 
UMP + CO2 + Glu 0.0084 0.002 0.016 0.0017 0.0118 0.0017 0.0074 0.0007 0.00645 0.00085 
UMP + Gln -> CMP + Glu 0.00355 0.00085 0.0068 0.0007 0.00505 0.00075 0.00315 0.00025 0.00275 0.00035 
R5P + Gln + Gln + Gly + Asp 
+ C1 + C1 + CO2 -> IMP + 
Glu + Glu + Fum 
0.0074 0.0018 0.01405 0.00145 0.0104 0.0015 0.0065 0.0006 0.00565 0.00075 
IMP + Asp -> AMP + Fum 0.0037 0.0009 0.00705 0.00075 0.00525 0.00075 0.0033 0.0003 0.0029 0.0004 
IMP + Gln -> GMP + Glu 0.00365 0.00085 0.00695 0.00075 0.00515 0.00075 0.0032 0.0003 0.0028 0.0004 
AMP -> DAMP 0.00024605 
0.00005
911 
0.00046
8065 
0.00004
9505 
0.00034
5835 
0.00004
9275 
0.00021
6685 
0.00002
0055 
0.00018
912 
0.00002
549 
CMP -> DCMP 0.000164035 
0.00003
9405 
0.00031
204 
0.00003
3 
0.00023
0555 
0.00003
2845 
0.00014
446 
0.00001
337 
0.00012
608 
0.00001
699 
GMP -> DGMP 0.000164035 
0.00003
9405 
0.00031
204 
0.00003
3 
0.00023
0555 
0.00003
2845 
0.00014
446 
0.00001
337 
0.00012
608 
0.00001
699 
UMP -> DUMP 0.00024605 
0.00005
911 
0.00046
8065 
0.00004
9505 
0.00034
5835 
0.00004
9275 
0.00021
6685 
0.00002
0055 
0.00018
912 
0.00002
549 
DUMP + C1 -> DTMP 0.00024605 
0.00005
911 
0.00046
8065 
0.00004
9505 
0.00034
5835 
0.00004
9275 
0.00021
6685 
0.00002
0055 
0.00018
912 
0.00002
549 
Glyc3P -> PA 4.10085E-05 
9.8515E
-06 
0.00007
8011 
0.00000
825 
5.76385
E-05 
8.2125E
-06 
3.61145
E-05 
3.3425E
-06 
0.00003
152 
0.00000
4249 
Glyc3P + Ser -> PS 0.00011619 
2.79105
E-05 
0.00022
1035 
0.00002
3375 
0.00016
331 
0.00002
327 
0.00010
2322 
9.4685E
-06 
8.93045
E-05 
1.20355
E-05 
Glyc3P + Ser -> PE + CO2 0.0003144 
0.00007
553 
0.00059
8085 
0.00006
3255 
0.00044
19 
0.00006
296 
0.00027
6875 
0.00002
5625 
0.00024
1655 
0.00003
2575 
Glyc3P + Ser + C1 + C1 + C1 
-> PC + CO2 
0.00042
376 
0.00010
18 
0.00080
611 
8.525E-
05 
0.00059
56 
8.486E-
05 
0.00037
318 
0.00003
454 
0.00032
571 
0.00004
39 
Glyc3P + G6P -> PI 0.000375915 
0.00009
0305 
0.00071
51 
0.00007
563 
0.00052
8355 
0.00007
5275 
0.00033
105 
0.00003
064 
0.00028
8935 
0.00003
8945 
Glyc3P -> TAG 0.000451095 
0.00010
8365 
0.00085
812 
0.00009
075 
0.00063
4025 
0.00009
0335 
0.00039
726 
0.00003
677 
0.00034
6725 
0.00004
6735 
AcCoA.c + AcCoA.c -> 
AcAcCoA 
0.00089
273 
0.00020
727 0.0017 0.0002 0.00125 0.00015 
0.00079
4515 
0.00007
3535 
0.00069
344 
0.00009
347 
AcAcCoA + AcCoA.c -> 
HMGCoA 
0.00089
273 
0.00020
727 0.0017 0.0002 0.00125 0.00015 
0.00079
4515 
0.00007
3535 
0.00069
344 
0.00009
347 
Table S5. Flux calculations from INCA used to constrain a genome scale 
metabolic model of S. cerevisiae. 
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 ST2803 ST7031 ST5413 ST2779 ST2780 
Reaction Equation Flux Std Error Flux 
Std 
Error Flux 
Std 
Error Flux 
Std 
Error Flux 
Std 
Error 
HMGCoA -> MVL 0.00089273 
0.00020
727 0.0017 0.0002 0.00125 0.00015 
0.00079
4515 
0.00007
3535 
0.00069
344 
0.00009
347 
MVL -> IPPP + CO2 0.00089273 
0.00020
727 0.0017 0.0002 0.00125 0.00015 
0.00079
4515 
0.00007
3535 
0.00069
344 
0.00009
347 
IPPP -> DMAPP 0.000300735 
0.00007
2245 
0.00057
208 
0.00006
05 
0.00042
2685 
0.00006
0225 
0.00026
484 
0.00002
451 
0.00023
1145 
0.00003
1155 
DMAPP + IPPP + IPPP + 
DMAPP + IPPP + IPPP -> 
CO2 + CO2 + CO2 + 
zymosterol 
0.00015
0365 
0.00003
6125 
0.00028
604 
0.00003
025 
0.00021
134 
0.00003
011 
0.00013
242 
0.00001
226 
0.00011
5573 
1.55775
E-05 
zymosterol + C1 -> ergosterol 4.78435E-05 
1.14935
E-05 
9.10135
E-05 
9.6265E
-06 
0.00006
7245 
0.00000
9581 
4.21335
E-05 
3.8995E
-06 
3.67735
E-05 
4.9565E
-06 
G6P + G6P -> Trehalose 0.00155 0.00035 0.003 0.0003 0.0022 0.0003 0.0014 0.0001 0.0012 0.0002 
G6P -> Glycogen 0.0355 0.0085 0.06745 0.00715 0.0499 0.0071 0.0312 0.0029 0.02725 0.00365 
G6P -> Glucan 0.07755 0.01865 0.1476 0.0156 0.10905 0.01555 0.0683 0.0063 0.05965 0.00805 
F6P -> Mannan 0.05525 0.01325 0.10505 0.01115 0.07765 0.01105 0.0486 0.0045 0.04245 0.00575 
CO2.ext -> CO2 8.59935 2.31555 27.3867 7.378 44.06555 
15.3292
5 9.26555 1.66225 7.5867 1.3627 
CO2 -> CO2.out 9.6942 2.5672 31.3324 8.093 47.7698 16.657 10.2415 1.7874 8.39815 1.46195 
GLC_113C -> Glc.ext 0.6856 0.1594 2.53175 0.60475 3.5224 1.1569 0.6848 0.0924 0.5723 0.0807 
GLC_U13C -> Glc.ext 0.12355 0.02885 0.4646 0.1114 0.64035 0.20935 0.121 0.0165 0.1014 0.0145 
Pyr.c -> Lac.c - - 1.23815 0.53785 - - - - - - 
Lac.c -> Lac.ext - - 1.23815 0.53785 - - - - - - 
OAA.c -> Mal.c - - - - 1.37955 0.63215 - - - - 
Mal.c -> Mal.ext - - - - 1.37955 0.63215 - - - - 
Asp -> Bala + CO2 - - - - - - 0.1405 0.0571 0.10505 0.04165 
Bala -> MalSA - - - - - - 0.1405 0.0571 0.10505 0.04165 
MalSA -> 3HP - - - - - - 0.1405 0.0571 0.10505 0.04165 
3HP -> 3HP.ext - - - - - - 0.1405 0.0571 0.10505 0.04165 
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Abstract 
Background 
 
Bio-based production of fuels and chemicals must be realised if society is to be able to 
reduce its dependence on petroleum. 3-Hydroxypropionic acid (3HP) is one such chemical 
that has the opportunity to be produced via biological means. There is a high demand for 
3HP derived products (the acrylic acid market alone is predicted to be worth USD 18.8 
billion by 2020), but current biological methods of production are unable to reach the 
titres, rates, and yields required to make the process economically viable. Many tools have 
been developed for the rational prediction of metabolic engineering targets, but success of 
these tools is still limited. 
 
Results 
 
In this study, we apply -omics level approaches to provide a characterisation of a high 3HP 
producing strain of the yeast S. cerevisiae (ST938), shown previously to be capable of titres 
of 14 g L-1. We first applied a transcriptomic analysis to ST938 to compare it to the WT 
strain. Introduction of the 3HP pathway caused widespread changes in the expression of 
genes across the genome. The engineered strain saw upregulation across glycolysis and the 
pentose phosphate pathway. We further applied 13C-based metabolic flux analysis to 
investigate how flux distribution was altered through implementation of a high production 
3HP pathway. The introduced pathway was shown to successfully divert flux from 
pyruvate, limiting the amount of flux into the TCA cycle. Significant flux was delivered to 
oxaloacetate, a precursor for 3HP biosynthesis, but only ~50% of this flux continues into 
3HP suggesting that there is still space to improve the efficiency of the downstream 
pathway. Using a combination of metabolic flux analysis, genome scale metabolic 
modelling, and transcriptomic profiling, we predicted a number of gene deletion strategies 
for the improvement of 3HP production. We characterised three of these strategies in vivo 
Abstract 
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through shake flask fermentations. The deletion of a gene connected to acetylated sterol 
transport - PRY1, increased 3HP titres by ~27% compared to the parental strain, opening 
questions into the role of this gene on the production of 3HP, and whether similar effects 
may be seen in other production pathways. The two other deletion strategies (JEN1 and 
PGI1 deletion) did not improve 3HP production, but have highlighted new targets for 
further research.  
 
Conclusions  
 
In this study, we present data on the transcriptome and fluxome of a high-level 3HP 
producer. We use the generated data to predict metabolic engineering strategies. One of 
the predicted strategies resulted in a ~27% improvement in 3HP titres, while other 
strategies suggested future work directions. This demonstrates the value of –omic data 
analysis for strain engineering. 
 
 
 
  
1 Introduction 
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1 Introduction 
Overuse of fossil fuels has led to a number of critical environmental issues that have left 
the global community with pressing challenges that must be addressed. Currently, many 
chemicals are derived from petroleum, and as such their long term use is generally not 
desirable. Wide arrays of chemicals can be sustainably produced from unicellular 
organisms such as yeasts and bacteria, and can help to reduce the global reliance on 
petrochemicals. 3-Hydroxypropionic acid (3HP) is one such chemical that can be 
produced biologically and can be used to generate derivative chemicals that have economic 
value. 3HP is a precursor of acrylic acid, and can also be polymerised to create a range of 
biodegradable and super-absorbent polymers. The market for acrylic acid is forecast to 
continue growing at a fast rate (compound annual growth rate of 7.6%), and is expected 
to be worth USD 18.8 billion by 2020 (Acrylic acid market report, Allied Market Research). 
Acrylic acid and 3HP are bulk chemicals, which means that they are produced in high 
amounts and therefore cheap to buy, meaning that they must be produced efficiently in 
order for bio-based production methods to compete with current petrochemical routes 
(Gustavsson and Lee, 2016; Shin et al., 2013).  
3HP is a natural metabolic intermediate in many archaea, as well as in at least one species 
of bacteria (Alber et al., 2006; Hugler et al., 2002; Zarzycki et al., 2009). Chloroflexus 
aurantiacus is a marine, phototrophic bacteria capable of fixing CO2 with 3HP as a 
metabolic intermediate, in what is known as the 3HP cycle (Holo, 1989; Tabita, 2009). It 
has also found to be a metabolic end product in some Lactobacillus species (Sobolov and 
Smiley, 1960; Talarico and Dobrogosz, 1990).  
High 3HP titres from glucose have been reported in engineered bacteria, although 
industrial production in bacterial hosts can be hampered by the requirement for 
fermentations to be carried out at near neutral pH (Abbott et al., 2009; Liu et al., 2018; 
Song et al., 2016). Efficient recovery of acids in bioprocessing is often dependent on the 
acid existing in its undissociated form, which predominates at pH values below the pKa 
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values of the acid (pKa for 3HP is 4.2). Downstream processing costs can therefore be 
minimised by performing fermentations at low pH, making organisms that can natively 
tolerate low pH such as Saccharomyces cerevisiae, attractive hosts for industrial 
production of acids (Van Maris et al., 2004).  
Two biosynthetic pathways have been shown to have promise for 3HP production from 
glucose in S. cerevisiae. One of these pathways utilises malonyl-CoA as a precursor to 3HP 
(Kumar et al., 2013). The malonyl-CoA reductase (MCR) gene from C. aurantiacus has 
been shown to be functional in S. cerevisiae, catalysing the two step reaction of malonyl-
CoA into 3HP via malonic semialdehyde (Alber et al., 2006; Hugler et al., 2002; Kildegaard 
et al., 2016). Natural cytoplasmic levels of acetyl-CoA, the precursor to malonyl-CoA, in 
S. cerevisiae are low and tightly regulated under glucose abundant conditions, with much 
research focussing on increasing cytosolic pools for the production of acetyl-CoA derived 
products (Chen et al., 2013; Kozak et al., 2014; Liu et al., 2017; Lv et al., 2016; Nielsen, 
2014; Shiba et al., 2007). Native acetyl-CoA biosynthesis is dependent on ATP and 
therefore high levels of aeration are required for maximal production (Pronk et al., 1996; 
van Rossum et al., 2016).  
The second pathway passes through β-alanine as an intermediate metabolite. Borodina et 
al., (2015) demonstrated that this pathway is theoretically capable of higher yields than the 
malonyl-CoA pathway, and it is not as dependent on high levels of oxygenation during 
fermentation, making the process more economically attractive. Borodina et al., (2015) 
tested this pathway in vivo in S. cerevisiae, and showed that β-alanine can be produced to 
high levels in yeast through the introduction of a heterologous aspartate-1-decarboxylase 
from Tribolium castaneum, panD. Pyruvate and β-alanine are interconverted to L-alanine 
and malonic semialdehyde via expression of yhxA from Bacillus cereus. In the final 
enzymatic step, Escherichia coli ydfG reduces malonic semialdehyde to 3HP (with 
NADPH as cofactor). The final optimised strain (ST938) produced 13.7 ± 0.3 g L-1 3HP 
in a controlled fed-batch fermentation, representing a 14% C-mol/C-mol yield on glucose. 
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While these results show that S. cerevisiae is a promising cell factory for 3HP production, 
further characterisation is required to enable engineering efforts to reach titres, rates, and 
yields that are required to make the process economically relevant.  
The “-omic” technologies are routinely used for strain characterisation in metabolic 
engineering practices to identify target areas for strain improvement (Petzold et al., 2015). 
In the present study we present the use of transcriptomic and 13C-based metabolic flux 
analysis (MFA) for the characterisation of ST938. We used these data to constrain a 
genome scale metabolic model of ST938 and to predict metabolic engineering strategies 
for achieving improvements in 3HP production.  
2 Materials and methods 
2.1 Strains  
E. coli DH5α was used for cloning, plasmid propagation, and plasmid storage. The 
parental S. cerevisiae strain used as the chassis for strain construction was an auxotrophic 
variant of CEN.PK (MATa ura- his- leu-), obtained as a kind gift from Peter Kötter, 
Johann Wolfgang Goethe University, Frankfurt, Germany. The engineered 3HP 
producing strain, ST938, is taken from the previously published work of (Borodina et al., 
2015). 
2.2 Knock-out cassette construction 
For gene knock-outs, kanMX expression cassettes were amplified from the yeast knock-
out collection for each target knock-out (Giaever et al., 2002). Each strain from the 
collection containing the desired knock-outs was re-streaked from glycerol stocks onto 
YPD agar plates containing 200 mg L-1 G418. Individual colonies were picked and served 
as the template for the amplification of the desired knock-out cassettes. Primers for knock-
out cassette amplification were chosen according to the accompanying materials of the 
knock-out collection. PCR was performed on each knock-out strain, and the successfully 
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amplified cassettes were gel purified before transformation into ST938. Complete lists of 
knock-out cassettes, and primers are included in the supplementary materials. 
2.3 Yeast transformations 
Yeast were chemically transformed with 500 ng of purified gene knock-out cassettes 
according to the lithium acetate method (Gietz and Schiestl, 2007). All transformants were 
selected on synthetic complete agar plates lacking uracil, histidine, and leucine to maintain 
selection pressure in ST938. 200 mg L-1 G418 was added to the synthetic complete (SC) 
agar plates for selection of the gene knock-out cassettes. The agar plates were incubated at 
30 ˚C for 2-3 days, after which time individual colonies were tested by PCR to confirm the 
correct integration of DNA fragment. Primers used for confirmation of insertions can be 
found in the supplementary materials. Correct isolates were then saved as glycerol stocks 
at -80 ˚C. 
2.4 Fermentation conditions and media 
For propagation of the strains from the knock-out collection, either YPD agar, or YPD 
broth containing 200 mg L-1 G418 was used.  YPD was prepared from 20 g L-1 glucose, 20 
g L-1 bacteriological peptone, 10 g L-1 yeast extract, and for agar plates; 10 g L-1 agar was 
added. For propagation of ST938, SC media lacking uracil, leucine, and histidine was 
prepared from SC drop-out powders. Selection and propagation of the knock-out variants 
of ST938 was performed with SC agar plates or SC liquid media, lacking uracil, leucine, 
and histidine, as well as containing 200 mg L-1 G418. Mineral media (MM) for the 
fermentations of the strains was prepared as previously reported, but with 50 g L-1 final 
glucose concentration in the 96-deep well plate screening experiment, and 100 g L-1 in the 
shake flask fermentation experiment (Jensen et al., 2014).  
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Small-scale fermentations were performed in 96-deep well plates, sealed with gas 
permeable membranes (EnzyScreen, Germany). Each strain was inoculated from glycerol 
stock into a 12 mL pre-culture tube containing 5 mL SC media (lacking leucine, uracil, and 
histidine and with G418 supplementation) and left overnight in a shaking incubator set to 
30 ˚C and 250 rpm. The following day, each well was filled with 500 µL of MM, and 
inoculated with the strain pre-cultures to a starting OD600 of 0.05. The 96-deep well plates 
were placed in a shaking incubator (250 rpm, 30 ˚C) for 72 hours, after which time samples 
were taken for analysis. These samples were measured for cellular density at 600 nm on an 
Implen P300 spectrophotometer, spun down at 10,000 x g for 10 minutes, and the 
supernatant stored at -20 ˚C until HPLC analysis of 3HP and selected metabolites was 
performed. Each fermentation was carried out in quadruplicate.  
For the shake flask fermentations, each strain was pre-cultured as for the 96-deep well 
plate fermentations. The following evening the strain cultures were inoculated into baffled 
250 mL shake flasks containing 25 mL of MM with 100 g L-1 glucose to a starting OD600 
of 0.05. The shake flasks were placed in a shaking incubator (300 rpm, 30 ˚C) for a total 
of 96 hours with samples being taken at regular intervals and analysed as described above. 
Each fermentation was carried out in triplicate.  
2.5 Analytical methods 
Quantification of 3HP, glucose, and secreted metabolites was performed via HPLC. 
Samples for analysis were taken, centrifuged, and the supernatant transferred to Nunc 96-
well plates with rubber sealed tops (Thermo Scientific, USA). Samples were separated in 
an Aminex HPX-87H ion exclusion column (Bio-Rad, USA), with a column temperature 
of 60 ˚C and flow rate of 600 µL min-1. A Dionex RI-101 Refractive Index Detector, and 
a DAD-3000 Diode Array Detector at 45 ˚C measured the compounds after separation 
(Dionex, USA). 30 µL of each sample was run for 45 minutes, with 1 mM H2SO4 as the 
eluent.  
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2.6 Chemicals and reagents 
Unless otherwise stated, all reagents and chemicals were purchased from Sigma-Aldrich, 
USA. 
2.7 Transcriptomic and gene set enrichment analysis 
The reference WT strain, and strain ST938 were grown in 1 L continuous cultivation 
bioreactors. After three residence times, biomass samples were harvested and total RNA 
extraction performed as previously described in (Kildegaard et al., 2014). Sequencing 
library preparation and cDNA sequencing was performed also as previously described in 
(Kildegaard et al., 2016). Differential gene expression analysis was performed with TopHat 
(2.0.13), and Cufflinks (2.2.1) with the reference genome for CEN.PK113-7D (Trapnell et 
al., 2012). Gene set enrichment analysis was performed with the goseq package for R, 
taking into account gene length bias (Young et al., 2010). The false discovery rate threshold 
for considering significantly enriched GO terms was set to < 0.05, following the method 
of Benjamini and Hochberg (1995).  
2.8 13C-labelled fermentations and flux analysis 
The labelled glucose fermentations, sample preparation, GC-MS analysis, and metabolic 
flux analysis were performed as previously published (Kildegaard et al., 2016). Cultivations 
were performed in 1 L bioreactors. Experimental fluxes were estimated with the FiatFlux 
toolbox for MATLAB (Zamboni et al., 2005). The calculated fluxes were used to constrain 
the iMM904 genome scale metabolic model of S. cerevisiae (Mo et al., 2009). Beneficial 
gene deletion strategies were predicted through the OptKnock software package 
implemented in the the CAMEO toolbox for Python (Burgard et al., 2003; Cardoso et al., 
2018).  
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2.10 Statistics 
The data generated from the shake flask fermentations were analysed with the GraphPad 
Prism software version 7 (GraphPad Software, Inc.). Statistical significance was calculated 
with Dunnett’s multiple comparisons test for one-way ANOVA. All values are expressed 
as the mean average ± SD. 
3 Results and discussion 
3.1 Transcriptome analysis 
To analyse how high-level production of 3HP affects the physiology of S. cerevisiae, we 
analysed the transcriptomic profile of the high-producer strain (ST938) against the WT 
Figure 1 (See over page). Map of metabolic fluxes and transcriptomic profile of the central 
carbon metabolism of ST938 compared to the WT strain (CEN.PK). Numbers over the reactions 
are the glucose uptake normalised fluxes, with the bold WT value on top, and the engineered 
strain value on the bottom. Key reactions were measured through 13C metabolic flux analysis, 
and the remaining reactions were calculated by fitting a genome scale metabolic model with the 
experimentally determined fluxes. Next to each reaction are the relative transcript levels of the 
main genes involved in each reaction. Genes written in white are heterologous or overexpressed 
genes. Relative transcript levels are taken as the log2 of the ST938/WT levels. Red values signify 
genes that are more highly expressed in ST938, and green values are those more highly expressed 
in the WT strain. Abbreviations: GLC glucose, G6P glucose-6-phosphate, 6PGL D-6-phospho-
glucono-δ-lactone, 6PGC 6-phospho-D-gluconate, RU5P ribulose-5-phosphate, XU5P xylulose-
5-phosphate, R5P ribose-5-phosphate, S7P sedoheptulose-7-phosphate, G3P glyceraldehyde-3-
phosphate, E4P erythrose-4-phosphate, F6P fructose-6-phosphate, FDP fructose-1,6-
diphosphate, DHAP dihydroxy-acetone-phosphate, GLYC3P glycerol-3-phosphate, GLYC 
glycerol, 13DPG 1,3-diphosphateglycerate, 3PG 3-phosphoglycerate, 2PG 2-phosphoglycerate, 
PEP phosphoenolpyruvate, PYRcyt pyruvate (cytosolic), ACALD acetaldehyde, EtOH ethanol, 
AC acetate, PYRmit pyruvate (mitochondrial), ACoAmit acetyl-CoA (mitochondrial), CIT 
citrate, ICIT isocitrate, AKG α-ketoglutarate, SUCCoA succinyl-CoA, SUC succinate, FUM 
fumarate, MAL malate, OAA oxaloacetate, ASP aspartate, B-ALA β-alanine, L-ALA L-alanine, 
MALSA malonic semialdehyde, 3HP 3-hydroxypropionate. 
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parental strain (CEN.PK). These data were generated from samples taken from carbon-
limited continuous cultivations of the WT and ST938 strains. In total 6506 transcripts were 
measured, of which there were 1246 transcripts that were found to be significantly 
differentially expressed (to a q value < 0.05) between ST938 and the parental WT strain.  
As shown in Figure 1, much of the central carbon metabolism pathways appear to be 
upregulated in ST938, particularly the reactions involved in glycolysis. ST938 exhibits a 
higher glucose uptake rate than the WT strain (0.659 vs. 0.463 mmol-1 cDW-1 h-1), and so 
this may cause genes involved in glucose assimilation to be upregulated in response. The 
hexokinases have a high degree of flux control over glycolysis, and their overexpression 
may then greatly increase the metabolism of glucose (Smallbone et al., 2013) UBC8, a gene 
involved in the negative regulation of gluconeogenesis, is significantly down-regulated in 
ST938, suggesting that this strain is under lower levels of glucose repression than WT. 
Most of the genes related to gluconeogenesis are also upregulated, although those involved 
in the glyoxylate cycle were not.  
Several degradation of allantoin (DAL) genes were significantly upregulated in ST938, with 
DAL2-6 showing higher than WT levels. The related degradation of urea gene DUR3, is 
also highly upregulated in ST938, suggesting that this strain is utilising the available 
nitrogen in the media faster than the WT, with the lower free nitrogen levels relieving 
nitrogen catabolite repression. Genes related to proline utilisation (PUT1, PUT2) were also 
found to be significantly upregulated compared to WT further indicating that the 
additional protein burden on ST938 may contribute to nitrogen starvation responses.  
There were only two annotated membrane transporters that were upregulated in ST938, 
one of them being MCH5. MCH5 encodes a plasma membrane transporter known to 
facilitate riboflavin transport in S. cerevisiae (Reihl and Stolz, 2005). The monocarboxylate 
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transporter-homologous (Mch) family of proteins have been reported to not transport 
monocarboxylic acids in yeast, although these results are those based on the uptake of 
lactate, pyruvate, and acetate, for which there exist other transporters such as Jen1p (Casal 
et al., 2008; Makuc et al., 2001). Further research would be needed to confirm that the Mch 
family are not involved in 3HP transport, and is only functioning to increase riboflavin 
uptake. Jen1p is the main transporter for pyruvate and lactate, and represents a candidate 
for 3HP transport due to 3HP’s chemical similarity to both these, although transcript levels 
in this study were not found to be significantly different between the WT and ST938 
strains. Genes related to acid stress such as; YAP1, MSN2, MSN4, and PDR12, did not 
show significant differences between the tested strains. Due to the cultivations being 
performed in a pH controlled bioreactor, it is expected that the strains should not 
experience significant acid stress.  
We performed a gene set enrichment analysis on ST938 using the gene ontology (GO) 
goseq package for R (Young et al., 2010). Gene set enrichment analysis can highlight 
functions that are over- or under-represented in a transcriptional data set, generating a 
high-level understanding of the regulatory processes within the host cell. Our analysis of 
ST938 is shown in Figure 2, with the GO identifiers referring to biological processes, 
cellular component, and molecular function terms. Many GO terms are significantly 
downregulated in ST938 vs. the WT strain, with many of these terms being related to 
cellular maintenance, such as ribosome processes, peptide biosynthesis and translation, 
and RNA processing. This apparent downregulation of protein production is perhaps 
linked to the introduction of the heterologous pathway. In particular, tcPanD is introduced 
into the yeast Ty4 retrotransposon site and is therefore present in multiple copies. High 
protein expression may cause metabolic stress to the host cell, thereby reducing the 
efficiency of production (Dürrschmid et al., 2008; Haddadin and Harcum, 2005; 
Hoffmann and Rinas, 2004). 
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Figure 2. Gene ontology enrichment analysis of ST938. The transcriptomic profiles of the WT 
strain and strain ST938 were used to generate gene sets that were under-represented (A), and 
over-represented (B) compared to the WT. Shown are all categories that had a false discovery 
rate < 0.05. The x axis shows the –log10 of the p values, where a higher –log10(p) value indicates 
a category with a higher statistical probability of being significant. 
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3.2 13C-based metabolic flux analysis 
While informative, transcriptomic data is unable to provide information on metabolic 
fluxes. Therefore, we examined the metabolism of ST938 through 13C-MFA. The 
experimentally derived fluxes were used to constrain the iMM907 genome-scale metabolic 
model (GEM) of S. cerevisiae (Mo et al., 2009), which we used to predict fluxes throughout 
the reaction network of ST938 (Figure 1). Our analysis shows that there are large changes 
between ST938 and the WT strain in the PP pathway, the TCA cycle, and the first steps 
of gluconeogenesis. The flux ratios through upper and lower glycolysis are close to 
identical in the WT strain and ST938. However, perhaps due to the increased uptake of 
glucose in ST938 (0.463 vs. 0.659 mmol-1 cDW-1 h-1), more flux gets diverted into the PP 
pathway to cope with the additional carbon flux. 
Higher flux is carried through pyruvate decarboxylase in ST938, although it produces less 
acetate than the WT strain. The additional flux is predicted to be channelled into acetoin 
biosynthesis. This observation is backed by the transcriptomic data, where the gene 
involved in the conversion of acetoin to butanediol, BDH1, is significantly up-regulated in 
ST938.  
The TCA cycle carries relatively less flux in ST938, compared to the WT strain. This effect 
is to be expected with the overexpression of pyruvate carboxylase genes. The resultant 
pool of oxaloacetate, cannot be fully converted to 3HP, and some of the excess flux is 
diverted through the phosphoenolpyruvate carboxykinase - Pck1p. The transcript levels 
of PCK1, are on the other hand, significantly lower in ST938 than in the WT. PCK1 is 
known to be regulated by Mcm1p and Cat8p, and while the levels of MCM1 mRNA 
remained almost the same between ST938 and the WT, CAT8 mRNA levels were 
significantly lower in ST938. CAT8 is normally expressed during the shift from 
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fermentative to oxidative metabolism (diauxic shift), and de-represses a range of genes 
involved in gluconeogenesis and ethanol utilisation (Haurie et al., 2001).  
3.3 Data-guided modification of ST938 
After analysis of both the transcriptomic and fluxomic data, we identified genes of interest 
that could be related to the performance of the 3HP pathway. We used the OptKnock 
algorithm on the 13C-MFA constrained GEM of yeast to predict gene deletion strategies, 
along with insights from the transcriptomic data set (Burgard et al., 2003). The OptKnock 
algorithm predicted four different gene deletion strategies; PSD1 – encoding a 
mitochondrially located phosphatidylserine decarboxylase, PGI1 – encoding a 
phosphoglucose isomerase responsible for an early step in glycolysis, OSM1 – encoding 
two forms of fumarate reductase, one locating to the mitochondria and the other to the 
endoplasmic reticulum, and JEN1 – encoding a monocarboxylate transporter (Aguilera 
and Zimmermann, 1986; Casal et al., 1999; Clancey et al., 1993; Muratsubaki and 
Enomoto, 1998). An additional knockout strategy was tested based on a highly 
overexpressed transcript in ST938, PRY1 – a gene encoding a protein implicated in 
acetylated sterol export (Choudhary and Schneiter, 2012).  
3.4 Fermentation profiles of knock-out designs 
After knock-out strains had been successfully constructed from the ST938 host via the 
disruption of the target genes by insertion of a kanMX cassette, they were screened for 
3HP production via microtitre plate fermentations. Out of the five gene deletion strategies 
that were tested, two of these (PSD1 and OSM1) showed only minimal 3HP production 
under microtitre plate fermentations (see Figure S3). The remaining three knock-out 
strains were further tested in shake flask fermentations in batch media containing 100 g L- 
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1 glucose. Each fermentation profile can be found in Figure 3, and a list of fermentation 
characteristics can be found in Table 1.  
The JEN1 knockout strain, ST8717, is predicted to increase 3HP production by the 
OptKnock algorithm as this gene is linked to reactions that transport lactate and pyruvate 
out of the cell, and thus the deletion of it should redirect flux into 3HP production. Jen1p 
is a monocarboxylate transporter, and its deletion completely prevents the uptake of both 
lactate and pyruvate in a WT strain suggesting that this is the only functional transporter 
for the uptake of both these monocarboxylates (Akita et al., 2000; Casal et al., 1999). Due 
to the close chemical similarity between lactate and 3HP, Jen1p is a candidate for 3HP 
transport in yeast. If Jen1p is involved in 3HP export then it would be expected that a 
knock-out would reduce 3HP titres, and an intracellular build up of 3HP would cause the 
host to be growth impaired. ST8717, showed only a slightly reduced growth rate compared 
 ST938 
ΔPGI1 
(ST8714) 
ΔJEN1 
(ST8717) 
ΔPRY1 
(ST8718) 
Growth Rate (h-1) 0.243 ± 0.004 0.198 ± 0.004 **** 0.231 ± 0.001 ** 0.234 ± 0.004 * 
Final OD600 66.33 ± 1.53 41.00 ± 1.73 **** 68.33 ± 2.31 ns 61.33 ± 1.53 * 
3HP (g L-1) 1.21 ± 0.06 0.68 ± 0.05 **** 1.15 ± 0.04 ns 1.54 ± 0.06 *** 
Peak ethanol (g L-1) 32.05 ± 1.14 35.06 ± 2.03 ns 37.79 ± 1.26 ** 34.14 ± 1.75 ns 
Glycerol (g L-1) 3.67 ± 0.19 7.03 ± 0.61 **** 4.53 ± 0.20 ns 2.92 ± 0.34 ns 
Acetate (g L-1) 5.95 ± 0.36 4.21 ± 0.26 ** 5.53 ± 0.30 ns 6.33 ± 0.53 ns 
Table 1. Fermentation characteristics of strains used in this study. Three gene deletion strategies 
were successfully implemented in the parental ST938 strain. Each value is the mean average 
with standard deviation of shake flask experiments performed in triplicate. Each value is 
evaluated for statistical significance compared to the control group (ST938). **** p ≤ 0.0001, 
*** p ≤ 0.001, ** p ≤0.01, * p ≤ 0.05, ns = non significant. 
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to ST938 (0.231 h-1 ± 0.001 vs. 0.246 h-1 ± 0.004). At the end of 96 hour shake flask 
fermentations containing 100 g L-1 glucose, the final optical density is also very close to 
the parental strain ST938, suggesting that this modification is only slightly detrimental to 
cellular growth and biomass accumulation. However, final 3HP titres were not significantly 
different in ST8717 (1.15 ± 0.04 vs. 1.21 ± 0.06 g L-1) indicating that this is not a successful 
strategy to increase 3HP production. This result does, however, suggest that Jen1p is not 
responsible for the majority of 3HP export in S. cerevisiae as there was no significant drop 
in 3HP titre which is not what might be expected if Jen1p were the major transporter for 
this molecule. Glycerol and acetate production did not appear to be significantly influenced 
by this gene deletion, but maximum ethanol titres were slightly higher than ST938. Further 
work is needed to identify the 3HP export mechanisms in S. cereviasiae, which may then 
lead to targets for improving export rates, in turn improving the production capabilities of 
the host strain. Several carboxylate transporters have been identified in S. cerevisiae and 
other yeasts, and further research may elucidate one that are optimal for 3HP transport 
(Casal et al., 2008). 
A deletion of the phosphoglucose isomerase gene PGI1 appears as an interesting strategy 
for increasing 3HP production in ST938. Pgi1p catalyses the interconversion of glucose-
6-phosphate into fructose-6-phosphate, feeding into upper glycolysis. Disruption of this 
reaction diverts flux through the PP pathway (Fiaux et al., 2003). However, a deletion of 
PGI1 renders S. cerevisiae incapable of growth on glucose as the sole carbon source 
(Aguilera, 1986). The cause for this is growth defect is thought to be the exhaustion of 
NADP+ through the PP pathway that reduces 2 moles of NADP+ per mole of glucose 
(Boles et al., 1993). The expression of a heterologous transhydrogenase from E. coli, 
UdhA, can restore the ability of a PGI1 deletion mutant to grow on on glucose – albeit at 
a decreased growth rate of 0.15 h-1 (Fiaux et al., 2003). The final step in the 3HP production 
pathway of ST938 is the conversion of malonic semialdehyde to 3HP with the coupled 
generation of 2 moles of NADP+ per mole of glucose. 3HP production via this pathway 
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is therefore capable of regenerating the NADP+ required for glucose oxidation through 
the PP pathway, and can couple glucose assimilation to product formation. Increased flux 
through the PP pathway should reduce the formation of ethanol, and increase the flux to 
product formation (Heux et al., 2008). We successfully created a PGI1 knock-out in ST938 
(ST8714), and as expected this strain had a lower growth rate compared to the parental 
strain (0.198 h-1 ± 0.004 vs. 0.246 h-1 ± 0.004), though this was considerably higher than 
that reported in the bacterial transhydrogenase overexpression strain constructed by Fiaux 
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Figure 3. Shake flask fermentations of engineered ST938 strains carrying predicted beneficial 
gene deletions. a) the fermentation profile for the parental strain 3HP producing strain ST938. 
b) the PGI1 deletion strain, ST8714. c) the JEN1 deletion strain, ST8717. d) the PRY1 deletion 
strain, ST8718. Each strain was fermented for 96 hrs in defined mineral media containing 100 g 
L-1 initial glucose concentrations. Each cultivation was performed in triplicate, with the error 
bars showing the standard deviation for each measurement.  
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et al., (2003). Total biomass accumulation was much lower for this strain compared to the 
parental strain. Under shake flask fermentations containing 100 g L-1 glucose, ST8714 
could only reach a final optical density of approximately 60% of ST938 (OD600 41 ± 1.73 
vs. 66 ± 1.53). 3HP production was also greatly reduced in ST8714, producing only ∼50% 
as much as ST938 (Table 1). Glycerol production on the other hand was greatly increased, 
with ∼100% more glycerol excreted by the end of the fermentation, indicating that this 
strain may have higher levels of NADH than ST938, that is then reoxidised through 
glycerol formation (Ansell et al., 1997; Nissen et al., 2000). In spite of such low 3HP titres, 
this strategy may show promise for future engineering attempts as ST8714 was able to fully 
utilize the glucose in the media with a decreased amount of carbon flux diverted into 
biomass accumulation. Further work is needed to better characterize this strain, as such a 
shift in carbon assimilation will cause wide reaching effects on regulatory mechanisms and 
metabolic pathways. The higher glycerol production indicates that ST8714 may have a 
redox imbalance, or subject to other stressors, and identification strategies to relieve these 
may boost 3HP titres and productivity.  
PRY1 was highly upregulated in ST938 vs. the WT strain in fed batch bioreactor 
fermentations. Pry1p has been identified as a secreted protein that binds acetylated sterols, 
and facilitates their solubilisation and transport out of the cell (Choudhary and Schneiter, 
2012). Mutants deficient in PRY1 have also been shown to be hypersensitive to eugenol, 
suggesting that Pry1p can also bind small hydrophobic molecules, helping in their 
detoxification (Choudhary and Schneiter, 2012). However, in a S. cerevisiae isolate tolerant 
to the organic solvent isooctane, PRY1 was significantly downregulated (Miura et al., 
2000). For these reasons, PRY1 deleted to investigate its role in 3HP production. Our 
PRY1 knockout strain, ST8718, showed a slightly reduced growth rate and biomass 
accumulation compared to the parental strain and had a 12 hour longer lag phase than any 
of the other tested strains (Figure 3d). The levels of secreted products were similar between 
4 Conclusions and future perspectives 
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ST938 and ST8718, but after 96 hours ST8718 had produced ~27% more 3HP. The cause 
for the increase in 3HP titres is not immediately evident from the limited literature on 
Pry1p function, but it appeared to continue producing ethanol into the ethanol utilisation 
stage of the fermentation. Due to the relatively little change in secreted products, it may 
be assumed that Pry1p does not directly affect the central carbon metabolism, and that its 
role in either acetylated sterol transport or stress response pathways influence 3HP 
production. It is possible that such a deletion may cause the strain to be less resistant to 
stresses faced during fermentation, which may limit its beneficial impact when 
fermentations are scaled up and increasing stresses are faced by the cells. We tested ST8718 
against ST938 for their abilities to withstand different stress factors. A spot test revealed 
that ST8718 had much less robust growth than ST938 on the plates even under control 
conditions. While ST938 growth was relatively unaffected by an incubation temperature 
of 37 ˚C or the addition of 2 mM H2O2, ST8718 was more sensitive to both of these 
stresses (Figure S4). Interestingly however, ST8718 appeared slightly less affected than 
ST938 when subjected to stress from high (30 g L-1) 3HP concentrations.  
4 Conclusions and future perspectives 
Through this study we have provided data on the transcriptional and flux level activities 
of a yeast strain capable of high-level production of 3HP (ST938). From the transcriptional 
analysis we discovered that much of the central carbon metabolism was upregulated in 
ST938. The relative carbon flux through the PP pathway was increased in ST938, while it 
was decreased in the TCA cycle, with more pyruvate flux being successfully diverted into 
oxaloacetate.  
We showed that the 3HP pathway was sufficient to enable the growth of a PGI1 deletion 
strain on glucose. Although higher production of 3HP was not achieved in this strain, it 
provides an example of how it may be able to couple flux through the PP pathway to 3HP 
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production, and further work on this may lead to a PGI1 deletion strain that can be an 
efficient host. The monocarboxylic acid transporter JEN1 is perhaps a likely candidate for 
3HP transport owing to the similar chemical structures of these compounds. We tested 
the effect of Jen1p on 3HP production and found that it is unlikely to be involved in the 
export of 3HP. We also tested the impact of PRY1 deletion on 3HP titres and this was 
found to improve final 3HP titres by ~27%, although the exact causes for this 
improvement are unclear. Pry1p has been implicated in stress responses and may as such 
have an indirect impact on 3HP biosynthesis.  
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Figure S1. Correlation analysis of the WT vs. ST938 transcriptomes. Values shown are the log2 
transformed gene expression values for each strain. Both strains were grown in 1 L bioreactors, 
with samples taken for RNAseq analysis once the strains had reached steady state. 
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Figure S3. Impact of computationally predicted gene knock-out strategies on the in vivo 
production of 3HP. Five gene knock-out strategies were implemented into the parental 3HP 
producer ST938. ST8713 - ∆PSD1, ST8714 - ∆PGI1, ST8716 - ∆OSM1, ST8717 - ∆JEN1, 
ST8718 - ∆PRY1. Each strain was cultivated in 96-deep well plates in quadruplicate in defined 
mineral media containing 50 g L-1.  
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Figure S2. Volcano plot of the RNAseq data for ST938 and the WT strain. The vertical dotted 
lines represent where the log2 fold change of gene expression is 2, or -2. Above the horizontal 
dotted line is where the results fall below the false discovery rate (q-value) significance threshold 
of 0.05.  
 
 
 
 157 
 
Figure S4. Stress tolerance of a PRY1 deletion in ST938. The parental 3HP producing strain 
ST938 was compared to the PRY1 deletion strain ST8718 for the inhibition of growth due to 
different stressors. Both strains were serially diluted (10-1, 10-2, 10-3, 10-4, 10-5, 10-6) from 
samples set to the same optical density (OD600 6). The strains were spotted for growth on; YPD 
at 30 ˚C (the control plate), YPD at 37 ˚C, YPD supplemented with H2O2 to a final concentration 
of 2mM at 30 ˚C, and YPD supplemented with 3-hydroxypropionic acid (3HP) to a final 
concentration of 30 g L-1. 
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Table S1. Primers used in this study 
Name Sequence (5’ -> 3’) 
PSD1_KO_fw 
PSD1_KO_rv 
PGI1_KO_fw 
PGI1_KO_rv 
NDP3_KO_fw 
NDP3_KO_rv 
FRDm_KO_fw 
FRDm _KO_rv 
L_LACt2r_KO_fw 
L_LACt2r_KO_rv 
PRY1_KO_fw 
PRY1_KO_rv 
ScAAT2_U1_fw 
ScAAT2_U1_rv 
PTEF1_fw 
PTEF1_rv 
TcPAND_U1_fw 
TcPAND_U1_rv 
PPGK1_rv 
EcYdfg_U2_fw 
EcYdfg_U2_rv 
BcBAPAT_U1_fw 
BcBAPAT_U1_rv 
ScPYC1_U1_fw 
ScPYC1_U1_rv 
ScPYC2_U2_fw 
ScPYC2_U2_rv 
ADH1_test_fw 
CYC1_test_rv 
TADH1_towards out 
X-4-up-out-sq 
XI-1-up-sq 
XII-1-up-out-sq 
GTAATCACATATCACATGCAGGGTA     
TCATGATGAATAATGCAAAACTCAAGAA      
GTGTGGGTGTATTGGATTATAGGAA      
TCAGGTATACTGGAGGCTTCATGAGTTA     
ACATTCTTGACATCTCAGCTTCTCT     
TCATTGGTAGATGTTCTTCTAGATTGGC      
TGAAGTAAAATAGTGATCGGGACTC      
TCAGTCATTCAGTTTGTTAGAAGAGGGA      
TATTCTCCACCAGGAAGTTAGTTTG      
TCAATTGTCTTATAGTGGCAAAAGCAAG  
ACCCATACCATATATAAACCCACCT 
TCAATTAAATTGAAATTGTCGAGTGTCG      
AGTGCAGGUAAAACAATGTCTGCCACTCTGTTCA 
CGTGCGAUTTACAATTTAGCTTCAATAGTATAG  
ACCTGCACUTTGTAATTAAAACTTAG 
CACGCGAUGCACACACCATAGCTTC   
AGTGCAGGUAAAACAATGCCAGCTACTGGTG  
CGTGCGAUTCACAAATCGGAACCCAATC      
ATGACAGAUTTGTTTTATATTTGTTG 
ATCTGTCAUAAAACAATGATCGTTTTAGTAACTGGAG 
CACGCGAUTTACTGACGGTGGACATTC 
AGTGCAGGUGCATGGTACCAAAACAATG 
CGTGCGAUATGAGGCCCAGGTCGAC 
AGTGCAGGUAAAACAATGTCGCAAAGAAAATTCG 
CGTGCGAUTCATGCCTTAGTTTCAACAG 
ATCTGTCAUAAAACAATGAGCAGTAGCAAGAAATTG 
CACGCGAUTTACTTTTTTTGGGATGGG 
GAAATTCGCTTATTTAGAAGTGTC 
CTCCTTCCTTTTCGGTTAGAG 
GTTGACACTTCTAAATAAGCGAATTTC 
CTCACAAAGGGACGAATCCT 
CTTAATGGGTAGTGCTTGACACG 
CTGGCAAGAGAACCACCAAT 
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Table S2. Strains used in this study 
Name ID Description Source 
WT CEN.PK ST001 CEN.PK WT strain without suxotrophies. Petter Kötter 
ST938 ST938 
 
 
Strain shown to produce high levels of 3HP through the 
β-alanine pathway of 3HP biosynthesis 
(Borodina et al., 2015) 
ST938ΔPSD1 ST8713 Deletion of PSD1 in strain ST938. PSD1 encodes a 
phosphatidylserine decarboxylase localised to the 
mitochondrial inner membrane. 
This study 
ST938ΔPGI1 ST8714 Deletion of PGI1 in strain ST938. PGI1 encodes 
phosphoglucose isomerase that converts glucose-6-
phosphate to fructose-6-phosphate in early glycolysis. 
This study 
ST938ΔOSM1 ST8715 Deletion of OSM1 in strain ST938. OSM1 encodes 
fumurate reductase, reducing fumurate to succinate. 
Located to both the cytosol and to the endoplasmic 
reticulum. 
This study 
ST938ΔJEN1 ST8717 Deletion of JEN1 in strain ST938. JEN1 encodes a 
monocarboxylate transporter responsible for lactate, 
pyruvate, and acetate. 
This study 
ST938ΔPRY1 ST8718 Deletion of PRY1 in strain ST938. PRY1 encodes a 
secreted protein involved in the transport of acetylated 
sterols. 
This study 
 
Table S3. Calculated central carbon fluxes  
 WT ST938 
Reaction Flux (mmol-1 cDW-1 h-1) StdErr 
Flux 
(mmol-1 cDW-1 h-1) StdErr 
GLC + ATP -> G6P 0.463 0.081 0.659 0.037 
G6P -> P5P + 2*NADPH +CO2 0.154 0.038 0.244 0.034 
G6P -> F6P 0.232 0.062 0.316 0.045 
F6P + ATP -> 2T3P 0.321 0.086 0.463 0.066 
2P5P -> S7P + T3P 0.05 0.013 0.08 0.012 
P5P + E4P -> F6P + T3P 0.039 0.013 0.067 0.013 
S7P + T3P -> E4P + F6P 0.05 0.013 0.08 0.012 
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T3P -> Ser + NADH 0.021 0.015 0.023 0.016 
Ser + NADH -> Gly + C1 0.029 0.023 0.022 0.018 
Gly + C1 -> Ser + NADH 0.016 0.012 0.008 0.006 
C1 + CO2 + NADH -> Gly 0 0.001 0 0.001 
T3P -> Pep + ATP + NADH 0.646 0.184 0.954 0.145 
PEP -> cytPYR + ATP 0.671 0.199 1.034 0.163 
mitPYR -> mitAcCoA + CO2 + NADH 0.316 0.154 0.417 0.133 
mitOAA + mitAcCoA -> CIT 0.309 0.154 0.41 0.133 
CIT -> OGA + CO2 + NADH 0.309 0.154 0.41 0.133 
OGA -> SUC + CO2 + 0.5ATP + NADH 0.27 0.129 0.353 0.111 
SUC -> FUM + NADH 0.27 0.129 0.353 0.111 
MAL -> mitOAA + NADH 0.248 0.12 0.317 0.099 
FUM -> MAL 0.27 0.129 0.353 0.111 
MAL -> mitPYR + CO2 + NADPH 0.023 0.012 0.036 0.019 
cytOAA + ATP -> PEP + CO2 0.049 0.017 0.106 0.023 
cytPYR + CO2 + ATP -> cytOAA 0.164 0.067 0.265 0.067 
acetate + 2ATP -> cytAcCoA 0.058 0.056 0.068 0.057 
Acetaldehyde -> acetate + NADPH 0.118 0.06 0.104 0.072 
Acetaldehyde + NADH -> ethanol 0 0.001 0 0.001 
T3P + NADH -> glycerol 0 0.001 0 0.001 
cytOAA -> mitOAA 0.099 0.047 0.163 0.05 
mitOAA -> cytOAAc 0.038 0.018 0.07 0.022 
cytPYR -> mitPYR 0.381 0.153 0.491 0.127 
cytPYR -> Acetaldehyde + CO2 0.118 0.06 0.104 0.072 
O2 + 2NADH -> 2P/O x ATP 1.038 0.423 1.411 0.348 
cytAcCoA +CO2 + 2 NADPH + ATP -> 3HP 0 0.001 0.164 0.029 
Biomass 0.041 0.001 0.044 0.01 
 
 
 
Table S4. Results from RNAseq. Transcripts which displayed significance (q < 
0.05), and had the highest Log2 fold changes (> 2) are displayed in the table. 
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Table S4. Results from RNAseq. Transcripts which displayed significance (q < 
0.05), and had the highest Log2 fold changes (> 2) are displayed in the table. 
Gene Name Gene ID Log2 Fold Change (ST938/WT) q-value 
APC4 YDR118W-A -3.49018 0.00108252 
ECM23 YPL021W -3.33541 0.0178557 
CRS5 YOR031W -3.30663 0.00108252 
BOP2 YLR267W -3.10454 0.00108252 
YMR244W YMR244W -3.00294 0.00108252 
YIL171W-A YIL171W-A -2.99842 0.00108252 
SRL4 YPL033C -2.97583 0.00108252 
CUP2 YGL166W -2.9576 0.00108252 
SPO20 YMR017W -2.94711 0.00108252 
URA3 YEL021W -2.87919 0.00108252 
YNR064C YNR064C -2.85443 0.00108252 
SPG1 YGR236C -2.78502 0.00108252 
YMR320W YMR320W -2.73402 0.00513697 
YNR063W YNR063W -2.66495 0.00108252 
PHO89 YBR296C -2.66128 0.00108252 
SPO74 YGL170C -2.63423 0.00108252 
YPT53 YNL093W -2.59801 0.00108252 
YOR019W YOR019W -2.5753 0.00108252 
YGR051C YGR051C -2.5702 0.00108252 
BDF2 YDL070W -2.53291 0.00108252 
SPG5 YMR191W -2.47289 0.00336367 
ADY2 YCR010C -2.44088 0.00108252 
YHR022C YHR022C -2.43229 0.00108252 
YMR018W YMR018W -2.4242 0.00108252 
RGI2 YIL057C -2.3857 0.00192982 
DSF1 YEL070W -2.3777 0.00108252 
YNL033W YNL033W -2.36218 0.00108252 
UTR5 YEL035C -2.34454 0.00570254 
ECM12 YHR021W-A -2.34181 0.00622172 
Table S4. Results from RNAseq. Transcripts which displayed significance (q < 
0.05), and had the highest Log2 fold changes (> 2) are displayed in the table. 
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NDJ1 YOL104C -2.34029 0.00459692 
YET2 YMR040W -2.33981 0.00108252 
YGR050C YGR050C -2.30282 0.00108252 
NGL3 YML118W -2.22753 0.00108252 
CSM4 YPL200W -2.1432 0.00108252 
YOR214C YOR214C -2.12186 0.020639 
CDC31 YOR257W -2.1123 0.00108252 
ALT2 YDR111C -2.101 0.00108252 
UFE1 YOR075W -2.09601 0.00108252 
YER184C YER184C -2.04174 0.00108252 
DAN1 YJR150C -2.03683 0.00108252 
YER187W YER187W -2.02159 0.00192982 
RNR3 YIL066C -2.021 0.00108252 
BAP2 YBR068C -2.01647 0.00108252 
NCE101 YJL205C -2.00146 0.00810498 
PRY1 YJL079C 2.019 0.00108252 
DAL5 YJR152W 2.42409 0.00769654 
MCH5 YOR306C 2.51504 0.00108252 
SCW4 YGR279C 2.58759 0.00108252 
PYC1 YGL062W 2.62953 0.00108252 
PUT1 YLR142W 2.7411 0.00108252 
PUT2 YHR037W 3.25557 0.00108252 
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5 Conclusions and Future Perspectives 
The work that has been presented in this thesis has aimed to contribute towards metabolic 
engineering efforts in Saccharomyces cerevisiae. I have presented three research studies 
into the engineering of S. cerevisiae for the production of hydroxy acids. In the following 
section I will attempt to provide a summary of these works, along with a view for the 
future development of the yeast cell factory. 
 
New tools for genetic engineering have been presented in Chapter 2, with the EasyClone-
MarkerFree methodology. This study provides a CRISPR-Cas9 toolkit for the 
chromosomal integration of genes without the requirement marker insertion, and also aims 
to advance standardisation within the field by using the standard EasyClone integration 
sites and cloning methodology. Genomic integration is a prerequisite for reproducibility as 
plasmid based systems are inherently noisy (Jensen et al., 2014). The use of defined, 
characterised, and standardised integration sites is also a prerequisite, as different sites of 
integration will show different expression profiles (Jessop-Fabre et al., 2016). It is hoped 
that this toolkit offers a user friendly method for genome engineering in yeast and will be 
used by the yeast community for engineering strains. In this paper, we used our 
methodology to test three different cytosolic acetyl-CoA supply strategies for improving 
3-hydroxypropionic acid (3HP) production in yeast. From this we discovered that the 
expression of a bacterial pyruvate dehydrogenase complex was able to increase 3HP titres 
by up to 95%. This result is a promising first step into the further engineering of this 
pathway to 3HP biosynthesis. Further study into this pathway is needed to resolve how 
this strategy helps to boost 3HP, and perhaps offer insights into how this process may be 
further optimised. Research into acetyl-CoA supply is also relevant for the production of 
many other chemicals, such as fatty acid ethyl esters that use acetyl-CoA as a building block 
for their production. 
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Chapter 3 presents research into the production of hydroxy acids in a Crabtree-negative 
strain of S. cerevisiae, the TAM strain (van Maris et al., 2004). This study uses metabolic 
flux analysis to uncover the metabolic changes that occur in the host strain when 
heterologous pathways for hydroxy acid production are inserted. We hope is that this data 
can help guide future engineering attempts in the TAM strain background. Currently, not 
much research has been done into the use of this host strain for 3HP production, but our 
results show that it may be a promising line of further inquiry. Learning from how the 
introduction of lactate production can restore some of the growth defects of the TAM 
strain may lead to novel strategies for 3HP production, and increase the productivity of 
this host beyond that of the WT background. At the centre of this is likely to be the detailed 
analysis and engineering of the redox cycles, that are of unquestionable importance to 
product formation strategies in yeast. 
 
In the final chapter of research, metabolic flux and transcriptomic analysis is used to 
characterise another 3HP producing strain, ST938. We present the results of this analysis, 
highlighting where there may be issues that are hindering higher 3HP titres. We used 
computational prediction algorithms to generate gene deletion strategies from the 
metabolic flux analysis that would be capable of improving the performance of ST938. It 
was however, a prediction gained from the transcriptomic data that yielded a strain with 
improved production capabilities. The deletion of PRY1 increased 3HP titres by 27%, but 
the role of this gene is not well characterised. Implicated in the transport of acetylated 
sterols out of the cell, questions remain as to the mechanisms behind the improved 3HP 
titres. Further study into the effects of this gene deletion in the production of other 
compounds may help to determine the role of this gene. Further analysis into the effects 
that this deletion has on the fitness of the strain is also desirable, as such a deletion may 
prove deleterious to the performance of the strain under stresses faced in large scale 
fermentations. We also created a PGI1 deletion strain. In a WT strain, deletion of PGI1 
prevents growth on glucose (Aguilera, 1986). However, the recycling of NADPH by the 
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3HP pathway allowed for the strain to still growth on glucose as the sole carbon source 
after deletion of PGI1. Although this strain did not produce high 3HP titres, it does open 
the door to future strategies to engineer the pentose phosphate pathway for increasing flux 
to 3HP. Finally, we deleted a monocarboxylate transporter gene, JEN1, and showed that 
this does not decrease the production of 3HP, providing evidence that this transporter is 
not likely to be involved in 3HP secretion. Inefficient product transport can negatively 
impact on the productivity of the host strain, and therefore the elucidation of native and 
heterologous transporters can help to improve the efficiency of biochemical production 
(Pérez-García and Wendisch, 2018; Zelle et al., 2008). Hence, the further study of 3HP 
transport mechanisms in yeast is a promising area of future research to increase the 
performance of ST938. 
 
The yeast, S. cerevisiae, has long been used in industrial processes for the production of 
ethanol, both in the beverage industry, and also for the production of bioethanol (Mohd 
Azhar et al., 2017). It has become a staple in the biopharmaceutical industry, too, for 
example in the production of recombinant proteins (Ferrer-Miralles et al., 2009; Nielsen, 
2013). In order to fully realise the potential of yeast as a production organism, it is 
necessary to gain a full and detailed understanding of its metabolism, and physiology. To 
gain this understanding, tools must be concurrently developed to engineer, analyse, and 
model the host. Great steps are being taken in all areas, with genetic tools allowing for 
facile gene insertions, deletions, and manipulations (Jakočiūnas et al., 2015; Kim et al., 
2016; Mans et al., 2015; Reider Apel et al., 2017; Sander and Joung, 2014; Vanegas et al., 
2017). Techniques are rapidly being developed that allow for fine control over pathway 
expression, and complex regulatory behaviour (Ajikumar et al., 2010; Dueber et al., 2009; 
Jones et al., 2015; Lee et al., 2013).  
 
-Omic analyses are now offering metabolic engineers an unprecedented amount of 
information over their strains (Alonso-Gutierrez et al., 2015; Chen and Nielsen, 2013; 
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Giaever et al., 2002; Kildegaard et al., 2016; van Maris et al., 2004; Petzold et al., 2015). 
Metabolic models are constantly being refined, with data from omic technologies helping 
to inform and improve those models (Chandrasekaran and Price, 2010; Fong et al., 2005; 
Heavner et al., 2013; Hucka et al., 2003; MacDonald et al., 2011). Steps too are being taken 
to minimise the amount of scientist man-hours that are currently spent on strain 
engineering by automating strain design and construction. Automation can take over the 
tedious, time-consuming, and error-prone tasks in routine metabolic engineering practices 
(Carbonell et al., 2018; Shih et al., 2015; Si et al., 2017). Scientists have then more time to 
focus on generating novel hypotheses, while at the same time producing more reproducible 
data. Many of these technologies, while progressing rapidly, are still in nascent form. 
Research must continue to be applied in these areas, and where possible are adapted to 
suit high throughput techniques.  
 
With the rapidly decreasing costs of DNA synthesis, cloning may soon not be a time-
consuming endeavour for laboratory scientists. Focus will then be shifted to the creation 
of ever larger libraries based on computational design strategies. Key to this will be the 
development of design of experiment tools that will be able to predict strategies capable 
of efficiently probing the possible phenotypic space. Coupled to this will be the need for 
ever improved methods for high throughput analysis of the created strains, both in the 
physical analysis, and in the computational methods needed to sift through the vast arrays 
of data generated.  
 
Undoubtedly, ever larger quantities of data will be produced, and so computational 
methods will need to keep pace, to integrate new data, and importantly, to draw lessons 
from them. The field of machine learning will need to be seamlessly woven into the fabric 
of metabolic engineering to predict new strain designs from generated data sets (Costello 
and Martin, 2018; Cuperlovic-Culf, 2018). Much work is still needed to increase the 
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modularity, orthogonality, and predictability of biological circuits so that it becomes as 
trivial to design a robust gene circuit as it is to build an electrical one.  
 
  
5.1 References 
 
 
 174 
5.1 References 
Aguilera, A. (1986). Deletion of the phosphoglucose isomerase structural gene makes growth and sporulation 
glucose dependent in Saccharomyces cerevisiae. Mol. Gen. Genet. 204, 310–316. 
Ajikumar, P.K., Xiao, W.-H., Tyo, K.E.J., Wang, Y., Simeon, F., Leonard, E., Mucha, O., Phon, T.H., Pfeifer, 
B., and Stephanopoulos, G. (2010). Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in 
&lt;em&gt;Escherichia coli&lt;/em&gt; Science (80-. ). 330, 70 LP-74. 
Alonso-Gutierrez, J., Kim, E.-. M., Batth, T.S., Cho, N., Hu, Q., and Chan, L.J.G. (2015). Principal component 
analysis of proteomics (PCAP) as a tool to direct metabolic engineering. Metab Eng 28. 
Carbonell, P., Jervis, A.J., Robinson, C.J., Yan, C., Dunstan, M., Swainston, N., Vinaixa, M., Hollywood, K.A., 
Currin, A., Rattray, N.J.W., et al. (2018). An automated Design-Build-Test-Learn pipeline for enhanced 
microbial production of fine chemicals. Commun. Biol. 1, 66. 
Chandrasekaran, S., and Price, N.D. (2010). Probabilistic integrative modeling of genome-scale metabolic and 
regulatory networks in Escherichia coli and Mycobacterium tuberculosis. Proc Natl Acad Sci USA 107. 
Chen, Y., and Nielsen, J. (2013). Advances in metabolic pathway and strain engineering paving the way for 
sustainable production of chemical building blocks. Curr. Opin. Biotechnol. 24, 965–972. 
Costello, Z., and Martin, H.G. (2018). A machine learning approach to predict metabolic pathway dynamics 
from time-series multiomics data. Npj Syst. Biol. Appl. 4, 19. 
Cuperlovic-Culf, M. (2018). Machine Learning Methods for Analysis of Metabolic Data and Metabolic Pathway 
Modeling. Metabolites 8. 
Dueber, J.E., Wu, G.C., Malmirchegini, G.R., Moon, T.S., Petzold, C.J., Ullal, A. V, Prather, K.L.J., and 
Keasling, J.D. (2009). Synthetic protein scaffolds provide modular control over metabolic flux. Nat. 
Biotechnol. 27, 753–759. 
Ferrer-Miralles, N., Domingo-Espin, J., Corchero, J.L., Vazquez, E., and Villaverde, A. (2009). Microbial 
factories for recombinant pharmaceuticals. Microb. Cell Fact. 8, 17. 
Fong, S.S., Burgard, A.P., Herring, C.D., Knight, E.M., Blattner, F.R., Maranas, C.D., and Palsson, B.O. (2005). 
In silico design and adaptive evolution of Escherichia coli for production of lactic acid. Biotechnol. Bioeng. 91, 
5.1 References 
 
 
 175 
643–648. 
Giaever, G., Chu, A.M., Ni, L., Connelly, C., Riles, L., Veronneau, S., Dow, S., Lucau-Danila, A., Anderson, K., 
Andre, B., et al. (2002). Functional profiling of the Saccharomyces cerevisiae genome. Nature 418, 387–391. 
Heavner, B.D., Smallbone, K., Price, N.D., and Walker, L.P. (2013). Version 6 of the consensus yeast 
metabolic network refines biochemical coverage and improves model performance. Database (Oxford) 2013. 
Hucka, M., Finney, A., Sauro, H.M., Bolouri, H., Doyle, J.C., Kitano, H., Arkin, A.P., Bornstein, B.J., Bray, D., 
Cornish-Bowden, A., et al. (2003). The systems biology markup language (SBML): a medium for representation 
and exchange of biochemical network models. Bioinformatics 19, 524–531. 
Jakočiūnas, T., Bonde, I., Herrgård, M., Harrison, S.J., Kristensen, M., and Pedersen, L.E. (2015). Multiplex 
metabolic pathway engineering using CRISPR/Cas9 in Saccharomyces cerevisiae. Metab Eng 28. 
Jensen, N.B., Strucko, T., Kildegaard, K.R., David, F., Maury, J., Mortensen, U.H., Forster, J., Nielsen, J., and 
Borodina, I. (2014). EasyClone: method for iterative chromosomal integration of multiple genes in 
Saccharomyces cerevisiae. FEMS Yeast Res. 14, 238–248. 
Jessop-Fabre, M.M., Jakociunas, T., Stovicek, V., Dai, Z., Jensen, M.K., Keasling, J.D., and Borodina, I. (2016). 
EasyClone-MarkerFree: A vector toolkit for marker-less integration of genes into  Saccharomyces cerevisiae via 
CRISPR-Cas9. Biotechnol. J. 11, 1110–1117. 
Jones, J.A., Toparlak, O.D., and Koffas, M.A.G. (2015). Metabolic pathway balancing and its role in the 
production of biofuels and chemicals. Curr. Opin. Biotechnol. 33, 52–59. 
Kildegaard, K.R., Jensen, N.B., Schneider, K., Czarnotta, E., Ozdemir, E., Klein, T., Maury, J., Ebert, B.E., 
Christensen, H.B., Chen, Y., et al. (2016). Engineering and systems-level analysis of Saccharomyces cerevisiae 
for production of 3-hydroxypropionic acid via malonyl-CoA reductase-dependent pathway. Microb. Cell Fact. 
15, 53. 
Kim, S.K., Han, G.H., Seong, W., Kim, H., Kim, S.-. W., and Lee, D.-. H. (2016). CRISPR interference-guided 
balancing of a biosynthetic mevalonate pathway increases terpenoid production. Metab Eng. 
Lee, M.E., Aswani, A., Han, A.S., Tomlin, C.J., and Dueber, J.E. (2013). Expression-level optimization of a 
multi-enzyme pathway in the absence of a high-throughput assay. Nucleic Acids Res 41. 
5.1 References 
 
 
 176 
MacDonald, J.T., Barnes, C., Kitney, R.I., Freemont, P.S., and Stan, G.-B. V (2011). Computational design 
approaches and tools for synthetic biology. Integr. Biol. (Camb). 3, 97–108. 
Mans, R., Rossum, H.M., Wijsman, M., Backx, A., Kuijpers, N.G.A., and Daran-lapujade, P. (2015). 
CRISPR/Cas9: a molecular Swiss army knife for simultaneous introduction of multiple genetic modifications in 
Saccharomyces cerevisiae. FEMS Yeast Res 15. 
van Maris, A.J.A., Geertman, J.-M.A., Vermeulen, A., Groothuizen, M.K., Winkler, A.A., Piper, M.D.W., van 
Dijken, J.P., and Pronk, J.T. (2004). Directed Evolution of Pyruvate Decarboxylase-Negative Saccharomyces 
cerevisiae, Yielding a C2-Independent, Glucose-Tolerant, and Pyruvate-Hyperproducing Yeast. Appl. Environ. 
Microbiol.  70, 159–166. 
Mohd Azhar, S.H., Abdulla, R., Jambo, S.A., Marbawi, H., Gansau, J.A., Mohd Faik, A.A., and Rodrigues, K.F. 
(2017). Yeasts in sustainable bioethanol production: A review. Biochem. Biophys. Reports 10, 52–61. 
Nielsen, J. (2013). Production of biopharmaceutical proteins by yeast: Advances through metabolic engineering. 
Bioengineered 4, 207–211. 
Pérez-García, F., and Wendisch, V.F. (2018). Transport and metabolic engineering of the cell factory 
Corynebacterium glutamicum. FEMS Microbiol. Lett. 365, fny166-fny166. 
Petzold, C.J., Chan, L.J.G., Nhan, M., and Adams, P.D. (2015). Analytics for Metabolic Engineering. Front. 
Bioeng. Biotechnol. 3, 135. 
Reider Apel, A., d’Espaux, L., Wehrs, M., Sachs, D., Li, R.A., Tong, G.J., Garber, M., Nnadi, O., Zhuang, W., 
Hillson, N.J., et al. (2017). A Cas9-based toolkit to program gene expression in Saccharomyces cerevisiae. 
Nucleic Acids Res. 45, 496–508. 
Sander, J.D., and Joung, J.K. (2014). CRISPR-Cas systems for editing, regulating and targeting genomes. Nat 
Biotech 32, 347–355. 
Shih, S.C.C., Goyal, G., Kim, P.W., Koutsoubelis, N., Keasling, J.D., Adams, P.D., Hillson, N.J., and Singh, 
A.K. (2015). A Versatile Microfluidic Device for Automating Synthetic Biology. ACS Synth. Biol. 4, 1151–
1164. 
Si, T., Chao, R., Min, Y., Wu, Y., Ren, W., and Zhao, H. (2017). Automated multiplex genome-scale 
5.1 References 
 
 
 177 
engineering in yeast. Nat. Commun. 8, 15187. 
Vanegas, K.G., Lehka, B.J., and Mortensen, U.H. (2017). SWITCH: a dynamic CRISPR tool for genome 
engineering and metabolic pathway control for cell factory construction in Saccharomyces cerevisiae. Microb 
Cell Fact 16. 
Zelle, R.M., de Hulster, E., van Winden, W.A., de Waard, P., Dijkema, C., Winkler, A.A., Geertman, J.-M.A., 
van Dijken, J.P., Pronk, J.T., and van Maris, A.J.A. (2008). Malic Acid Production by Saccharomyces cerevisiae: 
Engineering of Pyruvate Carboxylation, Oxaloacetate Reduction, and Malate Export . Appl. Environ. 
Microbiol. 74, 2766–2777. 
  
5.1 References 
 
 
 178 
 
 
